data_2k52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k52 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.34 112.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.15 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.31 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 38.06 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 60.2 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.21 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 74.45 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.11 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.34 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.54 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 72.41 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.44 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 74.34 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.12 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.41 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.14 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.42 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.1 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.13 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.52 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 72.4 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.3 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.11 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.24 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.34 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.23 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.24 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 62.23 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.34 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.41 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.14 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.51 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.44 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.654 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.41 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.2 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.2 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' HB3' HD22 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.13 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.22 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.24 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.24 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.11 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.15 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.44 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.24 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.55 111.536 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.43 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.22 112.099 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 70.13 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.21 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.23 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.22 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.11 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.21 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.22 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.15 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.43 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.54 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.22 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.43 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 71.22 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.22 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.654 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 74.1 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.092 0.472 . . . . 71.23 111.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.4 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.11 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.44 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.3 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.45 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.05 111.35 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.31 109.91 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.31 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 71.01 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.54 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.1 111.617 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.54 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.03 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 72.42 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.14 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 44.52 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.42 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 63.52 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.11 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD12 ' CE1' ' A' ' 68' ' ' PHE . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.01 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.24 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 62.15 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.44 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.02 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.13 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.22 110.64 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 71.3 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.545 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.44 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.14 111.263 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.31 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.42 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.12 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.24 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.42 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 71.44 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.33 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.1 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 ' HE2' ' A' ' 38' ' ' MET . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.1 111.487 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 73.05 110.706 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.4 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.33 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.42 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.15 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.41 110.404 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 75.41 112.457 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.14 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.12 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.41 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.01 110.902 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.24 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.14 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.22 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.11 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.41 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.53 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.14 111.033 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HD12 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.41 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.45 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 72.22 110.432 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.1 pt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.05 111.988 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 66' ' ' ILE . 46.9 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.11 111.989 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 75.4 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.14 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 75.12 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.45 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.54 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.51 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.52 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 74.41 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.12 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 75.53 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.42 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 74.42 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 37.68 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 70.51 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.14 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.34 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 61.23 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.43 111.161 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.33 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.22 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.14 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 74.21 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 74.42 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.55 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.2 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.15 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.03 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.703 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.02 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 75.21 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.44 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 74.43 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.53 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.703 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.4 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.1 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.41 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HB3' HD22 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 73.41 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 74.25 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.15 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.51 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.53 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.1 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.42 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.14 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.14 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.55 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 HD21 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.24 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.34 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 75.02 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.33 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.12 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 62.31 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.04 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.41 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.13 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.2 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.54 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.4 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 64.1 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 73.52 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.13 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.11 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.567 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.53 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.45 111.186 -179.017 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.485 HG21 HG12 ' A' ' 29' ' ' VAL . 96.7 t . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 72.44 112.253 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.43 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.3 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.24 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.54 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.11 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.45 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.04 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.52 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.23 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 75.44 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 73.01 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.13 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.3 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.21 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.33 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.41 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.43 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.31 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.42 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.13 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.35 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.01 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.41 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.34 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.22 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.34 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.04 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.45 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.12 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.11 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.34 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 72.43 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.35 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.33 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 64.44 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.41 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.44 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.2 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.43 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.1 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 71.41 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.45 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.52 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.42 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.54 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.35 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.15 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.51 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.51 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.24 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.51 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.13 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.11 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 72.12 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.04 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.22 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.42 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.42 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.05 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 HG12 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.11 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.53 111.949 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.34 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD12 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.13 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.42 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 71.34 112.055 -176.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 71.42 112.347 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.24 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.44 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.14 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.34 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 74.5 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.05 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.23 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.13 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.32 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.32 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 70.43 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 61.15 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.12 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.15 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 64.14 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 36.45 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.2 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 64.1 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.22 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.35 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.43 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.21 112.448 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 36.45 114.546 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.02 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.737 HD23 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.05 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.35 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 61.23 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.3 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.692 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.12 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.737 ' SD ' HD23 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.33 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.42 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.21 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 72.53 110.467 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.11 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.24 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.34 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.53 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.42 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.3 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.14 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.32 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.11 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.31 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.23 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.2 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.44 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 71.21 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.24 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.34 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.35 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.53 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.11 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.31 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.14 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 75.41 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.24 111.135 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.22 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.44 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.692 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.561 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.2 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.44 HG23 HD12 ' A' ' 25' ' ' LEU . 91.2 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.55 112.745 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.33 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.04 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.01 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 61.02 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.03 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.1 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 63.15 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 38.65 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.43 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.33 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.52 111.744 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.23 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.42 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.14 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.31 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.42 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.22 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.11 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.11 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.12 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' A' ' 11' ' ' GLY . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 74.14 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.13 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.44 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.14 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 40.41 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.41 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.04 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.52 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.4 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.53 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.33 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.562 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.44 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 63.14 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.33 112.248 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.23 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.23 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 74.11 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.22 111.186 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.22 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.45 111.116 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.24 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.4 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.43 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.04 111.803 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.32 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.24 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.32 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.52 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.41 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.55 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.55 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.01 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.24 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.04 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.12 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.54 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.3 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.14 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.31 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.22 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 69' ' ' LYS . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.13 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.21 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 72.41 111.576 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.697 HG23 HD12 ' A' ' 25' ' ' LEU . 87.5 t . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.31 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.41 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.33 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.23 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.24 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.2 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.44 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.13 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.04 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.52 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.33 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.54 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.44 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 74.11 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.42 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.32 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 75.0 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.51 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.23 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.34 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 13' ' ' VAL . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.24 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.4 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.24 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.34 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.11 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.24 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.21 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.31 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.02 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.13 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.24 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.24 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.14 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.43 111.013 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.12 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.733 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.03 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.4 112.308 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.04 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HB3' HD22 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.34 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.13 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 71.13 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.33 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.42 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.51 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.3 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.41 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.14 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.32 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.51 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.23 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 75.31 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.13 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.52 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.31 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.11 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.14 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.14 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.54 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.45 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.43 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.33 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.41 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.33 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 74.24 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.22 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.478 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.43 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.44 111.986 -178.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.506 HG23 HG13 ' A' ' 29' ' ' VAL . 61.8 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.22 112.883 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.41 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.24 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.1 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 75.22 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 74.13 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.52 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.33 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.23 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.32 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 75.1 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.44 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.52 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.24 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.02 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.3 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.31 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.35 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.02 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.13 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.32 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 71.52 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.12 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 64.13 112.324 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.33 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.54 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.23 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.15 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.2 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.4 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.45 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.667 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.11 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.701 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.41 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.13 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.44 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 74.11 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.45 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.13 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.14 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.31 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 72.21 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.54 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.51 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.21 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.31 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.24 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.35 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.34 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.14 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.14 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.22 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.22 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.3 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.02 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 74.01 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.3 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 75.35 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.14 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.03 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 54.11 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.35 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.667 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 64.42 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.23 112.257 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.32 111.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.44 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.13 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.12 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.2 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.4 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 38.18 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.53 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.41 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.23 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 71.45 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.33 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.43 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.4 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.41 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 38.18 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 73.42 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.1 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.34 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.32 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 74.02 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.14 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.42 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.24 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.24 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.33 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.2 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.728 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 73.04 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.43 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.23 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.562 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.13 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.01 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.23 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.15 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.41 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.32 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 74.41 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.42 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.51 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.15 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.35 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.13 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.42 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.51 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.32 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.24 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 75.01 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.42 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.31 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.11 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.02 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.42 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.33 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.476 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.13 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.22 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.22 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.24 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.45 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.03 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG12 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.3 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.14 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 75.33 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.52 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.769 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 75.24 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.322 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 29' ' ' VAL . 83.9 t . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.14 111.903 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.53 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.03 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.42 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.23 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.34 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 74.32 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.04 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.33 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.33 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.441 HG23 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 71.13 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.14 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.13 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.12 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.45 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.41 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.14 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.43 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.52 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.441 ' ND2' HG23 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.21 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.24 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.35 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.24 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 73.14 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.44 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.43 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 38.24 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.23 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 HD23 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.31 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.1 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.03 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.22 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.34 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 63.34 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.21 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.12 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.34 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 73.24 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.14 111.863 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.21 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.15 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 74.33 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 65.21 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.23 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.3 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.02 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.24 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.32 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.11 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.1 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.22 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.32 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.51 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.03 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.621 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 70.52 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.54 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.4 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.35 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 63.22 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.621 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 75.33 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 74.45 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 75.14 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.51 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.13 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.32 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.31 111.366 178.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 51.11 112.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.479 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.33 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.15 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 37.21 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.13 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.22 111.008 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 75.35 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.41 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.22 113.2 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.13 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.33 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.44 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 71.32 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 63.41 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.23 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 74.35 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.01 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.21 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.44 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.41 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 72.24 109.465 170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.34 108.74 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.55 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.05 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.02 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.44 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.3 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.15 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.59 HD13 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.2 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.12 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.34 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.1 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.15 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.22 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.41 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.54 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.31 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.43 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.41 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.13 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.41 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 37.21 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.44 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.1 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.44 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.33 110.839 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.43 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' HB2' HD11 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.34 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.43 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 63.54 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.43 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.31 110.147 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.54 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.13 112.569 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.556 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.32 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.556 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.12 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 74.12 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.44 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.04 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.34 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.24 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 72.32 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 55' ' ' GLN . 10.9 pt . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 62.53 111.637 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 75.02 111.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.23 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.15 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.24 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.12 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.21 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 73.24 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.2 110.044 167.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.45 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.13 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.23 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.2 111.917 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.42 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.15 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.41 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.42 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.22 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.44 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.52 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.44 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.23 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.11 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 74.31 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.03 112.347 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.14 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 74.25 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.12 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.42 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.41 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HD3' HD13 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.13 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.11 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.3 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.23 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.14 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 64.3 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.24 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.544 HD13 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 70.4 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.32 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.3 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.31 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.44 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.11 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.44 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 74.23 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 62.1 110.71 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.44 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.35 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.33 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 70.24 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.753 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.55 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.01 112.742 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.24 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.52 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.13 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.02 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.4 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.13 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.11 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD12 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.23 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.13 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.31 112.378 -175.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 29' ' ' VAL . 74.4 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.01 112.69 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.15 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.24 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.12 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.45 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.32 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.11 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.11 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.53 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.21 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.43 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 73.42 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.55 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.33 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 73.01 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.42 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.45 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.01 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 72.13 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.52 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.42 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.22 110.464 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.11 113.224 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.495 HG12 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.44 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 75.13 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.34 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.53 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.35 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.35 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 71.51 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 64.23 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.582 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.13 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.41 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.02 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.52 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.23 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.54 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.44 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.24 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.541 HD22 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.33 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.14 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.44 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.21 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.45 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 72.44 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 HD21 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.22 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 61.2 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.42 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.01 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.3 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 52.22 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.22 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.13 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.03 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.44 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 71.24 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.44 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.54 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.11 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.34 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.492 ' HB2' HD12 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.12 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.41 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.42 111.392 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.552 ' HB2' ' HZ3' ' A' ' 7' ' ' LYS . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.42 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.44 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.42 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HZ3' ' HB2' ' A' ' 4' ' ' GLU . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.3 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 71.31 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 74.44 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 70.25 110.465 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.524 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.32 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.23 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.43 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.476 HG23 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 74.22 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.21 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.12 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.33 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.43 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.44 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.44 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.52 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.12 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' ND2' HG23 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.15 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD23 ' HA3' ' A' ' 11' ' ' GLY . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.14 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.31 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.35 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 72.24 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 71.25 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.21 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 37.71 113.781 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 55.43 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.503 HD23 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.21 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.22 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.21 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.53 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.375 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.503 ' SD ' HD23 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.41 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.52 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.4 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HB3' HD22 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.51 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.13 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.22 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.22 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.22 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.43 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.24 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.35 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.15 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 74.23 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.42 110.991 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.2 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB2' HD12 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.45 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.2 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.43 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.41 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.55 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.42 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 62.33 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 64.03 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.495 HG12 HG12 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.22 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.22 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.43 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.11 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.01 111.638 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.673 HG23 HD12 ' A' ' 25' ' ' LEU . 60.8 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 73.41 110.92 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.03 113.429 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.11 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 73.54 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.14 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.41 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 64.12 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 71.24 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.12 111.675 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 73.13 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 74.54 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.33 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.44 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.12 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.31 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.1 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.673 HD12 HG23 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.33 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.31 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 71.41 111.855 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.41 112.158 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.32 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.23 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.41 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.51 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.672 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.13 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 72.32 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.32 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.715 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 75.5 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.672 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.41 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.14 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.23 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.32 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.42 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.34 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.33 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.43 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.31 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.13 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.34 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.53 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 73.53 111.895 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.34 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.02 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.553 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.04 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.44 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.42 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.44 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.43 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.1 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.33 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.21 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.24 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.42 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 74.1 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.3 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.21 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.34 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.715 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.32 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.23 112.421 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 29' ' ' VAL . 84.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.32 111.72 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.24 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.22 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.35 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.04 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 74.13 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.43 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.11 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.03 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.33 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.11 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 71.52 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.3 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.24 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 74.21 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.15 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.34 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.14 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 74.23 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.44 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 74.14 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.41 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.53 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.44 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.33 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.448 HG12 HG23 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 37.26 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.12 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.656 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.21 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.22 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.41 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.23 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.656 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.12 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.24 112.056 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.12 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB3' HD22 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.21 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.45 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.34 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.43 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.32 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.54 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.34 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.21 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.23 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.14 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.02 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.34 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.53 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.02 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 70.12 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD1' HG23 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.34 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.35 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.41 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.44 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.04 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.51 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.03 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.45 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 74.3 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.24 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.53 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 75.12 112.316 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.21 111.41 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.03 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.54 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.44 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.51 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 72.15 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.1 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 71.21 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.04 112.98 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.03 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.4 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.52 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.34 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.21 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.33 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 73.25 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 64.04 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.4 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.01 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.35 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.34 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.42 111.166 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.11 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.13 112.989 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.22 112.855 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.43 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.11 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.13 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 72.33 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.62 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.31 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.02 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.12 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 74.54 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.62 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.4 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.31 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 63.43 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.15 112.689 -176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 75.21 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 73.32 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.14 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 54.42 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.24 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.32 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.45 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.12 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.34 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.21 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.2 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.24 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.708 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.13 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.12 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.03 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.44 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.13 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 71.12 112.19 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.14 112.191 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.34 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.14 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 75.31 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.43 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.42 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.33 110.745 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.45 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 63.41 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 73.02 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.41 112.253 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 HD12 ' A' ' 25' ' ' LEU . 62.6 t . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 72.3 111.982 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.43 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.31 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 54.22 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.13 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 75.15 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.22 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.45 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 74.03 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.53 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 62.21 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.21 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.22 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.44 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.01 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.34 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.23 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.42 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.42 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.41 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.31 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD12 HG23 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.12 110.613 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.41 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.41 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.12 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.43 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.42 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.21 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.76 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.24 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.52 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.05 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.52 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.22 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.76 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.11 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.41 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.53 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.05 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.43 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 62.22 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.53 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.03 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.22 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.18 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 75.11 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.23 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.51 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.22 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 71.44 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.31 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.24 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.43 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.54 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 75.04 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 75.03 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.55 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.53 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.42 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.33 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.53 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.53 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.13 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.31 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.31 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.625 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.54 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.04 111.729 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.41 113.216 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.12 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.44 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.52 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.23 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.437 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 75.11 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' HG11 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 75.34 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.51 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.24 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.14 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.44 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.05 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.33 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.35 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.33 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.55 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 75.15 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.22 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.51 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.1 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.04 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.24 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.32 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.23 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.31 112.036 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 63.54 112.105 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.411 HG12 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.12 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 63.3 110.79 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.34 113.264 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.12 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.679 HD23 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.21 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.32 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.24 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.12 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.21 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' HD23 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 74.15 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 75.1 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.54 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.12 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.13 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.21 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.01 111.177 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.11 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.45 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.42 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD12 HD21 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.42 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.11 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.2 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.11 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.1 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.42 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.32 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.21 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.12 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.41 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.24 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.54 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.2 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.34 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.34 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.44 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 71.45 112.178 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.44 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 74.1 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.33 111.389 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.33 112.201 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.31 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.42 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.44 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.23 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 61.52 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 35.97 113.374 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.01 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.45 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.41 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.42 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.43 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.34 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.14 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 63.21 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.53 113.514 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.41 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.3 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.04 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.52 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.44 110.252 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.42 109.588 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.42 112.16 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.45 112.406 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.23 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD22 HG13 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.21 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.23 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.22 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.43 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.44 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.02 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.34 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.33 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 75.43 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 74.44 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.34 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.24 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.35 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 62.02 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.24 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.31 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.14 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.01 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.05 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.661 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.54 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.23 111.492 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.14 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.43 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.11 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.11 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 75.0 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.622 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.1 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.33 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.24 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.13 111.306 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.3 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.41 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.55 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.661 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.21 112.652 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.743 0.306 . . . . 75.43 111.762 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.35 156.3 17.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.395 -0.366 . . . . 73.23 110.483 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t -118.92 128.67 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.34 112.04 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.15 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.31 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 38.06 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 60.2 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.21 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 74.45 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.11 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.34 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.54 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 72.41 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.44 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 74.34 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.12 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.41 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.14 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.42 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.1 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.13 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.52 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 72.4 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.3 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.11 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.24 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.34 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.23 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.24 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 62.23 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.34 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.41 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.14 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.51 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.44 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.654 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.41 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.2 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.2 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' HB3' HD22 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.13 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.22 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.24 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.24 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.11 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.15 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.44 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.24 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.55 111.536 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.43 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.22 112.099 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 70.13 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.21 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.23 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.22 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.11 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.21 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.22 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.15 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.43 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.54 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.22 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.43 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 71.22 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.22 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.654 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 74.1 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt -123.92 145.98 49.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.78 -14.73 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.446 2.097 . . . . 64.54 112.44 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tt -81.7 79.86 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.399 -0.593 . . . . 71.05 109.399 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.964 -0.541 . . . . 63.4 111.74 -176.607 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.508 0.194 . . . . 74.54 110.718 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -78.09 144.03 36.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.741 0.305 . . . . 74.13 110.33 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t -105.2 125.37 60.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.092 0.472 . . . . 71.23 111.479 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.4 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.11 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.44 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.3 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.45 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.05 111.35 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.31 109.91 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.31 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 71.01 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.54 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.1 111.617 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.54 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.03 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 72.42 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.14 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 44.52 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.42 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 63.52 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.11 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD12 ' CE1' ' A' ' 68' ' ' PHE . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.01 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.24 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 62.15 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.44 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.02 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.13 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.22 110.64 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 71.3 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.545 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.44 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.14 111.263 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.31 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.42 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.12 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.24 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.42 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 71.44 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.33 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.1 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 ' HE2' ' A' ' 38' ' ' MET . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.1 111.487 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 73.05 110.706 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.4 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.33 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.42 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.15 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.41 110.404 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 75.41 112.457 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.14 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.12 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.41 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.01 110.902 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.24 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.14 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.22 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.11 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.41 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.53 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.14 111.033 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HD12 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.41 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.45 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 72.22 110.432 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 37.1 pt -123.71 134.44 25.31 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.05 111.988 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 Cg_exo -78.24 117.37 4.09 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.758 2.305 . . . . 74.41 111.391 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD22 ' H ' ' A' ' 73' ' ' LEU . 2.2 pt? -105.4 163.96 12.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.138 0.494 . . . . 73.3 112.048 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.514 -0.755 . . . . 62.21 111.484 -179.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.706 0.289 . . . . 75.42 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -142.01 143.22 33.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.858 0.361 . . . . 74.11 110.787 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 66' ' ' ILE . 46.9 t -89.56 135.69 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.11 111.989 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 75.4 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.14 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 75.12 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.45 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.54 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.51 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.52 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 74.41 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.12 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 75.53 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.42 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 74.42 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 37.68 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 70.51 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.14 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.34 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 61.23 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.43 111.161 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.33 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.22 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.14 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 74.21 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 74.42 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.55 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.2 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.15 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.03 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.703 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.02 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 75.21 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.44 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 74.43 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.53 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.703 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.4 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.1 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.41 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HB3' HD22 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 73.41 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 74.25 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.15 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.51 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.53 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.1 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.42 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.14 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.14 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.55 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 HD21 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.24 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.34 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 75.02 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.33 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.12 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 62.31 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.04 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.41 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.13 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.2 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.54 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.4 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 64.1 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 73.52 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.13 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.11 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.567 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.53 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG12 ' OE2' ' A' ' 74' ' ' GLU . 24.3 pt -91.59 151.54 42.56 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.45 111.186 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.49 -15.81 4.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.187 2.592 . . . . 55.41 114.357 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 tp -139.74 102.62 4.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.682 0.277 . . . . 65.43 111.354 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' OE2' HG12 ' A' ' 71' ' ' ILE . 72.3 mm-40 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.761 -0.637 . . . . 73.55 111.412 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.531 0.205 . . . . 53.02 111.421 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -110.8 144.38 39.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.936 0.398 . . . . 63.14 111.0 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG21 HG12 ' A' ' 29' ' ' VAL . 96.7 t -119.23 124.98 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 72.44 112.253 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.43 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.3 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.24 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.54 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.11 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.45 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.04 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.52 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.23 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 75.44 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 73.01 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.13 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.3 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.21 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.33 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.41 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.43 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.468 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.31 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.42 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.13 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.35 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.01 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.41 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.34 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.22 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.34 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.04 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.45 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.12 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.11 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.34 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 72.43 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.35 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.33 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 64.44 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.41 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.44 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.2 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.43 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.1 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 71.41 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.45 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.52 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.42 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.54 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.35 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.15 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.51 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.51 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.24 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.51 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.13 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.11 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 72.12 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.04 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.22 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.42 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.42 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.05 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.454 HG12 HG12 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.11 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.53 111.949 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.34 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD12 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.13 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.42 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt -108.95 128.8 24.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 71.34 112.055 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 74.4 Cg_endo -75.95 91.68 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.178 1.918 . . . . 64.51 111.396 172.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.91 88.87 0.39 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.973 0.416 . . . . 73.24 110.005 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' PRO . 10.2 pt-20 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.586 -0.721 . . . . 73.35 111.695 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.722 0.296 . . . . 71.31 111.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -107.44 157.22 18.16 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.99 0.424 . . . . 55.43 110.384 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t -110.42 128.98 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 71.42 112.347 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.24 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.44 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.14 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.34 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 74.5 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.05 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.23 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.13 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.32 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.32 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 70.43 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 61.15 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.12 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.15 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 64.14 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 36.45 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.2 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 64.1 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.22 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.35 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.43 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.21 112.448 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 36.45 114.546 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.02 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.737 HD23 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.05 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.35 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 61.23 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.3 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.692 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.12 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.737 ' SD ' HD23 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.33 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.42 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.21 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 72.53 110.467 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.11 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.24 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.34 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.53 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.42 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.3 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.14 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.32 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.11 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.31 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.23 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.2 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.44 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 71.21 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.24 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.34 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.35 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.53 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.11 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.31 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.14 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 75.41 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.24 111.135 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.22 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.44 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.692 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.561 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.2 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt -131.96 144.57 53.77 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.87 114.85 3.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.45 2.1 . . . . 70.11 111.769 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.47 120.05 10.94 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.554 0.576 . . . . 51.32 112.554 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.751 -0.642 . . . . 70.23 110.828 174.064 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.683 0.277 . . . . 73.12 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.14 161.05 14.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.594 -0.275 . . . . 73.04 110.271 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.44 HG23 HD12 ' A' ' 25' ' ' LEU . 91.2 t -127.85 123.27 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.55 112.745 -173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.33 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.04 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.01 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 61.02 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.03 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.1 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 63.15 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 38.65 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.43 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.33 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.52 111.744 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.23 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.42 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.14 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.31 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.42 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.22 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.11 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.11 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.12 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' A' ' 11' ' ' GLY . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 74.14 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.13 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.44 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.14 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 40.41 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.41 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.04 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.52 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.4 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.53 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.33 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.562 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.44 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 63.14 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.33 112.248 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.23 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.23 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 74.11 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.22 111.186 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.22 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.45 111.116 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.24 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.4 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.43 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.04 111.803 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.32 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.24 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.32 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.52 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.41 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.55 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.55 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.01 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.24 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.04 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.12 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.54 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.3 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.45 HG12 HG12 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.14 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.31 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.22 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 69' ' ' LYS . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.13 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.21 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt -132.85 140.27 37.16 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 72.41 111.576 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.96 141.88 19.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.413 2.075 . . . . 71.53 112.427 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 HD21 ' N ' ' A' ' 74' ' ' GLU . 5.9 tt -126.48 132.74 51.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.825 0.345 . . . . 65.21 110.451 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' N ' HD21 ' A' ' 73' ' ' LEU . 16.2 pt-20 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.581 -0.724 . . . . 75.22 111.964 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 24.1 ttt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.769 0.319 . . . . 53.31 111.536 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -136.73 149.13 47.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.413 -0.358 . . . . 73.13 110.16 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.697 HG23 HD12 ' A' ' 25' ' ' LEU . 87.5 t -111.56 130.43 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.31 112.553 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.41 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.33 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.23 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.24 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.2 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.44 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.13 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.04 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.52 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.33 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.54 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.44 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 74.11 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.42 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.32 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 75.0 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.51 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.23 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.34 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 13' ' ' VAL . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.24 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.4 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.24 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.538 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.34 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.11 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.24 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.21 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.31 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.02 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.13 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.24 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.24 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.14 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.43 111.013 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.801 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.12 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.733 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.03 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.401 HG21 ' HG3' ' A' ' 72' ' ' PRO . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.4 112.308 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.04 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HB3' HD22 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.34 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.13 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 71.13 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.33 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.42 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.51 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.3 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.41 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.14 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.32 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.51 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.23 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 75.31 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.13 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.52 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.31 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.11 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.14 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.14 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.54 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.45 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.43 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.33 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.41 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.33 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 74.24 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.801 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.22 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.478 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.43 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.18 139.68 36.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.44 111.986 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HG3' HG21 ' A' ' 39' ' ' ILE . 7.8 Cg_exo -72.94 108.42 2.58 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.618 2.212 . . . . 75.41 111.543 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.05 106.44 11.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.069 0.461 . . . . 73.23 110.697 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.973 -0.537 . . . . 54.34 111.156 178.335 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 25.8 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.883 0.373 . . . . 74.22 111.202 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.51 133.85 13.48 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.291 -0.413 . . . . 72.13 110.11 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.506 HG23 HG13 ' A' ' 29' ' ' VAL . 61.8 t -120.54 124.46 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.22 112.883 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.41 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.24 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.1 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 75.22 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 74.13 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.52 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.33 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.23 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.32 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 75.1 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.448 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.44 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.52 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.24 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.02 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.3 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.31 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.35 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.02 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.13 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.32 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 71.52 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.12 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 64.13 112.324 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.33 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.54 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.23 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.15 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.701 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.2 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.4 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.45 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.667 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.11 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.701 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.41 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.13 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.44 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 74.11 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.45 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.13 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.14 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.31 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 72.21 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.54 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.51 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.21 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.31 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.24 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.35 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.34 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.14 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.14 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.22 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.22 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.3 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.02 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 74.01 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.3 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 75.35 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.14 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.03 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 54.11 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.35 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.667 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 64.42 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt -107.62 121.6 43.71 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.23 112.257 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 39' ' ' ILE . 54.9 Cg_endo -69.27 134.25 28.54 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.395 2.063 . . . . 65.44 112.331 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.91 126.18 30.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 71.42 110.48 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 . . . . . 0 C--O 1.255 1.342 0 CA-C-O 118.774 -0.631 . . . . 65.14 111.483 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.573 0.225 . . . . 75.4 111.276 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.68 146.07 41.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.899 0.38 . . . . 74.33 110.48 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.28 135.82 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.32 111.98 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.44 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.13 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.12 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.2 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.4 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 38.18 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.53 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.41 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.23 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 71.45 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.33 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.43 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.4 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.41 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 38.18 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 73.42 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.1 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.34 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.32 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 74.02 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.14 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.42 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.24 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.24 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.33 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.2 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.728 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 73.04 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.43 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.23 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.562 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.13 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.01 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.23 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.15 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.41 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.32 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 74.41 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.42 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.51 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.15 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.35 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.13 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.42 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.51 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.32 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.24 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 75.01 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.42 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.31 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.11 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.02 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.42 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.33 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.476 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.13 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.22 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.22 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.24 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.45 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.03 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG12 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.3 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.14 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 75.33 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.562 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.52 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.769 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 75.24 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt -132.51 133.45 23.61 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.322 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.51 75.14 2.03 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.013 1.809 . . . . 61.15 111.719 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.4 tp -71.51 130.0 40.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.862 -0.608 . . . . 74.12 111.848 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.76 -0.638 . . . . 75.11 111.597 177.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.378 0.132 . . . . 71.44 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -119.46 143.32 47.58 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.899 0.381 . . . . 73.15 111.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 29' ' ' VAL . 83.9 t -109.99 121.52 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.14 111.903 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.53 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.03 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.42 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.23 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.34 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 74.32 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.04 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.33 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.33 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 HG23 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 71.13 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.14 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.13 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.12 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.45 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.41 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.14 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.43 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.52 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' ND2' HG23 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.21 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.24 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.35 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.24 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 73.14 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.44 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.43 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 38.24 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.23 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 HD23 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.31 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.1 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.03 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.22 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.34 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 63.34 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.21 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.12 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.34 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 73.24 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.14 111.863 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.21 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.15 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 74.33 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 65.21 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.23 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.3 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.02 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.24 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.32 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.11 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.1 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.22 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.32 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.51 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.03 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.621 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 70.52 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.54 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.4 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.35 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 63.22 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.621 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 75.33 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 74.45 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 75.14 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.51 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.13 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.32 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 15.4 pt -110.49 132.17 21.69 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.31 111.366 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 12.2 Cg_exo -71.11 67.91 2.52 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.816 2.344 . . . . 72.11 112.373 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 tt -101.45 113.59 26.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.835 0.35 . . . . 75.21 110.194 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.676 -0.678 . . . . 72.14 111.806 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.881 0.372 . . . . 75.35 111.548 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 157.47 44.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.369 -0.378 . . . . 74.31 110.303 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.24 136.16 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 51.11 112.675 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.479 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.33 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.15 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 37.21 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.13 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HD2' HD12 ' A' ' 73' ' ' LEU . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.22 111.008 176.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 75.35 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.41 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.22 113.2 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.13 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.33 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.44 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 71.32 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 63.41 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.23 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 74.35 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.01 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.21 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.44 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.41 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 72.24 109.465 170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.34 108.74 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.55 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.05 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.02 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.44 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.3 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.15 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.59 HD13 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.2 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.12 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.34 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.1 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.15 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.22 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.41 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.54 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.31 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.43 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.41 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.13 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.41 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 37.21 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.44 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.1 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.44 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 73' ' ' LEU . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.33 110.839 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.43 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' HB2' HD11 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.34 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.43 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 63.54 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.43 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.31 110.147 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.54 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.13 112.569 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.556 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.32 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.556 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.12 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 74.12 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.44 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.04 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.34 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.24 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 72.32 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.9 pt -125.52 139.97 35.26 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 62.53 111.637 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 8.9 Cg_exo -73.9 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.389 2.726 . . . . 73.11 113.645 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD12 ' HD2' ' A' ' 8' ' ' PHE . 6.7 tt -74.69 127.51 33.32 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.116 -0.328 . . . . 75.53 110.116 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 112.226 0.454 . . . . 64.43 112.226 -177.298 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.607 0.241 . . . . 73.34 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -114.55 127.38 55.77 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.785 0.326 . . . . 64.23 110.498 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -89.05 127.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 75.02 111.599 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.23 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.15 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.24 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.12 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.21 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 73.24 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.2 110.044 167.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.45 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.13 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.23 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.2 111.917 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.42 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.15 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.41 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.42 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.22 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.44 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.52 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.44 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.23 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.11 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 74.31 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.03 112.347 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.14 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 74.25 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.12 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.42 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD23 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.41 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HD3' HD13 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.13 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.11 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.3 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.605 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.23 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.14 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 64.3 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.24 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.544 HD13 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 70.4 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.32 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.3 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.31 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.44 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.11 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.44 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 74.23 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 62.1 110.71 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.44 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.35 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.33 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 70.24 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.753 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.55 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.01 112.742 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.24 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.52 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.13 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.02 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.4 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.13 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.11 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD12 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.23 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.13 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt -132.84 145.6 57.79 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.31 112.378 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.93 103.27 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.556 2.171 . . . . 73.03 111.211 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.11 122.53 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.995 0.426 . . . . 74.21 112.031 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.397 -0.811 . . . . 74.3 111.436 175.781 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' A' ' 26' ' ' ASN . 57.0 ttp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.694 0.257 . . . . 74.21 111.694 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -102.36 135.03 44.7 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.543 -0.54 . . . . 55.24 109.543 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.495 HG21 HG12 ' A' ' 29' ' ' VAL . 74.4 t -94.57 125.44 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.01 112.69 -171.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.15 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.24 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.12 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.45 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.32 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.11 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.11 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.53 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.21 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.43 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 73.42 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.55 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.33 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 73.01 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.42 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.45 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.01 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 72.13 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.52 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.42 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.527 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.22 110.464 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.11 113.224 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.495 HG12 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.44 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 75.13 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.34 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.53 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD23 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.35 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.35 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 71.51 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 64.23 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.582 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.13 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.41 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.02 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.52 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.23 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.54 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.44 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.24 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.541 HD22 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.33 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.14 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.44 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.21 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.45 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 72.44 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 HD21 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.22 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 61.2 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.42 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.01 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.3 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 52.22 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.22 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.13 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.03 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.44 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 71.24 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.44 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.54 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.11 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.34 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.492 ' HB2' HD12 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.12 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.41 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt -132.77 151.07 77.41 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.42 111.392 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.51 154.56 18.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.429 2.086 . . . . 74.42 112.678 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.39 108.45 11.75 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.079 0.466 . . . . 72.33 110.291 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.792 -0.623 . . . . 73.41 111.346 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.713 0.292 . . . . 74.13 111.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.33 149.71 42.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.888 0.375 . . . . 71.34 110.258 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t -107.47 134.02 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 -170.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' HB2' ' HZ3' ' A' ' 7' ' ' LYS . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.42 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.44 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.42 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HZ3' ' HB2' ' A' ' 4' ' ' GLU . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.3 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 71.31 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 74.44 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 70.25 110.465 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.524 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.32 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.23 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.43 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 HG23 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 74.22 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.21 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.12 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.33 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.43 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.44 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.44 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.52 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.12 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' ND2' HG23 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.15 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD23 ' HA3' ' A' ' 11' ' ' GLY . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.14 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.31 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.35 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 72.24 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG12 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 71.25 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.21 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 37.71 113.781 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 55.43 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.503 HD23 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.21 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.22 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.21 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.53 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.375 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.503 ' SD ' HD23 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.41 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.52 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.4 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HB3' HD22 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.51 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.13 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.22 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.22 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.22 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.43 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.24 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.35 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.15 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 74.23 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.42 110.991 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.2 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB2' HD12 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.45 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.2 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.43 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.41 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.55 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.42 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 62.33 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 64.03 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.495 HG12 HG12 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.22 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.22 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.43 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.11 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt -130.89 144.92 55.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.01 111.638 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.16 167.49 24.79 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.085 2.523 . . . . 51.53 113.122 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 tp -149.74 124.56 9.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.141 -0.481 . . . . 73.02 110.928 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.254 -0.879 . . . . 75.43 112.455 -178.179 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 26' ' ' ASN . 42.6 ttp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.523 0.201 . . . . 74.23 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -110.05 165.89 11.37 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.195 -0.669 . . . . 71.5 109.195 170.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.673 HG23 HD12 ' A' ' 25' ' ' LEU . 60.8 t -107.79 137.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 73.41 110.92 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.03 113.429 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.11 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 73.54 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.14 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.41 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 64.12 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 71.24 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.12 111.675 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 73.13 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 74.54 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.33 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.44 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.12 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.31 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.1 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.673 HD12 HG23 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.33 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.31 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 71.41 111.855 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.41 112.158 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.32 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.23 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.41 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.51 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.672 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.13 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 72.32 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.32 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.715 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 75.5 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.672 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.41 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.14 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.23 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.32 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.42 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.34 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.33 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.43 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.31 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.13 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.34 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.53 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 73.53 111.895 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.34 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.02 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.553 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.04 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.44 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.42 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.44 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.43 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.443 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.1 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.33 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.21 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.24 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.42 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 74.1 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.3 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.21 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.34 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.715 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.32 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt -132.41 144.3 52.44 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.23 112.421 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.3 144.58 41.67 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.616 2.21 . . . . 62.32 112.739 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.47 130.27 35.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.335 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.082 -0.508 . . . . 75.03 111.904 178.277 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.601 0.239 . . . . 73.21 111.432 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -90.52 155.55 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.893 0.378 . . . . 73.45 111.111 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.448 HG23 HG12 ' A' ' 29' ' ' VAL . 84.3 t -127.16 132.13 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.32 111.72 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.24 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.22 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.35 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.04 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 74.13 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.43 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.11 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.03 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.33 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.11 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 71.52 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.3 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.24 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 74.21 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.15 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.34 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.14 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 74.23 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.44 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 74.14 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.41 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.53 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.44 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.33 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.448 HG12 HG23 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 37.26 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.12 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.656 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.21 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.22 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.41 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.23 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.656 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.12 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.582 HG13 ' HD3' ' A' ' 72' ' ' PRO . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.24 112.056 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.12 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB3' HD22 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.21 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.45 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.34 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.43 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.32 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.54 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.34 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.21 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.23 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.14 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.02 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.34 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.53 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.02 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 70.12 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD1' HG23 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.34 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.35 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.41 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.44 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.04 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.51 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.03 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.45 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 74.3 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HB2' HD13 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.24 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.53 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt -109.89 133.65 20.9 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 75.12 112.316 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.582 ' HD3' HG13 ' A' ' 39' ' ' ILE . 73.7 Cg_endo -79.77 87.14 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.142 1.895 . . . . 70.3 111.64 172.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 73' ' ' LEU . 2.5 pt? -76.57 152.09 36.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.087 -0.506 . . . . 74.53 112.108 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 115.895 -0.593 . . . . 74.55 111.623 178.052 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.663 0.268 . . . . 75.15 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.22 129.73 32.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.946 0.403 . . . . 75.02 110.963 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.07 122.83 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.21 111.41 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.03 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.54 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.44 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.51 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 72.15 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.1 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 71.21 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.04 112.98 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.03 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.4 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.504 HG23 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.52 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.34 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.21 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.33 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 73.25 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 64.04 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.4 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.01 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.35 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.34 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' HG23 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.42 111.166 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.11 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.13 112.989 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.22 112.855 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.43 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.11 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.13 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 72.33 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.62 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.31 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.02 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.12 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 74.54 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.62 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.4 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.31 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 63.43 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.15 112.689 -176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 75.21 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 73.32 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.14 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 54.42 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.24 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.32 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.45 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.12 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.34 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.21 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.2 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.24 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.708 ' HB2' HD11 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.13 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.12 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.03 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.44 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.13 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 71.12 112.19 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.14 112.191 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.34 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.14 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 75.31 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.43 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.42 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.33 110.745 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.45 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 63.41 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 73.02 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt -108.61 149.46 39.45 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.41 112.253 -174.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 109.89 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.229 1.953 . . . . 74.31 111.596 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.42 96.51 1.49 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.079 0.466 . . . . 64.11 110.702 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.834 -0.603 . . . . 72.22 111.512 179.471 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.632 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.1 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.524 0.202 . . . . 74.45 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.2 141.16 35.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.839 0.352 . . . . 71.2 110.717 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 HD12 ' A' ' 25' ' ' LEU . 62.6 t -121.91 132.21 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 72.3 111.982 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.43 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.31 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 54.22 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.13 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 75.15 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.22 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.45 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 74.03 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.53 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 62.21 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.21 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.22 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.44 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.01 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.34 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.23 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.42 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.42 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.41 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.31 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD12 HG23 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.632 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.12 110.613 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.41 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.41 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.12 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.43 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.42 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.21 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.76 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.24 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.52 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.05 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.52 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.22 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.76 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.11 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.41 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.53 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.05 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.43 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 62.22 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.53 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.03 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.22 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.18 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 75.11 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.23 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.51 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.22 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 71.44 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.31 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.24 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.43 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.54 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 75.04 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 75.03 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.55 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.53 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.42 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.33 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.53 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.53 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.13 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.31 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.31 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.625 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.54 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt -110.56 150.06 41.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.04 111.729 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.71 92.48 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 70.21 113.424 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 73' ' ' LEU . 2.4 pt? -71.5 151.43 43.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.99 0.424 . . . . 64.41 111.175 175.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.368 -0.825 . . . . 73.22 112.464 -177.068 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 111.889 0.329 . . . . 73.05 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -107.89 158.55 17.24 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.837 -0.431 . . . . 71.21 109.837 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t -106.58 144.29 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.41 113.216 -170.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.12 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.44 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.52 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.23 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.437 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 75.11 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CE2' HG11 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 75.34 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.51 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.24 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.14 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.44 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.05 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.33 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.35 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.33 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.55 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 75.15 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.22 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.51 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.1 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.04 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.24 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.32 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.23 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.31 112.036 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 63.54 112.105 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.411 HG12 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.12 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 63.3 110.79 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.34 113.264 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.12 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.679 HD23 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.21 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.32 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.24 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.12 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.21 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.679 ' SD ' HD23 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 74.15 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 75.1 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.54 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.12 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.13 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 73.24 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.21 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.49 HD21 ' N ' ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.01 111.177 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.11 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.45 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.42 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD12 HD21 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.42 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.11 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.2 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.11 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.1 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.42 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.32 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.21 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.12 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.41 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.24 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.54 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.2 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.34 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.34 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.44 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 71.45 112.178 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.44 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 74.1 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.9 125.63 32.17 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.33 111.389 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.22 83.71 0.59 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.196 1.931 . . . . 54.42 112.478 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.2 pt? -59.34 112.34 1.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.383 0.611 . . . . 72.43 111.197 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.762 -0.637 . . . . 75.1 112.199 -177.616 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.4 ttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.712 0.291 . . . . 70.4 111.586 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.19 136.76 21.56 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.14 110.598 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.25 134.19 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.33 112.201 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.31 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.42 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.44 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.427 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.23 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 61.52 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 35.97 113.374 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.01 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.45 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.41 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.42 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.43 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.34 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.14 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 63.21 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.53 113.514 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.41 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.491 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.3 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.04 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.52 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.44 110.252 174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.509 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.42 109.588 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.42 112.16 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.45 112.406 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.23 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD22 HG13 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.21 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.23 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.22 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.43 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.44 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.02 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.34 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.33 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 75.43 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 74.44 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.34 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.24 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.35 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 62.02 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.24 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.31 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.14 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.01 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.05 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.661 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.54 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.23 111.492 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.14 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.43 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.11 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.11 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 75.0 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.622 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.1 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.33 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.24 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.13 111.306 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.3 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.41 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.55 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.661 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt -119.19 148.52 45.27 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.21 112.652 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.53 127.8 16.17 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.756 2.304 . . . . 61.04 111.569 172.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.14 97.42 4.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.858 0.361 . . . . 74.05 110.821 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.688 -0.672 . . . . 62.51 111.208 175.178 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.340000000000003 112.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.149999999999999 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.310000000000002 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 31.34 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 33.509999999999998 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.209999999999994 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 70.019999999999996 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.340000000000003 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.540000000000006 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 61.43 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.25 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 73.439999999999998 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.119999999999997 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.409999999999997 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.140000000000001 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.420000000000002 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.099999999999994 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.129999999999995 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.519999999999996 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 54.32 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.299999999999997 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.109999999999999 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.239999999999995 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.340000000000003 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.230000000000004 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.240000000000002 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 51.229999999999997 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.641 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.230000000000004 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.409999999999997 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.140000000000001 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.510000000000005 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.439999999999998 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.200000000000003 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.200000000000003 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.129999999999995 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.239999999999995 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.239999999999995 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.150000000000006 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.439999999999998 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.230000000000004 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 46' ' ' LEU . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.549999999999997 111.536 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.430000000000007 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 52' ' ' ILE . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.219999999999999 112.099 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 54.140000000000001 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.209999999999994 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.230000000000004 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.219999999999999 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.109999999999999 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.209999999999994 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.219999999999999 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.150000000000006 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.430000000000007 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.540000000000006 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.219999999999999 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.430000000000007 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 64.439999999999998 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 61.229999999999997 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.092 0.472 . . . . 71.230000000000004 111.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.400000000000006 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.109999999999999 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.439999999999998 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.299999999999997 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.450000000000003 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' HD22 ' A' ' 25' ' ' LEU . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.049999999999997 111.35 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.310000000000002 109.91 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.310000000000002 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 52.119999999999997 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.540000000000006 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' VAL . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.099999999999994 111.617 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.540000000000006 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.030000000000001 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.549999999999997 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 54.310000000000002 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.140000000000001 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 41.299999999999997 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.420000000000002 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 62.140000000000001 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 9' ' ' TYR . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.009999999999998 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.239999999999995 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 54.439999999999998 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.439999999999998 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.109999999999999 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.019999999999996 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.130000000000003 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 54' ' ' VAL . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.219999999999999 110.64 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 65.510000000000005 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.439999999999998 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 36' ' ' ARG . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.140000000000001 111.263 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.310000000000002 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.120000000000005 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.239999999999995 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.420000000000002 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.409999999999997 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 62.549999999999997 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.329999999999998 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.099999999999994 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.099999999999994 111.487 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 14' ' ' THR . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 72.230000000000004 110.706 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.399999999999999 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.329999999999998 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.420000000000002 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.409999999999997 110.404 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 33' ' ' LEU . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 54.100000000000001 112.457 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.140000000000001 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.120000000000005 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.409999999999997 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 67' ' ' ASP . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.009999999999998 110.902 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.239999999999995 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.140000000000001 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.219999999999999 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.109999999999999 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.409999999999997 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.530000000000001 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.140000000000001 111.033 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.409999999999997 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.450000000000003 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 71.430000000000007 110.432 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.1 pt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.049999999999997 111.988 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 66' ' ' ILE . 46.9 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.109999999999999 111.989 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 70.439999999999998 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.140000000000001 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 63.409999999999997 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.450000000000003 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.540000000000006 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.510000000000005 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.520000000000003 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 61.240000000000002 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.120000000000005 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.420000000000002 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 64.200000000000003 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 33.229999999999997 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 64.150000000000006 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.140000000000001 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.340000000000003 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 54.149999999999999 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 17' ' ' GLU . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.430000000000007 111.161 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.329999999999998 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.140000000000001 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 64.099999999999994 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 64.150000000000006 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.549999999999997 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.200000000000003 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.150000000000006 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.030000000000001 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.020000000000003 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 74.239999999999995 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.439999999999998 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 72.140000000000001 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.530000000000001 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.399999999999999 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.100000000000001 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.409999999999997 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HB3' HD21 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 65.430000000000007 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 73.140000000000001 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.413 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.150000000000006 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.509999999999998 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.530000000000001 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.099999999999994 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.420000000000002 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.109999999999999 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.140000000000001 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.549999999999997 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.239999999999995 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.340000000000003 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 64.219999999999999 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.329999999999998 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.120000000000005 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 61.450000000000003 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 66' ' ' ILE . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.040000000000006 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.409999999999997 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.129999999999995 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.200000000000003 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.540000000000006 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.400000000000006 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 51.439999999999998 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 71.25 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.129999999999995 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.109999999999999 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.530000000000001 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.450000000000003 111.186 -179.017 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 29' ' ' VAL . 96.7 t . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 70.219999999999999 112.253 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.430000000000007 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.299999999999997 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.240000000000002 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.540000000000006 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.450000000000003 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.040000000000006 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.519999999999996 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.230000000000004 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 60.32 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 53.140000000000001 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.129999999999995 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.299999999999997 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.210000000000001 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.329999999999998 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.409999999999997 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.430000000000007 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.420000000000002 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.349999999999994 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.530000000000001 110.01 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.409999999999997 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.340000000000003 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.219999999999999 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.340000000000003 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.039999999999999 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.450000000000003 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.109999999999999 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.340000000000003 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 63.140000000000001 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.349999999999994 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.329999999999998 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 55.219999999999999 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.409999999999997 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.439999999999998 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.200000000000003 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.430000000000007 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.100000000000001 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 62.229999999999997 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.120000000000005 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.519999999999996 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.420000000000002 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.540000000000006 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.350000000000001 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.684 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HD22 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.510000000000005 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.509999999999998 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.240000000000002 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.129999999999995 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.109999999999999 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 51.509999999999998 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.040000000000006 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.219999999999999 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.420000000000002 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.049999999999997 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.109999999999999 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.109999999999999 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.530000000000001 111.949 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.340000000000003 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.129999999999995 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.420000000000002 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 65.319999999999993 112.055 -176.84 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 70.540000000000006 112.347 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.239999999999995 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.439999999999998 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.140000000000001 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.340000000000003 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.140000000000001 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 73.420000000000002 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.049999999999997 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.553 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.230000000000004 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.129999999999995 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.319999999999993 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.319999999999993 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 61.020000000000003 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 55.240000000000002 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.120000000000005 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.150000000000006 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 45.329999999999998 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 32.509999999999998 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.200000000000003 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 60.25 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.219999999999999 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.430000000000007 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.209999999999994 112.448 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.230000000000004 112.542 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 22.120000000000001 114.546 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.019999999999996 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.75 HD21 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.049999999999997 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.349999999999994 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 44.32 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.299999999999997 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.702 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.120000000000005 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.75 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.209999999999994 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 65.109999999999999 110.467 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.109999999999999 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.240000000000002 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.340000000000003 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.530000000000001 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.420000000000002 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.299999999999997 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.140000000000001 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.319999999999993 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.109999999999999 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.230000000000004 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.439999999999998 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 64.519999999999996 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.239999999999995 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.350000000000001 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.530000000000001 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.109999999999999 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.310000000000002 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.140000000000001 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 50.420000000000002 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.405 ' H ' ' HA2' ' A' ' 31' ' ' GLY . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.239999999999995 111.135 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.219999999999999 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.439999999999998 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.702 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.200000000000003 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 25' ' ' LEU . 91.2 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.549999999999997 112.745 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.329999999999998 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.040000000000006 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.009999999999998 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 52.219999999999999 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.030000000000001 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.099999999999994 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 61.439999999999998 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 23.309999999999999 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.430000000000007 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.329999999999998 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 48' ' ' VAL . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.519999999999996 111.744 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.229999999999997 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.420000000000002 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.140000000000001 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.310000000000002 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.420000000000002 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.219999999999999 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.109999999999999 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.109999999999999 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.120000000000005 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 3' ' ' VAL . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 64.239999999999995 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.129999999999995 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.140000000000001 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 30.129999999999999 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.409999999999997 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.039999999999999 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.519999999999996 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.400000000000006 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.530000000000001 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.329999999999998 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.439999999999998 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 61.25 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 46' ' ' LEU . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.329999999999998 112.248 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.230000000000004 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.471 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.230000000000004 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 72.409999999999997 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.129999999999995 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 52' ' ' ILE . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.186 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.219999999999999 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' THR . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.450000000000003 111.116 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.240000000000002 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.400000000000006 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.430000000000007 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.040000000000006 111.803 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.319999999999993 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.239999999999995 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.319999999999993 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.520000000000003 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.409999999999997 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.549999999999997 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.010000000000005 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.239999999999995 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.039999999999999 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.55 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.120000000000005 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.539999999999999 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.140000000000001 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.310000000000002 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.219999999999999 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.129999999999995 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 64.129999999999995 111.576 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 25' ' ' LEU . 87.5 t . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.310000000000002 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.409999999999997 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.329999999999998 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.229999999999997 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.239999999999995 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.439999999999998 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.129999999999995 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.040000000000006 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.520000000000003 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.329999999999998 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.539999999999999 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.439999999999998 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 70.209999999999994 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.420000000000002 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.319999999999993 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 73.299999999999997 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.509999999999998 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.230000000000004 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.239999999999995 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LEU . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.239999999999995 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.400000000000006 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.762 HD12 HG21 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.239999999999995 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.340000000000003 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.109999999999999 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.239999999999995 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.209999999999994 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.310000000000002 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.020000000000003 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.129999999999995 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.240000000000002 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.239999999999995 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.140000000000001 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 36' ' ' ARG . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.430000000000007 111.013 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.812 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.120000000000005 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.732 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.030000000000001 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.399999999999999 112.308 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.040000000000006 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.340000000000003 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.130000000000003 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 54.399999999999999 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.329999999999998 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.420000000000002 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.509999999999998 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.299999999999997 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.409999999999997 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.140000000000001 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.319999999999993 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.230000000000004 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 71.549999999999997 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.129999999999995 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.520000000000003 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.310000000000002 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.109999999999999 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.140000000000001 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.140000000000001 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.540000000000006 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.450000000000003 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.430000000000007 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.329999999999998 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.409999999999997 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG23 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.329999999999998 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 73.239999999999995 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.812 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.219999999999999 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.430000000000007 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.439999999999998 111.986 -178.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 29' ' ' VAL . 61.8 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.219999999999999 112.883 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.409999999999997 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.239999999999995 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.099999999999994 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 72.530000000000001 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 72.430000000000007 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.520000000000003 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.329999999999998 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.230000000000004 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.319999999999993 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 74.400000000000006 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.468 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.519999999999996 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.019999999999996 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.299999999999997 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.310000000000002 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.349999999999994 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.019999999999996 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.129999999999995 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.319999999999993 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 54.009999999999998 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.119999999999997 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 55.25 112.324 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.329999999999998 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.540000000000006 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.230000000000004 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.150000000000006 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.200000000000003 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.400000000000006 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.450000000000003 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.666 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.109999999999999 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.71 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.409999999999997 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.129999999999995 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 51.420000000000002 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.450000000000003 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.607 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.129999999999995 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.140000000000001 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.310000000000002 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 60.030000000000001 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.540000000000006 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.510000000000005 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.209999999999994 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.310000000000002 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.349999999999994 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.340000000000003 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.140000000000001 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.140000000000001 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.219999999999999 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.219999999999999 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.299999999999997 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.019999999999996 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 64.439999999999998 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.299999999999997 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 72.040000000000006 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.140000000000001 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.421 HG23 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.030000000000001 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 42.299999999999997 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.349999999999994 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 63.100000000000001 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.129999999999995 112.257 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.319999999999993 111.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.439999999999998 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.439999999999998 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.129999999999995 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.120000000000005 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.200000000000003 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.399999999999999 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 33.439999999999998 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.530000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.409999999999997 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.230000000000004 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 65.140000000000001 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.329999999999998 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.430000000000007 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.409999999999997 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 33.399999999999999 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 42.200000000000003 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.099999999999994 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.340000000000003 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.319999999999993 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 71.140000000000001 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.140000000000001 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.420000000000002 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.239999999999995 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.239999999999995 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.329999999999998 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.200000000000003 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 61.539999999999999 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.430000000000007 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.230000000000004 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.129999999999995 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.786 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.010000000000005 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.230000000000004 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.150000000000006 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.409999999999997 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.319999999999993 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 64.519999999999996 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.420000000000002 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.510000000000005 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.150000000000006 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.350000000000001 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.129999999999995 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.420000000000002 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.510000000000005 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.319999999999993 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.239999999999995 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 53.509999999999998 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.420000000000002 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.310000000000002 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.109999999999999 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.019999999999996 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.420000000000002 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.329999999999998 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.501 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.129999999999995 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.219999999999999 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.219999999999999 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.239999999999995 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.450000000000003 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.299999999999997 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.140000000000001 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 73.439999999999998 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.519999999999996 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.786 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 70.430000000000007 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.322 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 29' ' ' VAL . 83.9 t . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.140000000000001 111.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.530000000000001 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.030000000000001 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.420000000000002 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.230000000000004 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.340000000000003 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 72.129999999999995 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.039999999999999 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.329999999999998 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.329999999999998 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.447 HG21 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 64.329999999999998 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.140000000000001 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.120000000000005 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.450000000000003 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.409999999999997 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.140000000000001 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.519999999999996 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.209999999999994 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.239999999999995 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.350000000000001 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.239999999999995 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 63.229999999999997 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.439999999999998 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 15.5 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.310000000000002 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.100000000000001 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.030000000000001 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.219999999999999 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.688 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 62.409999999999997 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.209999999999994 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.120000000000005 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.340000000000003 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 62.329999999999998 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.140000000000001 111.863 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.209999999999994 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.150000000000006 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 62.130000000000003 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 45.25 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.230000000000004 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.299999999999997 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.019999999999996 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.319999999999993 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.109999999999999 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.099999999999994 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.219999999999999 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.319999999999993 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.510000000000005 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.030000000000001 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.62 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 63.119999999999997 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.540000000000006 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.399999999999999 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.349999999999994 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 62.039999999999999 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.62 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 61.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 55.539999999999999 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 74.109999999999999 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.510000000000005 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.129999999999995 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.319999999999993 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.310000000000002 111.366 178.588 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 43.420000000000002 112.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.329999999999998 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.150000000000006 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 30.23 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.129999999999995 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.219999999999999 111.008 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 72.239999999999995 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 113.2 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.129999999999995 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.329999999999998 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.439999999999998 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 70.540000000000006 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 60.340000000000003 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.230000000000004 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 64.450000000000003 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.009999999999998 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.209999999999994 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.409999999999997 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA3' ' A' ' 11' ' ' GLY . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 63.200000000000003 109.465 170.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.340000000000003 108.74 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.549999999999997 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.049999999999997 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.020000000000003 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.439999999999998 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.299999999999997 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.150000000000006 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.59 HD11 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.540000000000006 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.200000000000003 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.120000000000005 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.340000000000003 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.099999999999994 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD11 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.150000000000006 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.219999999999999 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.409999999999997 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.614 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.540000000000006 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.129999999999995 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.310000000000002 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.430000000000007 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.409999999999997 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.129999999999995 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.409999999999997 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 32.039999999999999 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.439999999999998 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.100000000000001 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.439999999999998 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.329999999999998 110.839 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.430000000000007 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HB2' HD13 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.340000000000003 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.430000000000007 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 40.119999999999997 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.310000000000002 110.147 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.540000000000006 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.130000000000003 112.569 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.319999999999993 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.120000000000005 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 73.140000000000001 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.439999999999998 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.040000000000006 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.340000000000003 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.239999999999995 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 65.409999999999997 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 55' ' ' GLN . 10.9 pt . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 60.32 111.637 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 53.210000000000001 111.599 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.229999999999997 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.150000000000006 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.239999999999995 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.120000000000005 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.209999999999994 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 64.239999999999995 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.200000000000003 110.044 167.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.450000000000003 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.129999999999995 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.230000000000004 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.200000000000003 111.917 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.420000000000002 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.150000000000006 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.409999999999997 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.420000000000002 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.219999999999999 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.439999999999998 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.519999999999996 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.439999999999998 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.229999999999997 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.109999999999999 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 71.299999999999997 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.030000000000001 112.347 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.140000000000001 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 70.239999999999995 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.120000000000005 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.409999999999997 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.129999999999995 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.109999999999999 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.299999999999997 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.230000000000004 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.140000000000001 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 61.140000000000001 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.239999999999995 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 63.329999999999998 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.319999999999993 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.299999999999997 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.310000000000002 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.130000000000003 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.439999999999998 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.109999999999999 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.439999999999998 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 53.310000000000002 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 61.299999999999997 110.71 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.439999999999998 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.349999999999994 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.329999999999998 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 43.200000000000003 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.753 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.549999999999997 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.010000000000005 112.742 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.519999999999996 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.129999999999995 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.019999999999996 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.400000000000006 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.129999999999995 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.109999999999999 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.230000000000004 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.635 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.129999999999995 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.310000000000002 112.378 -175.967 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 29' ' ' VAL . 74.4 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.010000000000005 112.69 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.150000000000006 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.239999999999995 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.119999999999997 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.450000000000003 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.319999999999993 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.109999999999999 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.109999999999999 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.530000000000001 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.210000000000001 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.430000000000007 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 71.450000000000003 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.549999999999997 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.329999999999998 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 71.530000000000001 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.420000000000002 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.450000000000003 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.010000000000005 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.617 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 71.0 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.439999999999998 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.520000000000003 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.420000000000002 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.219999999999999 110.464 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.109999999999999 113.224 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.439999999999998 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 73.109999999999999 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.340000000000003 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.530000000000001 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.349999999999994 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.350000000000001 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 61.229999999999997 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 63.039999999999999 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.129999999999995 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.409999999999997 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.020000000000003 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.519999999999996 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.230000000000004 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.540000000000006 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.439999999999998 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.240000000000002 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.140000000000001 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.439999999999998 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.210000000000001 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.450000000000003 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 70.129999999999995 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 54.329999999999998 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.420000000000002 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.299999999999997 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 51.329999999999998 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.219999999999999 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.129999999999995 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.030000000000001 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.439999999999998 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 45.130000000000003 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.439999999999998 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.540000000000006 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.109999999999999 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.219999999999999 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.120000000000005 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.409999999999997 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.420000000000002 111.392 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.239999999999995 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.420000000000002 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.040000000000006 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.420000000000002 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.299999999999997 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 70.120000000000005 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 63.140000000000001 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 50.219999999999999 110.465 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.547 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.319999999999993 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.229999999999997 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.483 HG21 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 64.340000000000003 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.209999999999994 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.119999999999997 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.329999999999998 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.439999999999998 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.439999999999998 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.329999999999998 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.149999999999999 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 3' ' ' VAL . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.140000000000001 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.310000000000002 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.349999999999994 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 64.5 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 61.340000000000003 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.209999999999994 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 23.440000000000001 113.781 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 54.210000000000001 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.209999999999994 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.219999999999999 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.209999999999994 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.530000000000001 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.519999999999996 111.375 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.409999999999997 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.520000000000003 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.400000000000006 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HB3' HD21 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.510000000000005 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.129999999999995 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.219999999999999 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.219999999999999 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.219999999999999 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.430000000000007 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.349999999999994 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.149999999999999 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 51.32 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.420000000000002 110.991 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.200000000000003 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.450000000000003 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.200000000000003 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.430000000000007 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.409999999999997 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.549999999999997 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.420000000000002 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 61.219999999999999 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 63.310000000000002 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.219999999999999 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.219999999999999 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.430000000000007 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HB2' HD11 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.109999999999999 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.010000000000005 111.638 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 25' ' ' LEU . 60.8 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 63.119999999999997 110.92 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.030000000000001 113.429 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.109999999999999 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 72.040000000000006 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.140000000000001 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.409999999999997 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 44.020000000000003 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 70.0 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' VAL . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.120000000000005 111.675 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' HG22 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 70.239999999999995 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 64.209999999999994 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.329999999999998 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.439999999999998 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.119999999999997 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.310000000000002 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.099999999999994 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.329999999999998 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.310000000000002 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 64.030000000000001 111.855 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.409999999999997 112.158 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.319999999999993 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.230000000000004 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.409999999999997 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.509999999999998 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.681 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.0 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 71.420000000000002 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.319999999999993 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.711 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 64.310000000000002 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.681 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.409999999999997 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.140000000000001 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.229999999999997 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.319999999999993 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.420000000000002 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.340000000000003 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.329999999999998 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.430000000000007 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.310000000000002 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.130000000000003 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.340000000000003 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.530000000000001 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 63.119999999999997 111.895 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.340000000000003 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.019999999999996 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.439999999999998 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.439999999999998 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.430000000000007 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.099999999999994 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.329999999999998 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.209999999999994 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.240000000000002 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.420000000000002 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 73.409999999999997 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.140000000000001 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.210000000000001 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.340000000000003 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.319999999999993 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.230000000000004 112.421 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 29' ' ' VAL . 84.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.319999999999993 111.72 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.240000000000002 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.219999999999999 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.349999999999994 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.040000000000006 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 72.140000000000001 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.430000000000007 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.109999999999999 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.030000000000001 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.329999999999998 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.109999999999999 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 64.519999999999996 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.299999999999997 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.239999999999995 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 64.340000000000003 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.340000000000003 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.140000000000001 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 64.310000000000002 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.439999999999998 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 64.209999999999994 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.409999999999997 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.530000000000001 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.439999999999998 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.329999999999998 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 15.42 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.120000000000005 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.209999999999994 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.219999999999999 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.409999999999997 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.230000000000004 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.676 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.120000000000005 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.239999999999995 112.056 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.119999999999997 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.209999999999994 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.450000000000003 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.340000000000003 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.430000000000007 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.319999999999993 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.540000000000006 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.340000000000003 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.210000000000001 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.140000000000001 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.019999999999996 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.340000000000003 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.020000000000003 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 53.039999999999999 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.350000000000001 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.409999999999997 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.439999999999998 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.040000000000006 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.510000000000005 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.030000000000001 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.450000000000003 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 73.420000000000002 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.239999999999995 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.530000000000001 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 53.119999999999997 112.316 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.209999999999994 111.41 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.030000000000001 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.540000000000006 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.439999999999998 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.510000000000005 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.447 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 63.119999999999997 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.100000000000001 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 51.020000000000003 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.039999999999999 112.98 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.030000000000001 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.400000000000006 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.512 HG21 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.519999999999996 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.209999999999994 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.329999999999998 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 55.009999999999998 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 61.229999999999997 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.010000000000005 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.349999999999994 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.340000000000003 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' ND2' HG21 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 11' ' ' GLY . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 111.166 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.129999999999995 112.989 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.219999999999999 112.855 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.430000000000007 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.109999999999999 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.130000000000003 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 54.420000000000002 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.310000000000002 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.019999999999996 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.120000000000005 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 63.509999999999998 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.349999999999994 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.400000000000006 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.310000000000002 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 53.310000000000002 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.150000000000006 112.689 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.209999999999994 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 54.240000000000002 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 65.040000000000006 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.140000000000001 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 51.25 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.240000000000002 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.319999999999993 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.450000000000003 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.120000000000005 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.340000000000003 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.209999999999994 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.200000000000003 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.239999999999995 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.129999999999995 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.119999999999997 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.030000000000001 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.439999999999998 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.129999999999995 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 70.530000000000001 112.19 -175.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.140000000000001 112.191 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.340000000000003 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.140000000000001 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 72.439999999999998 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.430000000000007 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.420000000000002 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.329999999999998 110.745 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.450000000000003 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 62.340000000000003 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 71.430000000000007 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.409999999999997 112.253 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 25' ' ' LEU . 62.6 t . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 64.329999999999998 111.982 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.430000000000007 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.310000000000002 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 42.130000000000003 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.129999999999995 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 72.209999999999994 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.219999999999999 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.450000000000003 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.530000000000001 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 53.520000000000003 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.439999999999998 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.009999999999998 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.229999999999997 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.420000000000002 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.420000000000002 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.310000000000002 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.120000000000005 110.613 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.409999999999997 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.409999999999997 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.120000000000005 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.430000000000007 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.420000000000002 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.209999999999994 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.767 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.239999999999995 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.520000000000003 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.049999999999997 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.519999999999996 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.219999999999999 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.767 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.109999999999999 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.409999999999997 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.530000000000001 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.049999999999997 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 61.100000000000001 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.530000000000001 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.030000000000001 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.219999999999999 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 111.18 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 74.030000000000001 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.229999999999997 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.510000000000005 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.219999999999999 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 62.100000000000001 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.310000000000002 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.239999999999995 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.430000000000007 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.540000000000006 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 73.420000000000002 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 73.349999999999994 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.549999999999997 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.530000000000001 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.420000000000002 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.329999999999998 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.530000000000001 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.530000000000001 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.129999999999995 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.310000000000002 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.310000000000002 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.639 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.540000000000006 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.040000000000006 111.729 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.409999999999997 113.216 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.119999999999997 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.32 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.519999999999996 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.230000000000004 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 72.510000000000005 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 73.200000000000003 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.510000000000005 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.240000000000002 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.140000000000001 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.439999999999998 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.049999999999997 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.329999999999998 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.349999999999994 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.329999999999998 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.549999999999997 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 73.420000000000002 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.219999999999999 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.510000000000005 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.099999999999994 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.040000000000006 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.239999999999995 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.319999999999993 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.230000000000004 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 112.036 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 54.229999999999997 112.105 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.120000000000005 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 54.350000000000001 110.79 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 30' ' ' ARG . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.340000000000003 113.264 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.120000000000005 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.687 HD21 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.209999999999994 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.319999999999993 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.239999999999995 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.119999999999997 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.209999999999994 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.687 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 72.310000000000002 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.540000000000006 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.120000000000005 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.129999999999995 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 64.209999999999994 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.209999999999994 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.009999999999998 111.177 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.109999999999999 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.450000000000003 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.420000000000002 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.109999999999999 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.200000000000003 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.109999999999999 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.099999999999994 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.319999999999993 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.209999999999994 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.120000000000005 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.409999999999997 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.239999999999995 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.540000000000006 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.200000000000003 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.340000000000003 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.340000000000003 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.439999999999998 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 64.310000000000002 112.178 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.439999999999998 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 62.539999999999999 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.329999999999998 111.389 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 59' ' ' VAL . 92.4 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.329999999999998 112.201 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.310000000000002 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.420000000000002 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.439999999999998 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 50.340000000000003 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 31.329999999999998 113.374 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.010000000000005 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.450000000000003 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.409999999999997 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.420000000000002 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.430000000000007 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.140000000000001 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 61.420000000000002 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.530000000000001 113.514 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.409999999999997 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.299999999999997 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.040000000000006 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.520000000000003 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 11' ' ' GLY . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 110.252 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.420000000000002 109.588 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.420000000000002 112.16 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.450000000000003 112.406 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.340000000000003 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.329999999999998 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.229999999999997 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.209999999999994 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.230000000000004 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.219999999999999 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.430000000000007 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.439999999999998 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.019999999999996 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.340000000000003 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.329999999999998 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 62.0 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 70.219999999999999 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.340000000000003 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.239999999999995 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.349999999999994 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 45.030000000000001 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.239999999999995 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.310000000000002 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.140000000000001 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.229999999999997 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.010000000000005 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.049999999999997 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.540000000000006 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.229999999999997 111.492 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.140000000000001 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.430000000000007 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.109999999999999 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.109999999999999 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 63.229999999999997 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.099999999999994 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.329999999999998 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.239999999999995 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.239999999999995 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.129999999999995 111.306 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.299999999999997 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.409999999999997 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.549999999999997 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.210000000000001 112.652 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.743 0.306 . . . . 75.430000000000007 111.762 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.35 156.3 17.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.395 -0.366 . . . . 73.230000000000004 110.483 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t -118.92 128.67 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.340000000000003 112.04 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.149999999999999 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.310000000000002 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 31.34 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 33.509999999999998 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.209999999999994 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 70.019999999999996 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.340000000000003 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.540000000000006 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 61.43 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.25 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 73.439999999999998 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.119999999999997 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.409999999999997 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.140000000000001 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.420000000000002 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.099999999999994 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.129999999999995 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.519999999999996 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 54.32 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.299999999999997 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.109999999999999 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.239999999999995 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.340000000000003 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.230000000000004 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.240000000000002 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 51.229999999999997 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.641 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.230000000000004 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.409999999999997 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.140000000000001 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.510000000000005 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.439999999999998 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.200000000000003 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.200000000000003 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.129999999999995 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.239999999999995 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.239999999999995 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.150000000000006 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.439999999999998 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.230000000000004 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 46' ' ' LEU . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.549999999999997 111.536 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.430000000000007 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 52' ' ' ILE . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.219999999999999 112.099 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 54.140000000000001 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.209999999999994 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.230000000000004 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.219999999999999 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.109999999999999 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.209999999999994 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.219999999999999 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.150000000000006 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.430000000000007 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.540000000000006 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.219999999999999 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.430000000000007 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 64.439999999999998 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.219999999999999 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 61.229999999999997 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt -123.92 145.98 49.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.78 -14.73 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.446 2.097 . . . . 64.540000000000006 112.44 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tt -81.7 79.86 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.399 -0.593 . . . . 71.049999999999997 109.399 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.964 -0.541 . . . . 63.399999999999999 111.74 -176.607 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.508 0.194 . . . . 74.540000000000006 110.718 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -78.09 144.03 36.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.741 0.305 . . . . 63.539999999999999 110.33 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t -105.2 125.37 60.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.092 0.472 . . . . 71.230000000000004 111.479 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.400000000000006 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.109999999999999 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.439999999999998 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.299999999999997 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.450000000000003 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' HD22 ' A' ' 25' ' ' LEU . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.049999999999997 111.35 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.310000000000002 109.91 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.310000000000002 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 52.119999999999997 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.540000000000006 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' VAL . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.099999999999994 111.617 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.540000000000006 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.030000000000001 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.549999999999997 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 54.310000000000002 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.140000000000001 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 41.299999999999997 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.420000000000002 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 62.140000000000001 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 9' ' ' TYR . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.009999999999998 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.239999999999995 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 54.439999999999998 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.439999999999998 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.109999999999999 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.019999999999996 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.130000000000003 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 54' ' ' VAL . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.219999999999999 110.64 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 65.510000000000005 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.439999999999998 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 36' ' ' ARG . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.140000000000001 111.263 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.310000000000002 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.120000000000005 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.239999999999995 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.420000000000002 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.409999999999997 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 62.549999999999997 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.329999999999998 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.099999999999994 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.099999999999994 111.487 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 14' ' ' THR . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 72.230000000000004 110.706 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.399999999999999 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.329999999999998 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.420000000000002 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.409999999999997 110.404 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 33' ' ' LEU . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 54.100000000000001 112.457 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.140000000000001 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.120000000000005 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.409999999999997 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 67' ' ' ASP . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.009999999999998 110.902 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.239999999999995 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.140000000000001 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.219999999999999 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.109999999999999 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.409999999999997 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.530000000000001 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.140000000000001 111.033 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.409999999999997 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.450000000000003 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 71.430000000000007 110.432 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 37.1 pt -123.71 134.44 25.31 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.049999999999997 111.988 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 Cg_exo -78.24 117.37 4.09 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.758 2.305 . . . . 74.409999999999997 111.391 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.2 pt? -105.4 163.96 12.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.138 0.494 . . . . 73.299999999999997 112.048 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.514 -0.755 . . . . 62.210000000000001 111.484 -179.23 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.706 0.289 . . . . 75.420000000000002 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -142.01 143.22 33.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.858 0.361 . . . . 74.109999999999999 110.787 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 66' ' ' ILE . 46.9 t -89.56 135.69 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.109999999999999 111.989 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 70.439999999999998 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.140000000000001 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 63.409999999999997 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.450000000000003 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.540000000000006 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.510000000000005 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.520000000000003 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 61.240000000000002 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.120000000000005 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.420000000000002 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 64.200000000000003 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 33.229999999999997 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 64.150000000000006 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.140000000000001 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.340000000000003 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 54.149999999999999 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 17' ' ' GLU . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.430000000000007 111.161 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.329999999999998 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.140000000000001 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 64.099999999999994 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 64.150000000000006 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.549999999999997 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.200000000000003 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.150000000000006 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.030000000000001 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.020000000000003 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 74.239999999999995 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.439999999999998 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 72.140000000000001 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.530000000000001 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.399999999999999 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.100000000000001 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.409999999999997 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HB3' HD21 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 65.430000000000007 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 73.140000000000001 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.413 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.150000000000006 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.509999999999998 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.530000000000001 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.099999999999994 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.420000000000002 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.109999999999999 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.140000000000001 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.549999999999997 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.239999999999995 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.340000000000003 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 64.219999999999999 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.329999999999998 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.120000000000005 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 61.450000000000003 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 66' ' ' ILE . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.040000000000006 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.409999999999997 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.129999999999995 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.200000000000003 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.540000000000006 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.400000000000006 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 51.439999999999998 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 71.25 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.129999999999995 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.109999999999999 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.530000000000001 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.458 HG12 ' OE2' ' A' ' 74' ' ' GLU . 24.3 pt -91.59 151.54 42.56 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.450000000000003 111.186 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.49 -15.81 4.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.187 2.592 . . . . 53.450000000000003 114.357 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 tp -139.74 102.62 4.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.682 0.277 . . . . 65.430000000000007 111.354 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' OE2' HG12 ' A' ' 71' ' ' ILE . 72.3 mm-40 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.761 -0.637 . . . . 72.239999999999995 111.412 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.531 0.205 . . . . 53.020000000000003 111.421 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -110.8 144.38 39.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.936 0.398 . . . . 63.140000000000001 111.0 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 29' ' ' VAL . 96.7 t -119.23 124.98 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 70.219999999999999 112.253 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.430000000000007 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.299999999999997 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.240000000000002 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.540000000000006 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.450000000000003 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.040000000000006 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.519999999999996 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.230000000000004 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 60.32 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 53.140000000000001 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.129999999999995 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.299999999999997 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.210000000000001 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.329999999999998 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.409999999999997 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.430000000000007 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.420000000000002 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.349999999999994 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.530000000000001 110.01 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.409999999999997 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.340000000000003 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.219999999999999 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.340000000000003 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.039999999999999 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.450000000000003 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.109999999999999 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.340000000000003 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 63.140000000000001 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.349999999999994 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.329999999999998 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 55.219999999999999 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.409999999999997 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.439999999999998 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.200000000000003 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.430000000000007 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.100000000000001 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 62.229999999999997 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.120000000000005 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.519999999999996 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.420000000000002 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.540000000000006 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.350000000000001 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.684 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HD22 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.510000000000005 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.509999999999998 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.240000000000002 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.129999999999995 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.109999999999999 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 51.509999999999998 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.040000000000006 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.219999999999999 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.420000000000002 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.049999999999997 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.109999999999999 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.109999999999999 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.530000000000001 111.949 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.340000000000003 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.129999999999995 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.420000000000002 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt -108.95 128.8 24.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 65.319999999999993 112.055 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 74.4 Cg_endo -75.95 91.68 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.178 1.918 . . . . 64.510000000000005 111.396 172.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.91 88.87 0.39 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.973 0.416 . . . . 73.239999999999995 110.005 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 72' ' ' PRO . 10.2 pt-20 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.586 -0.721 . . . . 73.349999999999994 111.695 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.722 0.296 . . . . 71.310000000000002 111.718 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -107.44 157.22 18.16 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.99 0.424 . . . . 55.43 110.384 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t -110.42 128.98 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 70.540000000000006 112.347 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.239999999999995 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.439999999999998 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.140000000000001 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.340000000000003 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.140000000000001 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 73.420000000000002 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.049999999999997 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.553 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.230000000000004 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.129999999999995 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.319999999999993 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.319999999999993 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 61.020000000000003 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 55.240000000000002 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.120000000000005 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.150000000000006 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 45.329999999999998 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 32.509999999999998 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.200000000000003 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 60.25 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.219999999999999 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.349999999999994 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.430000000000007 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.209999999999994 112.448 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.230000000000004 112.542 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 22.120000000000001 114.546 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.019999999999996 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.75 HD21 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.049999999999997 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.349999999999994 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 44.32 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.299999999999997 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.702 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.120000000000005 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.75 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.420000000000002 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.209999999999994 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 65.109999999999999 110.467 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.109999999999999 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.240000000000002 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.340000000000003 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.530000000000001 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.420000000000002 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.299999999999997 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.140000000000001 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.319999999999993 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.109999999999999 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.310000000000002 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.230000000000004 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.439999999999998 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 64.519999999999996 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.239999999999995 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.350000000000001 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.530000000000001 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.109999999999999 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.310000000000002 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.140000000000001 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 50.420000000000002 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.405 ' H ' ' HA2' ' A' ' 31' ' ' GLY . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.239999999999995 111.135 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.219999999999999 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.439999999999998 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.702 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.200000000000003 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt -131.96 144.57 53.77 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.87 114.85 3.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.45 2.1 . . . . 70.109999999999999 111.769 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.47 120.05 10.94 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.554 0.576 . . . . 51.32 112.554 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.751 -0.642 . . . . 70.230000000000004 110.828 174.064 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.683 0.277 . . . . 73.120000000000005 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.14 161.05 14.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.594 -0.275 . . . . 73.040000000000006 110.271 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 25' ' ' LEU . 91.2 t -127.85 123.27 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.549999999999997 112.745 -173.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.329999999999998 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.040000000000006 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.009999999999998 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 52.219999999999999 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.030000000000001 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.099999999999994 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 61.439999999999998 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 23.309999999999999 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.430000000000007 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.329999999999998 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 48' ' ' VAL . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.519999999999996 111.744 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.229999999999997 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.420000000000002 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.140000000000001 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.310000000000002 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.420000000000002 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.219999999999999 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.109999999999999 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.109999999999999 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.120000000000005 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 3' ' ' VAL . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 64.239999999999995 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.129999999999995 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.140000000000001 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 30.129999999999999 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.409999999999997 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.039999999999999 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.519999999999996 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.400000000000006 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.530000000000001 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.329999999999998 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.439999999999998 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 61.25 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 46' ' ' LEU . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.329999999999998 112.248 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.230000000000004 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.471 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.230000000000004 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 72.409999999999997 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.129999999999995 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 52' ' ' ILE . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.186 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.219999999999999 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' THR . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.450000000000003 111.116 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.240000000000002 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.400000000000006 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.430000000000007 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.040000000000006 111.803 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.319999999999993 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.239999999999995 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.319999999999993 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.520000000000003 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.409999999999997 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.549999999999997 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.010000000000005 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.239999999999995 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.039999999999999 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.55 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.120000000000005 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.539999999999999 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.140000000000001 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.310000000000002 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.219999999999999 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.129999999999995 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt -132.85 140.27 37.16 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 64.129999999999995 111.576 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.96 141.88 19.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.413 2.075 . . . . 71.530000000000001 112.427 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 74' ' ' GLU . 5.9 tt -126.48 132.74 51.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.825 0.345 . . . . 65.209999999999994 110.451 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' N ' HD23 ' A' ' 73' ' ' LEU . 16.2 pt-20 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.581 -0.724 . . . . 50.32 111.964 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 24.1 ttt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.769 0.319 . . . . 53.310000000000002 111.536 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -136.73 149.13 47.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.413 -0.358 . . . . 73.129999999999995 110.16 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 25' ' ' LEU . 87.5 t -111.56 130.43 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.310000000000002 112.553 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.409999999999997 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.329999999999998 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.229999999999997 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.239999999999995 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.439999999999998 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.129999999999995 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.040000000000006 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.520000000000003 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.329999999999998 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.539999999999999 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.439999999999998 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 70.209999999999994 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.420000000000002 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.319999999999993 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 73.299999999999997 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.509999999999998 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.230000000000004 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.239999999999995 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LEU . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.239999999999995 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.400000000000006 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.762 HD12 HG21 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.239999999999995 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.340000000000003 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.109999999999999 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.239999999999995 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.209999999999994 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.310000000000002 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.020000000000003 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.129999999999995 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.240000000000002 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.239999999999995 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.140000000000001 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 36' ' ' ARG . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.430000000000007 111.013 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.812 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.120000000000005 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.732 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.030000000000001 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 72' ' ' PRO . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.399999999999999 112.308 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.040000000000006 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.340000000000003 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.130000000000003 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 54.399999999999999 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.329999999999998 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.420000000000002 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.509999999999998 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.299999999999997 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.409999999999997 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.140000000000001 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.319999999999993 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.230000000000004 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 71.549999999999997 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.129999999999995 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.520000000000003 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.310000000000002 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.109999999999999 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.140000000000001 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.140000000000001 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.540000000000006 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.450000000000003 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.430000000000007 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.329999999999998 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.409999999999997 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG23 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.329999999999998 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 73.239999999999995 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.812 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.219999999999999 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.430000000000007 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.18 139.68 36.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.439999999999998 111.986 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HG3' HG21 ' A' ' 39' ' ' ILE . 7.8 Cg_exo -72.94 108.42 2.58 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.618 2.212 . . . . 75.409999999999997 111.543 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.05 106.44 11.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.069 0.461 . . . . 73.230000000000004 110.697 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.973 -0.537 . . . . 51.409999999999997 111.156 178.335 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 25.8 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.883 0.373 . . . . 74.219999999999999 111.202 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.51 133.85 13.48 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.291 -0.413 . . . . 72.129999999999995 110.11 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 29' ' ' VAL . 61.8 t -120.54 124.46 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.219999999999999 112.883 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.409999999999997 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.239999999999995 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.099999999999994 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 72.530000000000001 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 72.430000000000007 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.520000000000003 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.329999999999998 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.230000000000004 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.319999999999993 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 74.400000000000006 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.468 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.519999999999996 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.019999999999996 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.299999999999997 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.310000000000002 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.349999999999994 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.019999999999996 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.129999999999995 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.319999999999993 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 54.009999999999998 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.565 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.119999999999997 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 55.25 112.324 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.329999999999998 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.540000000000006 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.230000000000004 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.150000000000006 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.200000000000003 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.400000000000006 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.450000000000003 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.666 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.109999999999999 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.71 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.409999999999997 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.129999999999995 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 51.420000000000002 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.450000000000003 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.607 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.129999999999995 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.140000000000001 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.310000000000002 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 60.030000000000001 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.540000000000006 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.510000000000005 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.209999999999994 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.310000000000002 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.349999999999994 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.340000000000003 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.140000000000001 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.140000000000001 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.219999999999999 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.219999999999999 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.299999999999997 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.019999999999996 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 64.439999999999998 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.299999999999997 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 72.040000000000006 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.140000000000001 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.421 HG23 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.030000000000001 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 42.299999999999997 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.349999999999994 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 63.100000000000001 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt -107.62 121.6 43.71 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.129999999999995 112.257 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' HG13 ' A' ' 39' ' ' ILE . 54.9 Cg_endo -69.27 134.25 28.54 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.395 2.063 . . . . 65.439999999999998 112.331 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.91 126.18 30.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 71.420000000000002 110.48 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 . . . . . 0 C--O 1.255 1.342 0 CA-C-O 118.774 -0.631 . . . . 65.140000000000001 111.483 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.573 0.225 . . . . 75.400000000000006 111.276 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.68 146.07 41.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.899 0.38 . . . . 72.120000000000005 110.48 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.28 135.82 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.319999999999993 111.98 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.439999999999998 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.439999999999998 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.129999999999995 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.120000000000005 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.200000000000003 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.399999999999999 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 33.439999999999998 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.530000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.409999999999997 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.230000000000004 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 65.140000000000001 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.329999999999998 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.430000000000007 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.409999999999997 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 33.399999999999999 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 42.200000000000003 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.099999999999994 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.340000000000003 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.319999999999993 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 71.140000000000001 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.140000000000001 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.420000000000002 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.239999999999995 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.239999999999995 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.329999999999998 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.200000000000003 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 61.539999999999999 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.430000000000007 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.230000000000004 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.129999999999995 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.786 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.010000000000005 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.230000000000004 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.150000000000006 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.409999999999997 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.319999999999993 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 64.519999999999996 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.420000000000002 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.510000000000005 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.150000000000006 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.350000000000001 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.129999999999995 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.420000000000002 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.510000000000005 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.319999999999993 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.239999999999995 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 53.509999999999998 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.420000000000002 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.310000000000002 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.109999999999999 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.019999999999996 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.420000000000002 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.329999999999998 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.501 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.129999999999995 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.219999999999999 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.219999999999999 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.239999999999995 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.450000000000003 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.030000000000001 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.299999999999997 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.140000000000001 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 73.439999999999998 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.519999999999996 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.786 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 70.430000000000007 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt -132.51 133.45 23.61 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.322 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.51 75.14 2.03 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.013 1.809 . . . . 61.149999999999999 111.719 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.4 tp -71.51 130.0 40.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.862 -0.608 . . . . 73.409999999999997 111.848 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.76 -0.638 . . . . 75.109999999999999 111.597 177.66 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.378 0.132 . . . . 71.439999999999998 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -119.46 143.32 47.58 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.899 0.381 . . . . 73.150000000000006 111.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 29' ' ' VAL . 83.9 t -109.99 121.52 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.140000000000001 111.903 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.530000000000001 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.030000000000001 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.420000000000002 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.230000000000004 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.340000000000003 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 72.129999999999995 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.039999999999999 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.329999999999998 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.329999999999998 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.447 HG21 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 64.329999999999998 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.140000000000001 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.120000000000005 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.450000000000003 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.409999999999997 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.140000000000001 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.519999999999996 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.209999999999994 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.239999999999995 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.350000000000001 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.239999999999995 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 63.229999999999997 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.439999999999998 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 15.5 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.310000000000002 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.100000000000001 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.030000000000001 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.219999999999999 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.688 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 62.409999999999997 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.209999999999994 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.120000000000005 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.340000000000003 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 62.329999999999998 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.140000000000001 111.863 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.209999999999994 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.150000000000006 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 62.130000000000003 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 45.25 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.230000000000004 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.299999999999997 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.019999999999996 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.319999999999993 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.109999999999999 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.099999999999994 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.219999999999999 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.319999999999993 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.510000000000005 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.030000000000001 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 63.119999999999997 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.540000000000006 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.399999999999999 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.349999999999994 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 62.039999999999999 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.62 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 61.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 55.539999999999999 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 74.109999999999999 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.510000000000005 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.129999999999995 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.319999999999993 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 15.4 pt -110.49 132.17 21.69 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.310000000000002 111.366 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 12.2 Cg_exo -71.11 67.91 2.52 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.816 2.344 . . . . 72.109999999999999 112.373 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 tt -101.45 113.59 26.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.835 0.35 . . . . 75.209999999999994 110.194 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.676 -0.678 . . . . 72.140000000000001 111.806 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.881 0.372 . . . . 75.349999999999994 111.548 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 157.47 44.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.369 -0.378 . . . . 74.310000000000002 110.303 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.24 136.16 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 43.420000000000002 112.675 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.329999999999998 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.150000000000006 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 30.23 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.129999999999995 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 73' ' ' LEU . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.219999999999999 111.008 176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 72.239999999999995 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 113.2 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.129999999999995 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.329999999999998 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.439999999999998 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 70.540000000000006 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 60.340000000000003 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.230000000000004 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 64.450000000000003 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.009999999999998 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.209999999999994 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.409999999999997 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA3' ' A' ' 11' ' ' GLY . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 63.200000000000003 109.465 170.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.47 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.340000000000003 108.74 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.549999999999997 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.049999999999997 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.020000000000003 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.439999999999998 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.299999999999997 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.150000000000006 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.59 HD11 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.540000000000006 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.200000000000003 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.120000000000005 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.340000000000003 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.099999999999994 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD11 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.150000000000006 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.219999999999999 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.409999999999997 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.614 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.540000000000006 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.129999999999995 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.310000000000002 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.430000000000007 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.409999999999997 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.129999999999995 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.409999999999997 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 32.039999999999999 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.439999999999998 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.100000000000001 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.439999999999998 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 73' ' ' LEU . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.329999999999998 110.839 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.430000000000007 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HB2' HD13 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.340000000000003 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.430000000000007 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 40.119999999999997 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.310000000000002 110.147 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.540000000000006 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.130000000000003 112.569 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.319999999999993 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.120000000000005 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 73.140000000000001 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.439999999999998 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.040000000000006 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.340000000000003 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.239999999999995 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 65.409999999999997 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.9 pt -125.52 139.97 35.26 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 60.32 111.637 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 8.9 Cg_exo -73.9 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.389 2.726 . . . . 73.109999999999999 113.645 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.5 HD12 ' HD2' ' A' ' 8' ' ' PHE . 6.7 tt -74.69 127.51 33.32 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.116 -0.328 . . . . 75.530000000000001 110.116 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 112.226 0.454 . . . . 52.119999999999997 112.226 -177.298 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.607 0.241 . . . . 73.340000000000003 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -114.55 127.38 55.77 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.785 0.326 . . . . 64.230000000000004 110.498 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -89.05 127.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 53.210000000000001 111.599 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.229999999999997 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.150000000000006 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.239999999999995 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.120000000000005 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.209999999999994 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 64.239999999999995 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.200000000000003 110.044 167.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.450000000000003 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.129999999999995 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.230000000000004 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.200000000000003 111.917 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.420000000000002 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.150000000000006 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.409999999999997 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.420000000000002 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.219999999999999 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.439999999999998 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.519999999999996 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.439999999999998 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.229999999999997 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.109999999999999 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 71.299999999999997 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.030000000000001 112.347 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.140000000000001 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 70.239999999999995 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.120000000000005 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.329999999999998 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.409999999999997 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.129999999999995 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.109999999999999 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.299999999999997 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.230000000000004 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.140000000000001 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 61.140000000000001 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.239999999999995 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 63.329999999999998 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.319999999999993 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.299999999999997 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.310000000000002 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.130000000000003 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.439999999999998 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.109999999999999 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.439999999999998 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 53.310000000000002 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 61.299999999999997 110.71 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.439999999999998 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.349999999999994 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.329999999999998 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 43.200000000000003 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 111.753 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.549999999999997 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.010000000000005 112.742 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.519999999999996 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.129999999999995 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.019999999999996 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.400000000000006 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.129999999999995 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.109999999999999 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.230000000000004 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.635 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.129999999999995 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt -132.84 145.6 57.79 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.310000000000002 112.378 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.93 103.27 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.556 2.171 . . . . 65.420000000000002 111.211 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.11 122.53 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.995 0.426 . . . . 71.400000000000006 112.031 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.397 -0.811 . . . . 65.549999999999997 111.436 175.781 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.694 0.257 . . . . 74.209999999999994 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -102.36 135.03 44.7 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.543 -0.54 . . . . 55.240000000000002 109.543 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 29' ' ' VAL . 74.4 t -94.57 125.44 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.010000000000005 112.69 -171.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.150000000000006 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.239999999999995 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.119999999999997 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.450000000000003 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.319999999999993 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.109999999999999 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.109999999999999 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.530000000000001 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.210000000000001 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.430000000000007 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 71.450000000000003 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.549999999999997 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.329999999999998 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 71.530000000000001 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.420000000000002 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.450000000000003 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.010000000000005 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.617 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 71.0 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.439999999999998 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.520000000000003 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.420000000000002 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.219999999999999 110.464 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.109999999999999 113.224 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.439999999999998 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 73.109999999999999 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.340000000000003 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.530000000000001 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.349999999999994 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.350000000000001 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 61.229999999999997 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 63.039999999999999 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.129999999999995 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.409999999999997 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.020000000000003 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.519999999999996 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.230000000000004 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.540000000000006 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.439999999999998 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.240000000000002 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.140000000000001 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.439999999999998 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.210000000000001 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.450000000000003 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 70.129999999999995 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 54.329999999999998 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.420000000000002 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.010000000000005 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.299999999999997 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 51.329999999999998 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.219999999999999 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.129999999999995 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.030000000000001 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.439999999999998 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 45.130000000000003 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.439999999999998 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.540000000000006 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.109999999999999 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.219999999999999 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.120000000000005 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.409999999999997 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt -132.77 151.07 77.41 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.420000000000002 111.392 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.51 154.56 18.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.429 2.086 . . . . 74.420000000000002 112.678 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.39 108.45 11.75 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.079 0.466 . . . . 72.329999999999998 110.291 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.792 -0.623 . . . . 73.409999999999997 111.346 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.713 0.292 . . . . 74.129999999999995 111.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.33 149.71 42.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.888 0.375 . . . . 71.340000000000003 110.258 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t -107.47 134.02 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.239999999999995 112.899 -170.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.420000000000002 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.040000000000006 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.420000000000002 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.299999999999997 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 70.120000000000005 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 63.140000000000001 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 50.219999999999999 110.465 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.547 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.319999999999993 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.229999999999997 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.483 HG21 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 64.340000000000003 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.209999999999994 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.119999999999997 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.329999999999998 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.439999999999998 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.439999999999998 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.329999999999998 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.149999999999999 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 3' ' ' VAL . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.140000000000001 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.310000000000002 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.349999999999994 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 64.5 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 61.340000000000003 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.209999999999994 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 23.440000000000001 113.781 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 54.210000000000001 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.209999999999994 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.219999999999999 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.209999999999994 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.530000000000001 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.519999999999996 111.375 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.409999999999997 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.520000000000003 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.400000000000006 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HB3' HD21 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.510000000000005 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.129999999999995 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.219999999999999 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.219999999999999 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.219999999999999 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.430000000000007 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.349999999999994 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.149999999999999 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 51.32 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.420000000000002 110.991 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.200000000000003 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.450000000000003 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.200000000000003 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.430000000000007 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.409999999999997 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.549999999999997 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.420000000000002 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 61.219999999999999 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 63.310000000000002 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.219999999999999 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.219999999999999 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.430000000000007 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HB2' HD11 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.109999999999999 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt -130.89 144.92 55.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.010000000000005 111.638 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.16 167.49 24.79 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.085 2.523 . . . . 51.530000000000001 113.122 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 tp -149.74 124.56 9.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.141 -0.481 . . . . 73.019999999999996 110.928 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.254 -0.879 . . . . 60.100000000000001 112.455 -178.179 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 ttp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.523 0.201 . . . . 74.230000000000004 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -110.05 165.89 11.37 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.195 -0.669 . . . . 71.5 109.195 170.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 25' ' ' LEU . 60.8 t -107.79 137.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 63.119999999999997 110.92 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.030000000000001 113.429 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.109999999999999 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 72.040000000000006 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.140000000000001 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.409999999999997 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 44.020000000000003 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 70.0 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' VAL . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.120000000000005 111.675 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' HG22 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 70.239999999999995 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 64.209999999999994 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.329999999999998 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.439999999999998 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.119999999999997 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.310000000000002 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.099999999999994 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.329999999999998 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.310000000000002 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 64.030000000000001 111.855 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.409999999999997 112.158 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.319999999999993 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.230000000000004 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.409999999999997 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.509999999999998 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.681 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.0 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 71.420000000000002 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.319999999999993 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.711 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 64.310000000000002 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.681 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.409999999999997 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.140000000000001 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.229999999999997 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.319999999999993 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.420000000000002 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.340000000000003 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.329999999999998 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.430000000000007 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.310000000000002 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.130000000000003 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.340000000000003 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.530000000000001 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 63.119999999999997 111.895 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.340000000000003 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.019999999999996 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.439999999999998 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.439999999999998 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.430000000000007 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.099999999999994 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.329999999999998 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.209999999999994 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.240000000000002 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.420000000000002 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 73.409999999999997 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.140000000000001 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.210000000000001 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.340000000000003 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.319999999999993 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt -132.41 144.3 52.44 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.230000000000004 112.421 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.3 144.58 41.67 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.616 2.21 . . . . 62.32 112.739 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.47 130.27 35.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 111.335 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 111.904 178.277 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.601 0.239 . . . . 73.209999999999994 111.432 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -90.52 155.55 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.893 0.378 . . . . 73.450000000000003 111.111 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 29' ' ' VAL . 84.3 t -127.16 132.13 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.319999999999993 111.72 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.240000000000002 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.219999999999999 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.349999999999994 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.040000000000006 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 72.140000000000001 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.430000000000007 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.109999999999999 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.030000000000001 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.329999999999998 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.109999999999999 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 64.519999999999996 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.299999999999997 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.239999999999995 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 64.340000000000003 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.340000000000003 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.140000000000001 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 64.310000000000002 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.439999999999998 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 64.209999999999994 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.409999999999997 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.530000000000001 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.439999999999998 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.329999999999998 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 15.42 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.120000000000005 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.209999999999994 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.219999999999999 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.409999999999997 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.230000000000004 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.676 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.120000000000005 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.584 HG13 ' HD3' ' A' ' 72' ' ' PRO . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.239999999999995 112.056 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.119999999999997 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.209999999999994 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.450000000000003 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.340000000000003 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.430000000000007 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.319999999999993 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.540000000000006 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.340000000000003 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.210000000000001 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.140000000000001 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.019999999999996 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.340000000000003 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.020000000000003 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 53.039999999999999 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.350000000000001 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.409999999999997 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.439999999999998 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.040000000000006 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.510000000000005 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.030000000000001 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.450000000000003 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 73.420000000000002 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.239999999999995 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.530000000000001 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt -109.89 133.65 20.9 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 53.119999999999997 112.316 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HD3' HG13 ' A' ' 39' ' ' ILE . 73.7 Cg_endo -79.77 87.14 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.142 1.895 . . . . 70.299999999999997 111.64 172.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.5 pt? -76.57 152.09 36.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.087 -0.506 . . . . 74.530000000000001 112.108 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 115.895 -0.593 . . . . 74.549999999999997 111.623 178.052 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.663 0.268 . . . . 75.150000000000006 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.22 129.73 32.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.946 0.403 . . . . 75.019999999999996 110.963 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.07 122.83 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.209999999999994 111.41 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.030000000000001 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.540000000000006 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.439999999999998 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.510000000000005 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.447 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 63.119999999999997 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.100000000000001 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 51.020000000000003 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.039999999999999 112.98 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.030000000000001 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.400000000000006 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.512 HG21 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.519999999999996 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.209999999999994 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.329999999999998 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 55.009999999999998 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 61.229999999999997 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.010000000000005 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.349999999999994 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.340000000000003 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' ND2' HG21 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 11' ' ' GLY . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 111.166 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.129999999999995 112.989 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.219999999999999 112.855 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.430000000000007 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.109999999999999 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.130000000000003 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 54.420000000000002 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.310000000000002 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.019999999999996 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.120000000000005 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 63.509999999999998 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.349999999999994 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.400000000000006 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.310000000000002 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 53.310000000000002 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.150000000000006 112.689 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.209999999999994 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 54.240000000000002 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 65.040000000000006 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.140000000000001 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 51.25 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.240000000000002 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.319999999999993 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.450000000000003 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.120000000000005 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.340000000000003 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.209999999999994 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.200000000000003 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.239999999999995 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.129999999999995 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.119999999999997 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.030000000000001 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.439999999999998 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.129999999999995 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 70.530000000000001 112.19 -175.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.140000000000001 112.191 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.340000000000003 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.140000000000001 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 72.439999999999998 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.430000000000007 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.420000000000002 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.329999999999998 110.745 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.450000000000003 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 62.340000000000003 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 71.430000000000007 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt -108.61 149.46 39.45 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.409999999999997 112.253 -174.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 109.89 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.229 1.953 . . . . 70.049999999999997 111.596 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.42 96.51 1.49 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.079 0.466 . . . . 64.109999999999999 110.702 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.834 -0.603 . . . . 72.219999999999999 111.512 179.471 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.1 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.524 0.202 . . . . 74.450000000000003 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.2 141.16 35.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.839 0.352 . . . . 71.200000000000003 110.717 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 25' ' ' LEU . 62.6 t -121.91 132.21 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 64.329999999999998 111.982 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.430000000000007 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.310000000000002 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 42.130000000000003 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.129999999999995 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 72.209999999999994 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.219999999999999 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.450000000000003 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 72.319999999999993 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.530000000000001 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 53.520000000000003 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.439999999999998 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.009999999999998 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.229999999999997 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.420000000000002 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.420000000000002 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.310000000000002 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.120000000000005 110.613 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.409999999999997 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.409999999999997 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.120000000000005 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.430000000000007 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.420000000000002 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.209999999999994 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.767 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.239999999999995 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.520000000000003 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.049999999999997 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.519999999999996 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.219999999999999 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.767 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.109999999999999 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.409999999999997 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.530000000000001 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.049999999999997 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 61.100000000000001 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.530000000000001 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.030000000000001 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.219999999999999 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 111.18 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 74.030000000000001 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.229999999999997 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.510000000000005 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.219999999999999 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 62.100000000000001 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.310000000000002 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.239999999999995 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.430000000000007 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.540000000000006 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 73.420000000000002 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 73.349999999999994 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.549999999999997 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.530000000000001 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.420000000000002 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.329999999999998 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.530000000000001 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.530000000000001 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.129999999999995 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.310000000000002 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.310000000000002 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.639 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.540000000000006 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt -110.56 150.06 41.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.040000000000006 111.729 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.71 92.48 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 50.030000000000001 113.424 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.4 pt? -71.5 151.43 43.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.99 0.424 . . . . 64.310000000000002 111.175 175.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.368 -0.825 . . . . 73.219999999999999 112.464 -177.068 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 111.889 0.329 . . . . 73.049999999999997 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -107.89 158.55 17.24 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.837 -0.431 . . . . 71.209999999999994 109.837 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t -106.58 144.29 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.409999999999997 113.216 -170.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.119999999999997 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.32 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.519999999999996 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.230000000000004 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 72.510000000000005 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 73.200000000000003 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.510000000000005 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.240000000000002 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.140000000000001 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.439999999999998 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.049999999999997 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.329999999999998 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.349999999999994 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.329999999999998 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.549999999999997 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 73.420000000000002 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.219999999999999 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.510000000000005 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.099999999999994 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.040000000000006 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.239999999999995 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.319999999999993 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.230000000000004 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 112.036 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 54.229999999999997 112.105 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.120000000000005 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 54.350000000000001 110.79 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 30' ' ' ARG . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.340000000000003 113.264 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.120000000000005 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.687 HD21 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.209999999999994 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.319999999999993 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.239999999999995 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.119999999999997 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.209999999999994 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.687 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 72.310000000000002 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.540000000000006 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.120000000000005 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.129999999999995 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 64.209999999999994 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.209999999999994 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.009999999999998 111.177 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.109999999999999 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.450000000000003 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.420000000000002 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.109999999999999 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.200000000000003 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.109999999999999 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.099999999999994 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.319999999999993 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.209999999999994 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.120000000000005 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.409999999999997 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.239999999999995 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.540000000000006 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.200000000000003 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.340000000000003 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.340000000000003 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.439999999999998 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 64.310000000000002 112.178 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.439999999999998 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 62.539999999999999 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.9 125.63 32.17 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.329999999999998 111.389 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.22 83.71 0.59 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.196 1.931 . . . . 54.420000000000002 112.478 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.2 pt? -59.34 112.34 1.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.383 0.611 . . . . 72.430000000000007 111.197 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.762 -0.637 . . . . 71.340000000000003 112.199 -177.616 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.4 ttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.712 0.291 . . . . 65.409999999999997 111.586 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.19 136.76 21.56 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.140000000000001 110.598 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 59' ' ' VAL . 92.4 t -89.25 134.19 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.329999999999998 112.201 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.310000000000002 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.420000000000002 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.439999999999998 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.230000000000004 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 50.340000000000003 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 31.329999999999998 113.374 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.010000000000005 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.450000000000003 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.409999999999997 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.420000000000002 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.430000000000007 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.329999999999998 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.140000000000001 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 61.420000000000002 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.530000000000001 113.514 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.409999999999997 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.299999999999997 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.040000000000006 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.520000000000003 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 11' ' ' GLY . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 110.252 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.420000000000002 109.588 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.420000000000002 112.16 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.450000000000003 112.406 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.340000000000003 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.329999999999998 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.229999999999997 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.209999999999994 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.230000000000004 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.219999999999999 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.430000000000007 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.439999999999998 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.019999999999996 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.340000000000003 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.329999999999998 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 62.0 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 70.219999999999999 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.340000000000003 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.239999999999995 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.349999999999994 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 45.030000000000001 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.239999999999995 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.310000000000002 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.140000000000001 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.229999999999997 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.010000000000005 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.049999999999997 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.540000000000006 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.229999999999997 111.492 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.140000000000001 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.430000000000007 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.109999999999999 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.109999999999999 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 63.229999999999997 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.099999999999994 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.329999999999998 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.239999999999995 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.239999999999995 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.129999999999995 111.306 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.299999999999997 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.409999999999997 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.549999999999997 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt -119.19 148.52 45.27 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.210000000000001 112.652 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.53 127.8 16.17 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.756 2.304 . . . . 61.039999999999999 111.569 172.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.14 97.42 4.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.858 0.361 . . . . 72.049999999999997 110.821 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.688 -0.672 . . . . 62.509999999999998 111.208 175.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.34 112.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.15 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.31 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 31.34 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 33.51 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.21 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 70.02 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.11 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.34 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.54 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 61.43 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.25 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 73.44 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.12 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.41 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.14 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.42 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.1 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.13 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.52 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 54.32 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.3 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.11 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.24 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.34 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.23 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.24 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 51.23 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.641 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.23 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.41 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.14 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.51 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.44 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.41 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.2 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.2 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.13 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.22 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.24 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.24 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.11 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.15 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.44 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.23 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 46' ' ' LEU . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.55 111.536 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.43 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 52' ' ' ILE . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.22 112.099 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 54.14 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.21 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.23 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.22 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.11 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.21 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.22 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.15 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.43 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.54 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.22 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.43 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 64.44 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.22 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 61.23 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.092 0.472 . . . . 71.23 111.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.4 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.11 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.44 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.3 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.45 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' HD22 ' A' ' 25' ' ' LEU . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.05 111.35 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.31 109.91 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.31 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 52.12 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.54 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' VAL . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.1 111.617 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.54 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.03 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 54.31 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.14 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 41.3 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.42 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 62.14 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.11 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 9' ' ' TYR . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.01 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.24 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 54.44 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.44 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.02 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.13 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 54' ' ' VAL . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.22 110.64 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 65.51 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.44 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 36' ' ' ARG . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.14 111.263 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.31 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.22 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.12 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.24 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.42 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 62.55 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.33 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.1 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.1 111.487 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 14' ' ' THR . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.706 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.4 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.33 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.42 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.15 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.41 110.404 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 33' ' ' LEU . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 54.1 112.457 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.14 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.12 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.41 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 67' ' ' ASP . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.01 110.902 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 71.22 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.24 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.14 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.22 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.11 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.41 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.53 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.14 111.033 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.41 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.45 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 71.43 110.432 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.1 pt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.05 111.988 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 66' ' ' ILE . 46.9 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.11 111.989 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 70.44 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.14 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 63.41 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.45 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.54 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.51 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.52 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 61.24 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.12 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.42 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 64.2 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 33.23 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 64.15 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.14 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.34 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 54.15 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 17' ' ' GLU . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.43 111.161 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.33 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.22 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.14 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 64.15 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.55 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.2 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.15 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.03 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.02 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 74.24 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.44 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 72.14 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.53 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.4 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.1 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.41 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HB3' HD21 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 65.43 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 73.14 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.413 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.15 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.51 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.53 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.1 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.42 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.11 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.14 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.55 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.24 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.34 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 64.22 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.33 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.12 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 61.45 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 66' ' ' ILE . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.04 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.41 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.13 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.2 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.54 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.4 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 51.44 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 71.25 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.13 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.11 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.53 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.45 111.186 -179.017 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 29' ' ' VAL . 96.7 t . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 70.22 112.253 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.43 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.3 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.24 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.54 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.11 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.45 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.04 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.52 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.23 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 60.32 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 53.14 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.13 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.3 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.21 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.33 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.41 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.43 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.31 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.42 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.13 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.35 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.01 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.41 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.34 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.22 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.34 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.04 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.45 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.12 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.11 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.34 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 63.14 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.35 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.33 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.41 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.44 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.2 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.43 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.1 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 62.23 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.12 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.52 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.42 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.54 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.35 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.684 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.15 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HD22 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.51 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.51 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.24 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.51 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.13 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.11 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 51.51 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.04 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.22 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.42 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.42 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.05 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.11 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.53 111.949 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.34 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.13 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.42 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 65.32 112.055 -176.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 70.54 112.347 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.24 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.44 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.14 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.34 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 73.42 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.05 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.553 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.23 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.13 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.32 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.32 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 61.02 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 55.24 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.12 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.15 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 45.33 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 32.51 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.2 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 60.25 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.22 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.35 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.43 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' HE21 ' A' ' 28' ' ' GLN . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.21 112.448 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HG2' ' A' ' 27' ' ' GLU . 30.3 mm-40 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 22.12 114.546 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.02 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.75 HD21 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.05 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.35 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 44.32 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.3 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.702 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.12 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.75 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.33 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.42 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.21 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 65.11 110.467 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.11 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.24 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.34 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.53 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.42 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.3 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.14 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.32 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.11 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.31 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.23 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.2 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.44 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 64.52 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.24 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.34 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.35 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.53 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.11 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.31 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.14 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 50.42 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.405 ' H ' ' HA2' ' A' ' 31' ' ' GLY . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.24 111.135 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.22 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.44 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.702 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.2 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 25' ' ' LEU . 91.2 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.55 112.745 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.33 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.04 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.01 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 52.22 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.03 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.1 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 23.31 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.43 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.33 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 48' ' ' VAL . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.52 111.744 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.23 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.42 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.14 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.31 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.42 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.22 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.11 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.11 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.12 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 3' ' ' VAL . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 64.24 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.13 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.44 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.14 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 30.13 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.41 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.04 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.52 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.4 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.53 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.33 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.44 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 61.25 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 46' ' ' LEU . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.33 112.248 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.23 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.471 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.23 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 72.41 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 52' ' ' ILE . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.22 111.186 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.22 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' THR . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.45 111.116 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.24 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.4 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.43 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.04 111.803 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.32 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.24 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.32 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.52 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.41 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.55 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.01 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.24 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.04 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.55 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.12 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.54 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.3 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.14 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.31 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.22 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.13 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.21 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 64.13 111.576 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 25' ' ' LEU . 87.5 t . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.31 112.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.41 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.33 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.23 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.24 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.2 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.44 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.13 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.04 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.52 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.33 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.54 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.44 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 70.21 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.42 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.32 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 73.3 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.51 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.23 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.24 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LEU . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.24 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.4 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.762 HD12 HG21 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.24 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.34 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.11 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.24 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.21 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.31 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.02 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.13 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.24 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.24 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.14 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 36' ' ' ARG . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.43 111.013 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.812 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.12 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.732 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.03 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.4 112.308 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.04 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.34 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.13 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 54.4 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.33 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.42 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.51 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.3 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.41 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.14 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.32 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.51 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.23 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 71.55 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.13 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.52 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.31 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.11 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.14 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.14 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.54 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.45 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.43 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.33 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.41 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG23 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.33 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 73.24 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.812 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.22 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.43 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.44 111.986 -178.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 29' ' ' VAL . 61.8 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.22 112.883 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.41 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.24 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.1 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 72.53 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 72.43 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.52 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.33 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.23 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.32 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 74.4 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.468 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.44 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.52 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.24 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.02 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.3 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.31 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.35 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.02 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.13 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.32 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 54.01 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 27' ' ' GLU . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.12 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.413 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.4 mm-40 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 55.25 112.324 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.33 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.54 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.23 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.15 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.2 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.4 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.45 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.666 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.11 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.71 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.41 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.13 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.44 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 51.42 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.45 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.607 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.13 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.14 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.31 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 60.03 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.54 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.51 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.21 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.31 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.24 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.35 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.34 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.14 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.14 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.22 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.22 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.3 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.02 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 64.44 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.3 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 72.04 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.14 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.421 HG23 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.03 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 42.3 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.35 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 63.1 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.13 112.257 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.32 111.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.44 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.13 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.12 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.2 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.4 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 33.44 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.53 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.41 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.23 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 65.14 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.33 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.43 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.4 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.41 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 33.4 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 42.2 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.1 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.34 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.32 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 71.14 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.14 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.42 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.24 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.24 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.33 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.2 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 61.54 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.43 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.23 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.13 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.786 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.01 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.23 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.15 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.41 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.32 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 64.52 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.42 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.51 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.15 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.35 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.13 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.42 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.51 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.32 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.24 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 53.51 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.42 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.31 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.11 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.02 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.42 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.33 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.501 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.13 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.22 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.22 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.24 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.45 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.03 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.3 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.14 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 73.44 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.52 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.786 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 70.43 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.322 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 29' ' ' VAL . 83.9 t . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.14 111.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.53 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.03 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.42 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.23 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.34 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 72.13 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.04 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.33 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.33 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.447 HG21 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 64.33 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.14 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.13 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.12 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.45 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.41 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.14 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.43 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.52 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.21 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.24 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.35 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.24 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 63.23 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.44 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.43 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 15.5 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.23 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.31 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.1 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.03 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.22 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.688 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.34 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 62.41 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.21 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.12 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.34 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 62.33 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.14 111.863 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.21 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.15 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 62.13 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 45.25 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.23 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.3 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.02 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.24 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.32 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.11 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.1 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.22 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.32 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.51 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.03 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.62 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 63.12 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.54 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.4 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.35 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 62.04 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.62 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 61.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 55.54 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 74.11 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.51 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.13 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.32 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.31 111.366 178.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 43.42 112.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.33 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.15 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 30.23 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.13 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.22 111.008 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 72.24 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.41 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.22 113.2 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.13 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.33 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.44 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 70.54 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 60.34 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.23 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 64.45 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.01 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.21 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.44 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.41 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA3' ' A' ' 11' ' ' GLY . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 63.2 109.465 170.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.34 108.74 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.55 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.05 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.02 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.44 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.3 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.15 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.59 HD11 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.2 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.12 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.34 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.1 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD11 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.15 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.22 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.41 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.614 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.54 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.31 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.43 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.41 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.13 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.41 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 32.04 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.44 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.1 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.44 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.33 110.839 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.43 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HB2' HD13 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.34 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.43 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 40.12 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.43 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.31 110.147 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.54 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.13 112.569 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.32 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.12 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 73.14 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.44 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.04 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.34 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.24 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 65.41 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 55' ' ' GLN . 10.9 pt . . . . . 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 60.32 111.637 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 53.21 111.599 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.23 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.15 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.24 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.12 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.21 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 64.24 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.2 110.044 167.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.45 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.13 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.23 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.2 111.917 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.42 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.15 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.41 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.42 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.22 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.44 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.52 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.44 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.23 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.11 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 71.3 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' HE21 ' A' ' 28' ' ' GLN . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.03 112.347 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.3 mm-40 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.14 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 70.24 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.12 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.42 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.41 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.13 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.11 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.3 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.23 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.14 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 61.14 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.24 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 63.33 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.32 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.3 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.31 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.44 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.11 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.44 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 53.31 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 61.3 110.71 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.44 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.35 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.33 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 43.2 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.753 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.55 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.01 112.742 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.24 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.52 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.13 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.02 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.4 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.13 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.11 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.23 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.635 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.13 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.31 112.378 -175.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 29' ' ' VAL . 74.4 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.01 112.69 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.15 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.24 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.12 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.45 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.32 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.11 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.11 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.53 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.21 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.43 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 71.45 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.55 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.33 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 71.53 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.42 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.45 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.01 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.617 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 71.0 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.52 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.42 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.22 110.464 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' HE21 ' A' ' 28' ' ' GLN . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.1 mm-40 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.11 113.224 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.44 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 73.11 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.34 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.53 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.35 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.35 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 61.23 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 63.04 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.13 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.41 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.02 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.52 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.23 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.54 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.44 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.24 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.33 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.14 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.44 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.21 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.45 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 70.13 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.22 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 54.33 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.42 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.01 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.3 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 51.33 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.22 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.13 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.03 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.44 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 45.13 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.44 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.54 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.11 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.22 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.12 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.41 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.42 111.392 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.42 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.04 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.42 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.3 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 70.12 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 63.14 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 50.22 110.465 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.547 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.32 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.23 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.43 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.483 HG21 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 64.34 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.21 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.12 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.33 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.43 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.44 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.44 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.33 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.12 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.15 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 3' ' ' VAL . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.14 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.31 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.35 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 64.5 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 61.34 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.21 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 23.44 113.781 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 54.21 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.21 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.22 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.21 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.53 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.375 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.41 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.52 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.4 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HB3' HD21 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.51 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.13 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.22 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.22 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.22 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.43 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.24 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.35 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.15 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 51.32 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.42 110.991 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.2 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.45 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.2 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.43 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.41 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.55 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.42 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 61.22 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 63.31 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.22 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.22 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.43 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HB2' HD11 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.11 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.01 111.638 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 25' ' ' LEU . 60.8 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 63.12 110.92 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.03 113.429 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.11 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 72.04 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.14 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.41 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 44.02 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 70.0 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' VAL . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.12 111.675 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' HG22 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 70.24 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 64.21 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.33 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.44 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.12 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.495 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.31 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.1 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.33 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.31 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' HE21 ' A' ' 28' ' ' GLN . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 64.03 111.855 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' A' ' 27' ' ' GLU . 23.5 mm-40 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.41 112.158 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.32 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.23 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.41 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.51 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.681 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.0 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 71.42 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.32 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.711 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 64.31 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.681 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.41 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.14 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.23 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.32 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.42 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.34 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.33 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.43 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.31 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.13 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.34 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.53 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 63.12 111.895 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.34 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.02 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.04 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.44 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.42 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.44 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.43 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.1 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.33 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.21 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.24 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.42 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 73.41 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.14 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.21 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.34 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.32 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.23 112.421 -176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 29' ' ' VAL . 84.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.32 111.72 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.24 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.22 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.35 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.04 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 72.14 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.43 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.11 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.03 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.33 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.11 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 64.52 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.3 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.24 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 64.34 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.15 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.34 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.14 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 64.31 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.44 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 64.21 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.41 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.53 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.44 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.33 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 15.42 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.12 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.21 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.22 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.41 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.23 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.676 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.12 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.24 112.056 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.12 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.21 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.45 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.34 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.43 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.32 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.54 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.34 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.21 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.23 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.14 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.02 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.34 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.53 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.02 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 53.04 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.34 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.35 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.41 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.44 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.04 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.51 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.03 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.45 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 73.42 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.24 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.53 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 53.12 112.316 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.21 111.41 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.03 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.54 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.44 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.51 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.447 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 63.12 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.1 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 51.02 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.04 112.98 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.03 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.4 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.512 HG21 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.52 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.34 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.21 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.33 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 55.01 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 61.23 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.4 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.01 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.35 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.34 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' ND2' HG21 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 11' ' ' GLY . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.42 111.166 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.11 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HG2' HE21 ' A' ' 28' ' ' GLN . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.13 112.989 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.8 mm-40 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.22 112.855 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.43 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.11 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.13 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 54.42 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.31 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.02 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.12 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 63.51 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.4 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.31 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 53.31 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.15 112.689 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 54.24 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 65.04 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.14 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 51.25 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.24 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.32 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.45 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.12 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.34 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.21 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.2 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.24 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.13 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.12 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.03 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.44 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.13 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 70.53 112.19 -175.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.14 112.191 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.34 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.14 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 72.44 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.43 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.42 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.33 110.745 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.45 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 62.34 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 71.43 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.41 112.253 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 25' ' ' LEU . 62.6 t . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 64.33 111.982 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.43 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.31 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 42.13 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.13 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 72.21 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.22 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.45 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 72.32 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.53 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 53.52 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.21 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.22 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.44 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.01 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.34 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.23 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.42 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.42 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.41 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.31 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.12 110.613 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.41 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.41 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.12 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.43 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.42 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.21 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.767 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.24 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.52 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.05 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.52 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.22 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.767 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.11 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.41 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.53 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.05 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.43 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 61.1 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.53 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.03 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.22 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.18 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 74.03 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.23 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.51 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.22 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 62.1 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.31 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.24 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.43 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.54 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 73.42 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 73.35 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.55 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.53 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.42 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.33 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.53 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.53 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.13 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.31 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.31 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.639 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.54 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.04 111.729 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.41 113.216 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.12 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.32 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.52 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.23 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 72.51 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 73.2 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.51 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.24 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.14 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.44 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.05 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.33 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.35 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.33 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.55 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 73.42 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.22 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.51 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.1 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.04 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.24 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.32 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.23 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG2' HE21 ' A' ' 28' ' ' GLN . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.31 112.036 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.422 HE21 ' HG2' ' A' ' 27' ' ' GLU . 28.4 mm-40 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 54.23 112.105 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.12 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 54.35 110.79 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 30' ' ' ARG . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.34 113.264 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.12 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.687 HD21 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.21 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.32 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.24 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.12 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.21 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.687 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 71.34 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 72.31 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.54 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.12 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.13 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 64.21 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.21 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.01 111.177 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.11 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.45 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.42 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.42 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.11 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.2 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.11 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.1 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.42 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.32 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.21 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.12 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.41 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.24 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.54 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.2 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.34 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.34 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.44 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 64.31 112.178 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.44 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 62.54 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.33 111.389 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 59' ' ' VAL . 92.4 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.33 112.201 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.31 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.42 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.44 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.23 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 50.34 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 31.33 113.374 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.01 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.45 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.41 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.42 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.43 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.33 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.14 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 61.42 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.53 113.514 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.41 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.3 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.04 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.52 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 11' ' ' GLY . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.44 110.252 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.42 109.588 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' HE21 ' A' ' 28' ' ' GLN . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.42 112.16 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.428 HE21 ' HG2' ' A' ' 27' ' ' GLU . 27.6 mm-40 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.45 112.406 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.23 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.21 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.23 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.22 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.43 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.44 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.02 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.34 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.33 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 62.0 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 70.22 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.34 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.24 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.35 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 45.03 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.24 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.31 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.14 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.01 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.05 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 65.34 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.54 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.23 111.492 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.14 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.43 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.11 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.11 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 63.23 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.1 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.33 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.24 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.13 111.306 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.3 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.41 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.55 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.21 112.652 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.743 0.306 . . . . 75.43 111.762 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.35 156.3 17.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.395 -0.366 . . . . 73.23 110.483 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.7 t -118.92 128.67 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.153 0.502 . . . . 73.34 112.04 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 7' ' ' LYS . 34.7 mt-10 -102.15 143.05 25.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.011 -0.541 . . . . 63.15 110.883 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.34 110.56 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.305 2.003 . . . . 71.31 112.246 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.02 -3.59 24.08 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.068 -0.587 . . . . 31.34 113.619 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 4' ' ' GLU . 34.9 mmtp -94.94 162.6 13.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.267 0.556 . . . . 33.51 112.16 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -95.84 132.07 41.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.903 -0.589 . . . . 75.21 111.548 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -147.15 153.1 39.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.277 0.56 . . . . 70.02 112.284 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -99.33 139.58 34.76 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.197 -0.456 . . . . 74.11 109.964 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.12 166.29 24.97 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.779 -0.724 . . . . 61.34 113.095 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 134.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.124 0.487 . . . . 71.54 111.674 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.95 125.16 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.149 -0.478 . . . . 61.43 112.153 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.5 p -90.22 -49.32 6.62 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.353 -0.385 . . . . 72.5 111.853 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 15' ' ' ARG . 13.1 ptt180 -153.43 150.64 29.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.804 0.335 . . . . 74.25 111.1 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.08 112.56 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.831 0.348 . . . . 73.44 111.304 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.5 mm-40 -94.36 161.92 14.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.93 0.395 . . . . 62.12 110.767 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -78.91 6.39 9.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.134 0.492 . . . . 63.41 111.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -135.09 11.77 3.58 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.083 -0.508 . . . . 72.14 111.359 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.3 -176.51 28.01 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.221 -0.514 . . . . 62.42 113.039 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.02 126.42 43.08 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.292 -0.534 . . . . 71.1 111.43 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 66.4 m-85 -78.27 122.9 26.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.933 0.397 . . . . 70.25 111.178 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.3 mt -121.34 136.61 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 112.068 0.396 . . . . 65.13 112.068 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -94.22 131.57 39.67 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.81 0.338 . . . . 75.52 110.998 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -101.0 -35.61 9.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.32 0.581 . . . . 54.32 110.86 173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 47.1 t30 -150.03 167.26 27.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.705 -0.679 . . . . 61.3 110.633 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -40.68 -48.6 2.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.588 0.958 . . . . 75.11 113.588 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -113.65 19.46 16.75 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.287 0.477 . . . . 71.24 112.287 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 93.3 t -122.53 111.63 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.129 0.418 . . . . 72.34 112.129 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 30' ' ' ARG . 13.9 ttp180 -135.67 150.63 49.65 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.196 -0.456 . . . . 65.23 110.934 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.68 -171.45 16.75 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.019 -0.61 . . . . 60.24 113.243 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -119.96 131.38 55.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.228 0.537 . . . . 51.23 111.675 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.641 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.3 tp -105.0 114.1 28.1 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.959 -0.564 . . . . 73.23 110.494 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -95.08 148.52 34.81 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 112.269 0.47 . . . . 74.41 112.269 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 43' ' ' LEU . 34.8 Cg_endo -65.14 -35.03 43.85 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.048 2.499 . . . . 62.14 115.006 -170.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -74.08 -14.95 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.104 0.478 . . . . 74.51 111.403 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.31 1.51 57.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.326 0.584 . . . . 74.44 110.399 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.686 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 96.7 mmm -98.9 139.23 34.88 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.657 -0.701 . . . . 72.41 111.435 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mm -99.63 -79.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.897 0.38 . . . . 75.2 111.772 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -82.7 -29.45 29.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.748 0.647 . . . . 72.2 112.748 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 46' ' ' LEU . 70.5 mt -102.36 132.62 48.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.276 0.473 . . . . 65.13 112.276 -177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.7 mmm180 -104.95 148.79 26.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.504 0.321 . . . . 72.5 110.697 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 35' ' ' PRO . 66.8 mt -50.03 -36.71 29.85 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.625 0.726 . . . . 54.22 110.834 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.02 -19.24 61.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.762 -1.108 . . . . 74.24 112.067 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -112.74 -2.49 14.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.889 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 41' ' ' LEU . 38.2 mt -87.7 143.98 26.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.726 0.298 . . . . 65.24 110.907 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -126.38 158.66 35.33 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.183 0.516 . . . . 72.11 111.09 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.92 119.05 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.132 -0.486 . . . . 75.15 110.856 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.64 -7.66 31.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.957 -0.64 . . . . 73.44 113.958 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.87 131.31 41.35 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 117.578 0.689 . . . . 71.25 111.835 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -83.4 110.2 17.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.08 -0.509 . . . . 71.23 110.487 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 46' ' ' LEU . 48.0 mt -110.8 131.11 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.003 0.43 . . . . 70.55 111.536 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.57 117.86 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.339 -0.391 . . . . 73.43 110.63 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 52' ' ' ILE . 23.6 m -135.49 162.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.567 0.699 . . . . 72.22 112.099 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -108.27 135.85 48.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 54.14 110.242 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 125.07 26.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.762 0.315 . . . . 72.21 111.674 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 54.8 mt -85.12 -68.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.958 0.409 . . . . 65.23 110.935 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -127.43 128.05 45.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.842 0.353 . . . . 63.43 111.346 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.4 t -106.39 105.09 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 109.76 -0.459 . . . . 75.22 109.76 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -105.06 102.87 38.64 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.647 -0.252 . . . . 72.11 111.475 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.68 -40.72 70.64 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.677 2.251 . . . . 74.21 112.388 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.0 pt-20 -61.19 -25.99 67.41 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.158 -0.473 . . . . 72.22 111.933 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -104.6 -18.0 14.49 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 111.881 0.326 . . . . 72.15 111.881 -178.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 65.2 -0.92 0.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.062 0.764 . . . . 74.43 113.062 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.78 160.12 19.03 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.014 0.435 . . . . 73.54 111.385 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.62 142.18 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.152 -0.477 . . . . 63.22 111.88 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -84.69 133.35 34.39 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.779 0.323 . . . . 71.43 110.828 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -108.8 146.92 32.86 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.094 0.473 . . . . 64.44 111.526 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.6 ttpt -126.33 133.46 51.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.802 -0.635 . . . . 74.22 110.485 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.5 t80 -88.12 132.58 34.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 61.23 110.59 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.0 pt -123.92 145.98 49.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.451 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.78 -14.73 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.446 2.097 . . . . 64.54 112.44 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tt -81.7 79.86 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.399 -0.593 . . . . 71.05 109.399 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.964 -0.541 . . . . 63.4 111.74 -176.607 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.508 0.194 . . . . 74.54 110.718 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -78.09 144.03 36.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.741 0.305 . . . . 63.54 110.33 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 59' ' ' VAL . 64.4 t -105.2 125.37 60.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.092 0.472 . . . . 71.23 111.479 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -89.93 156.67 46.77 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 73.4 111.306 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.59 108.63 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.762 1.641 . . . . 41.11 111.542 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.87 7.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.431 -0.35 . . . . 73.44 113.51 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -85.32 161.52 19.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.195 0.521 . . . . 74.3 112.099 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -124.18 122.92 39.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.747 -0.66 . . . . 75.45 110.991 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' HD22 ' A' ' 25' ' ' LEU . 96.1 m-85 -143.61 154.04 43.15 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.841 0.353 . . . . 73.05 111.35 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.8 ttmt -95.19 109.1 21.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.966 0.413 . . . . 61.31 109.91 169.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.84 163.44 12.65 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.888 -0.672 . . . . 75.31 113.129 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.62 135.94 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.266 0.555 . . . . 52.12 112.039 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -75.09 118.8 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.949 -0.569 . . . . 73.54 111.746 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HG13 ' A' ' 48' ' ' VAL . 58.7 p -81.93 -58.29 3.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.83 0.348 . . . . 72.1 111.617 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 23.8 ptt85 -147.94 154.75 40.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.069 0.462 . . . . 74.54 111.745 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.32 130.79 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.085 -0.507 . . . . 71.03 111.415 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.04 168.79 9.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.703 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -81.99 10.11 7.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.05 0.452 . . . . 75.25 111.786 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -136.9 13.35 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.316 -0.402 . . . . 54.31 111.405 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.69 -172.31 23.12 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.255 -0.498 . . . . 42.14 112.974 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.64 132.72 46.8 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.617 -0.343 . . . . 41.3 111.542 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -77.37 118.16 19.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.918 0.39 . . . . 73.42 111.149 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.53 137.3 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.384 0.513 . . . . 62.14 112.384 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -93.86 124.75 38.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.162 -0.472 . . . . 74.11 111.367 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 9' ' ' TYR . 60.7 mt -95.28 -25.34 16.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.06 0.457 . . . . 53.01 110.691 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -161.27 167.28 26.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.893 -0.594 . . . . 72.24 110.508 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.13 -29.45 9.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.568 0.581 . . . . 54.44 112.568 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -119.87 9.99 11.45 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.388 0.514 . . . . 62.32 112.388 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.3 t -127.1 123.41 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.301 0.482 . . . . 73.44 112.301 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -142.25 153.94 44.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.265 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.61 -165.64 12.89 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.209 -0.52 . . . . 64.02 112.739 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.9 tp -130.86 122.59 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.951 0.405 . . . . 63.13 111.585 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 54' ' ' VAL . 45.7 tp -101.46 114.34 28.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.92 0.39 . . . . 60.22 110.64 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 13.2 mtm180 -92.06 156.09 42.48 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.442 -0.344 . . . . 65.51 111.742 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.8 Cg_endo -66.28 -20.16 55.69 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.29 1.993 . . . . 71.44 112.369 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 36' ' ' ARG . 17.2 mtp180 -68.85 -29.87 68.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.09 0.472 . . . . 74.14 111.263 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 3.0 m-20 -94.9 -4.98 45.91 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.459 0.647 . . . . 72.31 111.405 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 4.9 mmt -79.45 108.79 13.25 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.847 -0.615 . . . . 71.22 112.141 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.1 mm -70.94 -66.91 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.814 0.34 . . . . 72.12 111.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.4 m -93.41 -50.66 5.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.561 0.578 . . . . 73.24 112.561 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 38' ' ' MET . 70.7 mt -79.56 150.64 31.04 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.672 0.619 . . . . 71.42 112.672 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -117.59 151.23 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.985 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 80.8 mt -55.62 -35.54 66.0 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.3 0.572 . . . . 62.55 111.041 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -59.38 -16.07 20.62 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.202 -0.908 . . . . 73.33 112.388 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -112.97 -5.47 13.8 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.47 0.544 . . . . 71.1 112.47 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.06 140.37 32.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.961 0.41 . . . . 64.1 111.487 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.77 152.35 40.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.097 0.475 . . . . 75.25 111.651 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 14' ' ' THR . 87.1 t -59.76 113.07 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.706 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.69 -13.07 17.92 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.07 -0.586 . . . . 42.4 113.601 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -71.71 129.64 39.18 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.592 0.696 . . . . 74.33 111.279 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -100.14 114.24 27.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.241 0.543 . . . . 70.42 111.216 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.78 140.57 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.074 -0.512 . . . . 73.15 111.851 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 65.3 mt -82.18 111.74 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.875 0.369 . . . . 63.41 110.404 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 33' ' ' LEU . 27.1 m -123.24 149.18 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.298 0.571 . . . . 54.1 112.457 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -101.67 126.48 48.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 75.14 110.597 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.89 105.38 7.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.67 -0.241 . . . . 73.12 110.94 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' HB2' ' A' ' 69' ' ' LYS . 59.1 mt -68.29 -58.71 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.151 0.5 . . . . 71.41 110.802 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 67' ' ' ASP . 26.1 m-20 -127.74 157.76 39.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.775 -0.648 . . . . 60.01 110.902 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.5 t -129.83 126.09 61.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.223 -0.444 . . . . 71.22 110.367 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 51.5 mtt180 -98.81 97.74 5.33 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.534 -0.303 . . . . 73.24 110.641 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 31.5 Cg_exo -59.37 -64.29 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.619 2.213 . . . . 72.14 113.415 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.84 -37.32 84.03 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.233 0.457 . . . . 63.5 112.233 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 mmtm -79.4 -16.99 55.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 111.975 0.361 . . . . 64.22 111.975 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 61.75 35.16 16.95 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.375 0.509 . . . . 72.11 112.375 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.4 mt-10 -126.09 147.29 49.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.313 -0.403 . . . . 71.41 110.428 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.5 mt -123.21 131.95 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.964 0.411 . . . . 51.53 111.772 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 32.6 m-20 -85.91 118.9 25.68 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.002 -0.545 . . . . 74.14 111.033 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 25' ' ' LEU . 17.6 m-85 -108.15 157.41 18.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.307 0.575 . . . . 63.41 112.524 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 37' ' ' ASP . 36.2 ttpt -138.76 147.98 43.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.515 -0.766 . . . . 75.45 110.809 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 64.3 t80 -88.81 134.11 34.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.432 -0.21 . . . . 71.43 110.432 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 37.1 pt -123.71 134.44 25.31 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.988 0.366 . . . . 74.05 111.988 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 3.3 Cg_exo -78.24 117.37 4.09 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.758 2.305 . . . . 74.41 111.391 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.2 pt? -105.4 163.96 12.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.138 0.494 . . . . 73.3 112.048 -175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 118.514 -0.755 . . . . 62.21 111.484 -179.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.706 0.289 . . . . 75.42 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -142.01 143.22 33.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.858 0.361 . . . . 74.11 110.787 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 66' ' ' ILE . 46.9 t -89.56 135.69 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.242 0.544 . . . . 72.11 111.989 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -120.34 129.41 25.34 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.31 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.41 122.91 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.315 2.01 . . . . 70.44 112.075 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.1 34.59 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.317 -0.468 . . . . 64.14 113.172 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -81.98 168.62 17.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.184 0.516 . . . . 63.41 112.044 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -102.86 133.08 48.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.847 -0.615 . . . . 71.45 112.109 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -146.59 145.39 30.07 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.133 0.492 . . . . 73.54 111.735 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -98.07 144.04 27.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.403 -0.362 . . . . 74.51 110.95 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.92 168.7 29.39 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.761 -0.733 . . . . 63.52 113.611 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.74 137.65 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 120.906 0.384 . . . . 61.24 111.643 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.0 t -73.1 130.94 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.036 0.446 . . . . 72.12 111.874 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -91.35 -64.4 1.13 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.203 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ptt-85 -144.04 156.87 44.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.395 -0.366 . . . . 71.42 110.834 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -97.09 121.82 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.946 0.403 . . . . 64.2 111.579 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 9.5 mm-40 -107.63 161.77 14.56 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.018 0.437 . . . . 33.23 111.191 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.3 10.19 2.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.971 0.415 . . . . 64.15 112.099 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -135.38 8.16 3.38 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.83 0.348 . . . . 73.14 111.371 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 142.08 179.11 18.79 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 116.378 -0.374 . . . . 64.34 112.563 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.53 131.26 56.23 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.175 -0.603 . . . . 54.15 111.41 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 17' ' ' GLU . 76.0 m-85 -76.9 117.76 18.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.117 0.484 . . . . 71.43 111.161 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.55 131.66 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.578 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -97.24 121.0 38.63 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.594 -0.275 . . . . 72.33 111.062 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.2 mt -80.56 -21.15 42.0 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.119 0.485 . . . . 72.22 110.929 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -164.6 167.29 19.41 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.769 -0.651 . . . . 70.14 110.347 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -48.31 -32.88 7.99 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.815 0.672 . . . . 64.1 112.815 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.55 11.54 13.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.376 0.51 . . . . 64.15 112.376 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.87 110.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.177 0.436 . . . . 73.55 112.177 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -109.21 148.24 31.26 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.036 0.446 . . . . 72.2 111.374 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -148.31 -176.13 21.51 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.187 -0.53 . . . . 71.15 112.873 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 tp -135.37 124.14 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.223 0.535 . . . . 72.03 111.569 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' SD ' ' A' ' 38' ' ' MET . 48.4 tp -101.2 115.79 31.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.071 -0.513 . . . . 54.02 110.625 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -99.31 141.88 23.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.045 0.387 . . . . 74.24 112.045 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' HD11 ' A' ' 43' ' ' LEU . 20.8 Cg_endo -60.8 -30.06 89.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.979 2.453 . . . . 75.44 113.995 -174.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.99 -17.51 61.45 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.982 -0.449 . . . . 72.14 111.735 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -101.33 9.68 41.4 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.083 0.468 . . . . 70.53 110.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.3 mmm -107.18 128.16 54.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.767 0.427 . . . . 61.4 111.846 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 70' ' ' TYR . 31.5 mm -88.01 -80.99 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.859 0.362 . . . . 61.1 111.877 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -77.94 -49.11 14.78 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.812 0.671 . . . . 73.41 112.812 -173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' HB3' HD21 ' A' ' 46' ' ' LEU . 92.3 mt -80.17 118.34 21.77 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.394 0.516 . . . . 65.43 112.394 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 mmt180 -89.95 146.81 24.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.959 -0.564 . . . . 73.14 111.033 175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.413 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.5 mt -53.21 -30.55 38.35 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.085 0.469 . . . . 71.15 111.369 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -60.11 -36.23 76.99 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.185 0.516 . . . . 45.51 111.85 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -89.19 -14.01 37.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.105 -0.498 . . . . 62.53 111.536 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 41' ' ' LEU . 43.7 mt -84.54 129.71 34.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.933 0.397 . . . . 72.1 110.963 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.88 175.45 8.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.973 0.416 . . . . 73.42 110.975 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.02 130.13 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.11 111.041 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.29 -11.27 61.75 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.943 -0.646 . . . . 43.32 113.835 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.58 117.29 9.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.422 0.611 . . . . 53.14 111.395 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.5 105.3 17.5 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.074 0.464 . . . . 73.55 110.61 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 46' ' ' LEU . 57.0 mt -107.39 135.71 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.228 0.537 . . . . 71.24 111.82 -173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -91.2 125.4 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.959 -0.564 . . . . 72.34 110.089 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.92 169.18 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.503 0.668 . . . . 64.22 112.563 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -105.98 139.01 41.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.586 -0.734 . . . . 63.43 110.38 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.36 136.51 38.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.742 0.306 . . . . 40.33 111.436 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 69' ' ' LYS . 31.7 mt -93.56 -67.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.257 0.551 . . . . 75.12 110.664 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.12 142.33 48.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.603 -0.726 . . . . 61.45 110.636 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 HG12 ' A' ' 66' ' ' ILE . 67.7 t -105.1 104.67 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.707 -0.479 . . . . 73.5 109.707 173.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -106.3 96.52 13.72 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 112.038 0.384 . . . . 74.04 112.038 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -28.36 24.71 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.44 2.093 . . . . 71.41 111.545 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 11.6 pt-20 -55.79 -46.15 78.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.586 -0.733 . . . . 71.13 112.076 176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.46 -3.76 42.83 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.481 -0.327 . . . . 72.2 111.091 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 61.68 29.94 18.32 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.996 0.518 . . . . 71.54 111.477 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -128.86 127.4 41.78 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.195 0.522 . . . . 71.4 111.613 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 3' ' ' VAL . 62.3 mt -107.53 118.94 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.007 -0.542 . . . . 51.44 110.227 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.53 132.71 34.14 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.997 0.369 . . . . 71.25 111.997 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 25.1 m-85 -110.39 164.22 12.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.199 0.523 . . . . 74.13 111.979 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -150.35 132.21 15.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.586 . . . . 61.11 111.361 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' ILE . 12.2 t80 -92.98 115.18 27.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.076 -0.713 . . . . 73.53 109.076 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.458 HG12 ' OE2' ' A' ' 74' ' ' GLU . 24.3 pt -91.59 151.54 42.56 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.127 -0.358 . . . . 70.45 111.186 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.49 -15.81 4.5 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.187 2.592 . . . . 53.45 114.357 -174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 tp -139.74 102.62 4.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.682 0.277 . . . . 65.43 111.354 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' OE2' HG12 ' A' ' 71' ' ' ILE . 72.3 mm-40 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.761 -0.637 . . . . 72.24 111.412 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.531 0.205 . . . . 53.02 111.421 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -110.8 144.38 39.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.936 0.398 . . . . 63.14 111.0 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 29' ' ' VAL . 96.7 t -119.23 124.98 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.151 0.501 . . . . 70.22 112.253 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -108.78 161.55 23.21 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.929 -0.578 . . . . 74.43 110.865 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 37.6 Cg_endo -65.96 144.85 78.03 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.283 1.989 . . . . 72.3 112.666 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.3 14.07 82.93 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.479 -0.391 . . . . 63.24 113.79 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -100.62 154.99 18.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.218 0.532 . . . . 72.54 112.119 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -101.01 116.81 33.72 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.15 -0.477 . . . . 74.11 111.032 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -143.16 142.26 31.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.539 0.685 . . . . 73.45 112.718 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 80.3 tttt -87.5 137.64 32.17 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.651 -0.704 . . . . 73.04 110.868 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.81 -178.18 15.54 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.039 -0.6 . . . . 70.52 113.209 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -127.82 138.29 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 120.864 0.364 . . . . 70.23 111.713 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -73.67 126.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.567 -0.288 . . . . 60.32 111.61 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.5 p -101.94 -42.61 6.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.166 0.432 . . . . 53.14 112.166 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -155.02 146.85 23.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.106 0.479 . . . . 75.13 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 mm -99.36 116.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 116.006 -0.543 . . . . 53.3 111.11 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 16.1 mm-40 -106.16 178.32 4.59 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.335 0.588 . . . . 52.21 112.269 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -83.86 8.16 15.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.915 -0.584 . . . . 74.5 111.807 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -142.65 14.39 1.95 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.403 . . . . 72.33 111.504 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.07 -176.13 20.2 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.425 -0.417 . . . . 73.41 112.58 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.83 132.8 56.39 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.582 -0.363 . . . . 73.43 111.29 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 61.4 m-85 -77.44 113.51 15.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.205 0.526 . . . . 74.31 111.116 177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.64 129.51 69.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.796 -0.638 . . . . 72.42 111.103 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.45 122.99 42.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.867 0.365 . . . . 74.13 111.101 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.78 -24.56 38.51 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.179 0.514 . . . . 72.35 110.525 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 58.2 t30 -160.52 167.0 28.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.01 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.82 -48.95 11.03 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 112.745 0.646 . . . . 73.41 112.745 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -97.72 1.49 48.57 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.519 0.562 . . . . 62.34 112.519 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 3' ' ' VAL . 60.1 t -109.93 105.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.427 0.528 . . . . 75.22 112.427 -175.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.05 139.9 43.3 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.074 -0.512 . . . . 72.34 110.929 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -143.38 176.95 22.53 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.862 -0.685 . . . . 55.04 113.406 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 tp -127.31 126.74 43.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.126 0.488 . . . . 72.45 111.47 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.1 tp -104.12 113.85 27.69 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.098 -0.501 . . . . 71.12 110.407 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -95.32 146.72 31.82 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-O 120.967 0.413 . . . . 75.11 111.904 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.09 -33.82 65.37 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.296 2.664 . . . . 74.34 114.602 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -78.16 -12.32 59.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.326 0.491 . . . . 63.14 112.326 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 12.3 m-20 -94.88 5.12 52.82 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.1 0.476 . . . . 74.35 111.28 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 33' ' ' LEU . 96.3 mmm -92.86 151.34 20.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.057 0.456 . . . . 62.33 111.958 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.1 mm -104.66 -67.68 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.841 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 m -115.76 -1.68 12.59 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.044 0.757 . . . . 73.41 113.044 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -114.92 131.76 56.77 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.289 0.566 . . . . 64.44 112.486 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -101.84 148.03 25.8 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.673 -0.694 . . . . 74.2 110.893 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.37 -28.31 58.8 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.486 0.66 . . . . 75.43 110.68 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.14 -11.42 57.22 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.216 -0.902 . . . . 61.1 111.746 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -112.16 -19.47 12.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.413 -0.358 . . . . 62.23 111.55 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 52' ' ' ILE . 59.7 mt -75.65 137.84 40.98 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.06 0.457 . . . . 65.12 111.43 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -123.5 159.2 29.6 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.973 0.416 . . . . 73.52 110.758 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.68 113.05 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.741 0.305 . . . . 64.42 110.326 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.1 -8.41 18.56 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.655 -0.783 . . . . 75.54 113.783 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -75.57 122.36 23.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.308 0.554 . . . . 63.35 110.938 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.684 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 52.1 mt-10 -93.35 121.83 35.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.217 -0.447 . . . . 72.15 111.121 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HD22 ' A' ' 46' ' ' LEU . 55.4 mt -120.81 137.69 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.866 0.365 . . . . 65.51 111.904 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.7 mt -83.67 110.7 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.972 0.415 . . . . 53.32 110.356 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.14 161.27 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.78 0.8 . . . . 62.51 112.488 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -104.53 121.35 43.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 62.24 110.414 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.53 94.41 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 75.51 110.647 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 69' ' ' LYS . 56.4 mt -57.47 -68.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.373 -0.376 . . . . 74.13 111.578 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 28.6 m-20 -132.66 146.21 51.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.147 0.499 . . . . 65.11 111.326 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.7 t -106.65 107.99 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.126 -0.488 . . . . 51.51 110.16 175.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -93.38 100.32 4.23 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.724 -0.216 . . . . 71.04 110.929 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 27.7 Cg_exo -61.81 -63.1 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.574 2.182 . . . . 63.22 112.819 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.2 -33.45 72.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.295 -0.411 . . . . 73.42 112.095 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.35 -16.73 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.762 0.282 . . . . 72.42 111.762 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 62.18 28.96 17.37 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.991 0.424 . . . . 70.05 111.677 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -125.65 126.53 44.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.55 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 59' ' ' VAL . 61.1 mt -108.06 124.78 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 110.095 -0.335 . . . . 71.11 110.095 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 50.9 m-20 -85.31 125.21 32.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.869 0.366 . . . . 60.53 111.949 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 20.6 m-85 -111.09 149.69 30.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.385 0.612 . . . . 74.34 112.132 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.3 ttpt -134.2 149.43 51.0 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.076 -0.965 . . . . 64.13 109.469 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -86.74 118.64 26.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.458 . . . . 74.42 109.821 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 pt -108.95 128.8 24.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.045 -0.525 . . . . 65.32 112.055 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 74.4 Cg_endo -75.95 91.68 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.178 1.918 . . . . 64.51 111.396 172.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.91 88.87 0.39 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.973 0.416 . . . . 73.24 110.005 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 72' ' ' PRO . 10.2 pt-20 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.586 -0.721 . . . . 73.35 111.695 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.722 0.296 . . . . 71.31 111.718 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -107.44 157.22 18.16 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.99 0.424 . . . . 55.43 110.384 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 25' ' ' LEU . 86.6 t -110.42 128.98 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.347 0.499 . . . . 70.54 112.347 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 39.6 mt-10 -110.55 153.12 43.68 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.847 -0.615 . . . . 73.24 110.635 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.86 138.31 67.87 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.332 2.021 . . . . 72.44 112.356 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.18 1.28 90.49 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.442 -0.408 . . . . 51.14 114.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 74.6 mmtt -93.04 145.01 24.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.453 0.626 . . . . 74.34 112.283 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.19 127.34 42.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.882 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -138.9 163.14 33.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.103 0.478 . . . . 73.42 112.052 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -99.0 121.74 41.36 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.322 -0.399 . . . . 75.05 110.348 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.553 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -124.52 166.31 17.2 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.047 -0.597 . . . . 73.23 112.553 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.17 135.43 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.109 0.481 . . . . 75.13 112.043 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.13 117.34 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.064 -0.517 . . . . 70.32 111.433 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.4 p -88.74 -51.21 5.78 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.665 0.269 . . . . 74.32 111.703 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -149.48 146.73 27.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.826 0.346 . . . . 61.02 110.984 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.9 114.5 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.949 0.404 . . . . 55.24 111.055 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 8.2 mm-40 -98.59 155.11 17.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 72.12 111.187 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -62.73 -12.54 24.53 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.934 -0.575 . . . . 72.15 112.088 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -121.42 11.32 10.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.141 0.423 . . . . 45.33 112.141 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 148.96 176.56 22.38 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.997 -0.62 . . . . 32.51 112.943 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.13 125.46 52.38 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 122.182 -0.599 . . . . 65.2 111.271 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 52.9 m-85 -79.14 116.1 19.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.355 0.597 . . . . 60.25 110.973 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 135.36 60.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.721 -0.672 . . . . 74.22 111.61 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -107.8 121.5 44.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.24 -0.436 . . . . 50.43 110.714 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD23 ' HA3' ' A' ' 11' ' ' GLY . 39.2 mt -80.35 -19.73 45.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.221 0.534 . . . . 75.35 111.201 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -164.01 162.42 23.18 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.982 -0.747 . . . . 65.43 108.982 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' HE21 ' A' ' 28' ' ' GLN . 44.6 tt0 -53.4 -46.9 69.89 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.448 0.536 . . . . 64.21 112.448 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HG2' ' A' ' 27' ' ' GLU . 30.3 mm-40 -84.47 4.15 33.03 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.5 t -110.52 138.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.126 0.489 . . . . 41.43 111.909 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -143.51 132.79 23.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.145 -0.48 . . . . 74.12 111.016 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -155.51 -177.85 29.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.326 -0.94 . . . . 22.12 114.546 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.0 tp -131.81 129.1 40.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.146 0.498 . . . . 74.02 111.342 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.75 HD21 ' SD ' ' A' ' 38' ' ' MET . 47.7 tp -95.74 118.85 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.079 -0.509 . . . . 75.05 110.582 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -89.31 132.69 36.71 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.409 -0.36 . . . . 74.35 111.923 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.49 -27.02 81.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.47 2.114 . . . . 44.32 112.849 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -65.8 -23.86 66.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.074 0.464 . . . . 70.3 111.27 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.702 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 43.0 m-20 -106.46 14.4 27.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.033 -0.531 . . . . 72.12 111.511 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.75 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.9 mmm -92.08 120.56 32.81 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.151 -0.477 . . . . 75.33 111.215 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.07 -82.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 111.92 0.341 . . . . 61.32 111.92 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -72.84 -51.28 19.47 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.268 0.556 . . . . 75.42 111.989 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 38' ' ' MET . 87.4 mt -89.9 142.56 27.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.275 0.472 . . . . 74.21 112.275 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 37.7 mmt180 -115.31 160.73 19.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.44 -0.345 . . . . 65.11 110.467 173.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -52.85 -34.81 56.01 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.29 0.567 . . . . 55.11 111.54 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -58.61 -21.2 52.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.434 -0.803 . . . . 54.24 112.585 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -112.82 -3.67 14.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.566 0.58 . . . . 74.34 112.566 -175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 41' ' ' LEU . 41.3 mt -85.95 138.55 31.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.899 0.381 . . . . 73.53 111.578 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -124.6 151.56 44.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.398 0.618 . . . . 71.42 111.774 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.95 118.89 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 72.3 111.125 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -22.37 11.54 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.124 -0.56 . . . . 72.14 113.536 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -63.0 117.2 6.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.097 0.448 . . . . 74.32 111.143 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.73 98.41 11.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.187 0.518 . . . . 74.11 110.186 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.9 143.99 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 74.31 111.966 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.46 111.63 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.218 0.533 . . . . 74.23 111.236 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.82 155.14 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.003 -0.544 . . . . 63.43 111.419 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -96.17 125.96 41.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.809 0.338 . . . . 73.2 111.047 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -73.7 101.68 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.437 -0.347 . . . . 71.44 110.534 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.5 mt -58.51 -68.18 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.51 -0.314 . . . . 64.52 111.369 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -138.11 148.77 45.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.196 0.522 . . . . 64.24 111.463 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.64 128.85 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.781 -0.645 . . . . 74.34 110.862 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 85.6 mtt-85 -117.19 98.31 51.79 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 112.269 0.47 . . . . 55.35 112.269 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.36 -24.61 43.01 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.36 2.04 . . . . 62.53 111.513 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 16.5 pt-20 -54.78 -40.29 69.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.311 -0.859 . . . . 65.11 111.811 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 12.6 mmmm -114.75 -12.35 12.16 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.056 -0.52 . . . . 63.31 111.37 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 60.98 39.73 16.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.514 0.673 . . . . 73.14 110.574 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.34 146.81 49.41 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.289 -0.869 . . . . 50.42 110.257 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.405 ' H ' ' HA2' ' A' ' 31' ' ' GLY . 55.0 mt -130.33 125.96 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 120.499 0.19 . . . . 65.24 111.135 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -85.25 137.22 33.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.773 0.321 . . . . 55.22 111.515 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 26.7 m-85 -116.55 158.53 23.52 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.396 0.617 . . . . 70.44 112.659 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.702 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.0 ttpt -131.12 143.17 50.45 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.333 -0.848 . . . . 73.5 110.553 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.3 t80 -89.45 138.48 31.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.794 0.33 . . . . 74.2 111.273 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.5 pt -131.96 144.57 53.77 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.717 0.294 . . . . 74.25 111.343 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.87 114.85 3.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.45 2.1 . . . . 70.11 111.769 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.47 120.05 10.94 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.554 0.576 . . . . 51.32 112.554 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.751 -0.642 . . . . 70.23 110.828 174.064 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.683 0.277 . . . . 73.12 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -94.14 161.05 14.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.594 -0.275 . . . . 73.04 110.271 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 25' ' ' LEU . 91.2 t -127.85 123.27 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.745 0.646 . . . . 71.55 112.745 -173.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -89.86 155.53 47.61 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.847 -0.615 . . . . 62.33 111.145 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 124.01 12.2 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.504 2.136 . . . . 71.04 112.843 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 8.91 54.53 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.445 -0.343 . . . . 61.01 113.641 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -93.53 159.53 15.19 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.265 0.839 . . . . 52.22 113.265 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -103.44 122.59 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.241 -0.89 . . . . 72.03 111.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -148.21 151.46 35.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.488 0.551 . . . . 65.1 112.488 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -92.9 128.96 38.95 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.043 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -129.7 164.51 22.48 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.895 -0.669 . . . . 23.31 113.118 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.1 134.47 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.172 0.511 . . . . 71.43 111.94 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 114.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.148 -0.478 . . . . 53.33 111.551 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 48' ' ' VAL . 66.2 p -78.85 -41.9 28.85 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 111.744 0.275 . . . . 74.52 111.744 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.0 ptt180 -156.28 153.14 28.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.015 0.436 . . . . 55.23 111.834 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.1 mm -98.32 122.52 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.933 -0.576 . . . . 73.42 111.4 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -114.28 154.19 28.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.321 0.582 . . . . 74.14 111.258 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -70.15 -3.82 18.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.892 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -122.31 11.75 10.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.409 -0.359 . . . . 62.31 111.745 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.39 -167.92 26.37 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.094 -0.574 . . . . 73.42 112.956 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.12 126.44 35.72 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.223 -0.575 . . . . 55.22 111.256 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -77.4 111.23 12.88 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.125 0.488 . . . . 74.11 110.977 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -111.17 132.72 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.153 -0.476 . . . . 63.11 111.912 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -98.54 116.62 31.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.39 -0.368 . . . . 72.12 110.792 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD12 HG21 ' A' ' 3' ' ' VAL . 81.6 mt -78.28 -30.06 48.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.582 0.706 . . . . 64.24 109.532 171.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -149.15 161.44 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.866 -1.061 . . . . 74.13 109.227 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -52.88 -32.77 46.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.034 0.445 . . . . 72.44 111.77 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -111.58 20.18 17.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.958 0.408 . . . . 73.14 111.672 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -134.41 103.8 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 122.576 0.351 . . . . 30.13 110.973 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -124.31 145.73 49.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.012 0.434 . . . . 75.41 112.019 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.69 -173.84 19.82 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.151 -0.547 . . . . 43.04 113.034 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.2 tp -124.59 122.97 39.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.047 0.451 . . . . 71.25 111.508 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD21 ' SD ' ' A' ' 38' ' ' MET . 54.4 tp -96.31 113.4 24.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.506 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 20.5 mtm-85 -92.7 147.64 34.55 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.611 -0.268 . . . . 72.52 111.626 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HD3' HD11 ' A' ' 43' ' ' LEU . 30.3 Cg_endo -61.63 -32.3 87.17 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.545 2.163 . . . . 75.4 112.92 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -74.93 -16.75 60.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.254 -0.43 . . . . 63.53 111.64 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.7 m-20 -95.48 5.84 50.52 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.307 0.575 . . . . 74.33 110.946 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.57 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.4 mmm -96.88 153.23 18.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.708 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.4 mm -107.36 -74.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.97 0.414 . . . . 71.44 111.381 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -86.92 -51.62 5.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.997 0.427 . . . . 61.25 111.819 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 46' ' ' LEU . 85.7 mt -79.5 126.95 31.53 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.248 0.462 . . . . 74.33 112.248 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -102.84 160.18 14.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.302 -0.408 . . . . 70.23 110.272 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.471 HD11 ' HD3' ' A' ' 35' ' ' PRO . 82.0 mt -53.3 -32.04 46.83 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.117 0.484 . . . . 74.23 111.438 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -59.87 -23.88 63.79 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 72.41 112.196 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.66 0.59 26.49 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 52' ' ' ILE . 32.3 mt -95.98 138.7 33.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.877 0.37 . . . . 70.22 111.186 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -127.45 163.41 24.14 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.024 0.44 . . . . 73.22 111.379 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' THR . 80.8 t -69.08 113.2 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.893 0.378 . . . . 74.45 111.116 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.97 -13.85 16.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.208 -0.52 . . . . 51.24 113.847 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -64.2 123.83 20.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 117.652 0.726 . . . . 74.4 112.016 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -88.7 107.26 18.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.261 0.553 . . . . 72.43 110.498 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 59.0 mt -110.7 141.34 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.98 -0.555 . . . . 74.04 111.803 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.0 mt -83.98 108.96 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 120.883 0.373 . . . . 64.32 110.661 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.09 170.58 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.503 0.668 . . . . 73.24 111.868 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -117.71 128.4 54.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 71.32 110.977 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 105.02 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 61.52 110.734 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 69' ' ' LYS . 46.1 mt -60.29 -70.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.122 0.487 . . . . 73.41 110.747 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -133.9 145.8 49.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.898 -0.592 . . . . 74.55 110.968 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 79.7 t -109.69 122.56 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 72.01 110.248 176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -100.69 98.17 7.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.879 -0.146 . . . . 73.24 111.333 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 38.6 Cg_exo -60.45 -33.51 93.95 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.352 2.035 . . . . 53.04 111.991 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.55 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.97 -41.44 87.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.439 -0.801 . . . . 75.12 112.278 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -105.14 -15.09 15.18 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.318 0.488 . . . . 60.54 112.318 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 65.97 14.77 9.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.151 0.501 . . . . 74.25 111.349 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -102.58 137.5 40.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.022 -0.535 . . . . 72.3 110.939 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.47 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -112.14 133.08 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.954 0.407 . . . . 71.14 111.49 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 34' ' ' ARG . 28.7 m-20 -85.38 126.8 34.05 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.407 -0.361 . . . . 63.31 110.585 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -109.99 153.04 25.12 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.633 0.605 . . . . 74.22 112.633 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.4 ttpm? -135.17 145.19 47.51 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.807 -0.633 . . . . 65.13 109.999 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 62.4 t80 -89.08 135.12 33.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.897 0.379 . . . . 72.21 110.694 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.8 pt -132.85 140.27 37.16 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.308 -0.405 . . . . 64.13 111.576 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.96 141.88 19.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.413 2.075 . . . . 71.53 112.427 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 74' ' ' GLU . 5.9 tt -126.48 132.74 51.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.825 0.345 . . . . 65.21 110.451 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' N ' HD23 ' A' ' 73' ' ' LEU . 16.2 pt-20 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.581 -0.724 . . . . 50.32 111.964 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 24.1 ttt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.769 0.319 . . . . 53.31 111.536 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -136.73 149.13 47.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.413 -0.358 . . . . 73.13 110.16 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG21 HD12 ' A' ' 25' ' ' LEU . 87.5 t -111.56 130.43 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.419 0.628 . . . . 62.31 112.553 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.33 152.09 39.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.553 -0.748 . . . . 75.41 111.024 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.68 118.11 5.19 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.403 2.069 . . . . 74.33 112.76 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.85 -8.94 31.92 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.339 -0.458 . . . . 62.23 113.546 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -84.63 158.45 20.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.038 0.446 . . . . 71.24 112.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.53 128.92 50.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.201 -0.454 . . . . 73.2 111.652 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -149.93 157.45 43.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.134 0.492 . . . . 71.44 111.632 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 37.7 ttmt -86.59 141.33 29.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.04 -0.355 . . . . 73.13 110.04 169.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 149.8 19.25 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.016 -0.611 . . . . 74.04 112.911 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.7 129.6 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.109 0.48 . . . . 53.52 111.238 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 23' ' ' ILE . 61.9 t -70.82 128.6 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.176 0.436 . . . . 74.33 112.176 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -92.86 -53.33 4.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.272 -0.422 . . . . 60.54 111.413 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -146.6 151.01 36.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.124 0.488 . . . . 73.44 112.164 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.3 mm -95.8 122.14 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.97 -0.559 . . . . 70.21 111.375 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -108.85 164.01 12.77 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.267 0.556 . . . . 55.42 111.755 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -69.55 -18.52 63.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.244 0.545 . . . . 74.32 111.117 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 20.42 13.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 73.3 111.748 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.49 -151.18 20.76 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 121.212 -0.518 . . . . 42.51 112.836 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.52 22.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.491 -0.417 . . . . 72.23 111.411 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.99 136.35 38.71 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.707 0.289 . . . . 71.24 110.658 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LEU . 53.2 mt -136.95 141.86 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.529 0.566 . . . . 72.24 112.529 -172.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.81 123.23 47.32 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.064 -0.516 . . . . 74.4 110.783 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.762 HD12 HG21 ' A' ' 3' ' ' VAL . 58.7 mt -83.89 -17.31 41.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.829 0.824 . . . . 72.24 110.01 172.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.3 t-20 -164.1 151.69 12.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.199 . . . . 63.34 108.121 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 32.4 tt0 -51.39 -25.24 5.84 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.181 0.515 . . . . 71.11 111.403 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.28 -29.51 15.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.114 -0.494 . . . . 73.24 112.035 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 3' ' ' VAL . 60.2 t -102.93 115.97 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.189 0.44 . . . . 73.21 112.189 -175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -126.17 153.04 45.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.276 -0.42 . . . . 73.31 111.587 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.27 -159.58 10.38 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.134 -0.555 . . . . 52.02 113.417 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 tp -136.33 132.71 36.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.12 0.486 . . . . 74.13 111.8 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 38' ' ' MET . 45.7 tp -95.68 127.45 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.287 -0.415 . . . . 63.24 110.69 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 34' ' ' ARG . 50.2 mtt180 -100.24 134.42 20.8 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 112.129 0.418 . . . . 64.24 112.129 -174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.1 Cg_exo -60.85 -32.26 92.53 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.217 2.611 . . . . 54.14 113.772 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 36' ' ' ARG . 45.7 mtt180 -62.64 -28.99 70.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.091 0.472 . . . . 74.43 111.013 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.812 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 7.2 m-20 -98.87 5.94 47.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.861 -0.609 . . . . 74.12 112.001 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.732 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -85.3 106.54 16.77 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 75.03 111.009 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 72' ' ' PRO . 48.8 mm -72.64 -65.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.308 0.485 . . . . 54.4 112.308 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -99.86 -48.55 4.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.772 0.656 . . . . 74.04 112.772 -173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 46' ' ' LEU . 61.5 mt -79.52 119.65 22.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.333 0.587 . . . . 75.34 112.195 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -92.01 147.89 22.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 62.13 110.563 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HG3' ' A' ' 35' ' ' PRO . 81.0 mt -51.81 -30.27 22.57 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.019 0.378 . . . . 54.4 112.019 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.13 -26.6 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.133 -0.485 . . . . 64.33 112.004 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -103.28 -8.1 20.6 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.42 0.526 . . . . 64.42 112.42 -173.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 42.3 mt -80.93 145.11 31.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.003 0.43 . . . . 53.51 111.956 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -127.46 174.94 8.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.015 0.436 . . . . 74.3 111.198 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.92 113.65 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.845 0.355 . . . . 75.5 110.814 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.01 -4.57 28.78 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.957 -0.64 . . . . 74.41 114.386 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -63.82 121.17 13.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 117.838 0.819 . . . . 72.14 111.848 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 49.9 mt-10 -81.9 100.27 9.54 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.176 -0.466 . . . . 70.32 110.689 175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.4 mt -107.36 137.21 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 74.51 111.683 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.9 mt -84.1 117.22 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.707 0.289 . . . . 70.23 110.984 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.94 166.07 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.602 0.715 . . . . 71.55 112.74 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -118.79 140.4 50.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.558 -0.746 . . . . 75.13 110.301 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.78 134.9 45.15 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.014 0.435 . . . . 53.52 111.979 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 59.2 mt -95.35 -70.93 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.012 0.434 . . . . 75.31 110.765 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -127.96 140.43 51.99 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.084 -0.507 . . . . 71.11 111.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 66' ' ' ILE . 93.2 t -121.53 106.06 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.029 0.442 . . . . 61.14 110.631 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -105.4 96.8 12.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.283 -0.417 . . . . 73.14 110.827 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -39.87 29.52 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.646 2.231 . . . . 71.54 112.638 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.92 -19.58 66.01 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.997 0.427 . . . . 73.45 111.708 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.87 -10.93 15.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.401 -0.363 . . . . 64.43 111.141 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 59.78 23.83 12.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.947 -0.57 . . . . 64.33 111.427 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -96.03 132.19 41.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.905 -0.589 . . . . 61.41 111.576 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG23 HG22 ' A' ' 59' ' ' VAL . 56.0 mt -129.77 110.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.746 0.308 . . . . 62.33 110.265 171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 51.9 m-20 -84.97 136.37 33.63 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.67 0.271 . . . . 65.0 111.178 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -111.17 155.24 23.21 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.172 0.511 . . . . 73.24 111.95 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.812 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 37.9 ttpt -132.71 141.27 48.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.68 -0.691 . . . . 64.22 110.588 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.492 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 57.3 t80 -89.02 131.38 35.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.598 0.237 . . . . 75.43 110.387 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.18 139.68 36.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 111.986 0.365 . . . . 75.44 111.986 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HG3' HG21 ' A' ' 39' ' ' ILE . 7.8 Cg_exo -72.94 108.42 2.58 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.618 2.212 . . . . 75.41 111.543 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.05 106.44 11.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.069 0.461 . . . . 73.23 110.697 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.973 -0.537 . . . . 51.41 111.156 178.335 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 25.8 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.883 0.373 . . . . 74.22 111.202 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -153.51 133.85 13.48 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.291 -0.413 . . . . 72.13 110.11 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 29' ' ' VAL . 61.8 t -120.54 124.46 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.883 0.697 . . . . 64.22 112.883 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -95.11 173.0 4.79 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.536 -0.757 . . . . 74.41 110.195 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 14.5 Cg_exo -70.66 154.67 64.04 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 121.834 1.689 . . . . 64.24 112.084 167.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 67.43 22.08 72.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.592 0.597 . . . . 74.1 114.592 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.4 mmpt? -95.32 150.19 20.53 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.478 0.639 . . . . 62.32 112.334 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.33 119.89 39.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.982 -0.553 . . . . 72.53 111.35 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -146.93 161.03 41.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.114 0.483 . . . . 72.43 111.582 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 40.5 ttmt -101.53 122.54 44.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.515 -0.311 . . . . 63.52 110.434 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.43 167.56 15.69 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.956 -0.64 . . . . 65.33 113.18 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 7.2 p -110.13 132.9 57.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.982 0.42 . . . . 71.23 111.653 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.85 127.21 32.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.968 0.413 . . . . 71.32 111.353 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 81.7 p -103.76 -64.35 1.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.114 0.413 . . . . 74.4 112.114 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.468 HH21 ' CD ' ' A' ' 17' ' ' GLU . 15.9 ptm180 -126.95 138.24 53.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.183 0.516 . . . . 74.44 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.82 120.42 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.823 -0.626 . . . . 73.52 111.42 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' CD ' HH21 ' A' ' 15' ' ' ARG . 26.2 mm-40 -107.26 176.87 5.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.124 0.488 . . . . 72.24 110.551 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -88.11 -21.93 24.39 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.098 0.475 . . . . 74.02 110.707 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -98.01 4.41 49.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.171 -0.468 . . . . 65.3 111.966 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.01 -169.45 31.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.118 -0.563 . . . . 65.31 113.097 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.49 126.69 28.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.266 -0.55 . . . . 72.35 111.154 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.56 124.46 27.64 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.196 0.522 . . . . 74.02 111.437 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.23 138.06 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.052 -0.522 . . . . 72.13 111.701 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.25 125.17 46.39 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.601 -0.272 . . . . 74.32 111.23 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.8 mt -89.25 -13.71 37.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.917 0.865 . . . . 54.01 109.176 168.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.565 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 45.0 t-20 -169.52 160.54 9.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.422 -1.263 . . . . 74.25 108.534 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 35.4 tt0 -48.11 -39.16 19.53 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.108 0.48 . . . . 61.12 111.772 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.413 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.4 mm-40 -95.5 -25.61 16.14 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.324 0.49 . . . . 55.25 112.324 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -91.95 102.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.131 0.491 . . . . 75.33 111.379 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.42 137.98 50.1 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 74.54 111.149 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.2 -164.79 10.88 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.864 -0.684 . . . . 71.23 113.33 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.36 130.07 48.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.126 0.488 . . . . 71.15 111.488 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD21 ' SD ' ' A' ' 38' ' ' MET . 56.5 tp -93.79 115.7 28.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.165 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 22.6 mtm180 -83.53 140.0 41.34 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 111.816 0.302 . . . . 71.2 111.816 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 43' ' ' LEU . 34.4 Cg_exo -59.5 -34.6 97.03 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.786 2.324 . . . . 72.4 113.449 -175.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -79.11 -13.53 59.68 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.278 0.473 . . . . 74.45 112.278 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.666 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.0 m-20 -98.42 10.05 41.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.29 0.567 . . . . 71.11 111.324 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.71 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.0 mmm -88.94 120.01 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.206 -0.452 . . . . 64.41 111.456 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 50.7 mm -80.4 -66.44 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 111.965 0.357 . . . . 64.13 111.965 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.7 m -90.38 -62.85 1.37 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.089 0.471 . . . . 73.44 112.181 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.9 mt -80.39 151.52 29.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.607 0.595 . . . . 51.42 112.607 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -116.16 162.18 17.83 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.98 -0.555 . . . . 75.45 110.025 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.607 HD11 ' HG3' ' A' ' 35' ' ' PRO . 80.6 mt -50.7 -34.91 28.62 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.337 0.589 . . . . 70.13 111.335 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -52.61 -36.15 55.83 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.19 -0.914 . . . . 75.14 112.273 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -98.48 -2.27 39.31 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.511 0.56 . . . . 54.31 112.511 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.6 mt -88.37 138.64 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 60.03 111.448 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -124.98 162.98 23.3 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.12 0.486 . . . . 71.54 111.316 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 115.01 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.375 -0.375 . . . . 74.51 110.507 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.57 -16.27 16.82 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.834 -0.698 . . . . 71.21 113.453 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.57 105.77 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 117.394 0.597 . . . . 71.31 111.915 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 51.9 mt-10 -83.68 107.07 15.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.995 -0.548 . . . . 74.24 110.811 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.5 mt -121.09 151.79 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.0 0.429 . . . . 73.35 111.948 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 57.5 mt -83.17 117.07 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.799 0.333 . . . . 74.34 110.96 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.83 150.6 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.184 0.516 . . . . 63.14 111.982 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.5 tt0 -98.17 125.93 43.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.362 -0.381 . . . . 64.5 111.135 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -72.98 93.65 1.77 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 71.5 110.84 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 69' ' ' LYS . 60.0 mt -54.66 -67.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.429 0.292 . . . . 74.14 111.622 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 31.5 m-20 -128.0 128.17 44.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.053 0.454 . . . . 72.22 111.438 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.439 HG21 HG12 ' A' ' 3' ' ' VAL . 66.6 t -107.83 105.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.445 -0.576 . . . . 72.22 109.445 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 72.0 mtp180 -108.2 98.39 26.56 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.079 0.4 . . . . 64.3 112.079 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.9 Cg_endo -60.34 -23.61 75.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.765 2.31 . . . . 75.02 112.556 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.3 pt-20 -62.24 -32.46 73.14 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.355 -0.384 . . . . 64.44 111.602 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.5 mmmm -120.17 -6.12 9.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.416 0.524 . . . . 45.3 112.416 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 62.89 12.37 5.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.698 0.399 . . . . 72.04 111.662 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.76 133.84 35.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.013 0.435 . . . . 72.14 111.422 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.421 HG23 HG22 ' A' ' 59' ' ' VAL . 64.2 mt -126.03 118.3 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.996 -0.547 . . . . 70.03 110.936 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -84.74 134.2 34.34 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.698 0.285 . . . . 42.3 111.108 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -114.46 153.25 30.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.371 0.605 . . . . 73.35 112.159 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 38.1 ttpt -131.52 147.1 52.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.591 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 39' ' ' ILE . 50.6 t80 -87.51 110.64 20.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.925 -0.398 . . . . 63.1 109.925 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.6 pt -107.62 121.6 43.71 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.257 0.466 . . . . 73.13 112.257 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HD3' HG13 ' A' ' 39' ' ' ILE . 54.9 Cg_endo -69.27 134.25 28.54 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.395 2.063 . . . . 65.44 112.331 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.91 126.18 30.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 71.42 110.48 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 . . . . . 0 C--O 1.255 1.342 0 CA-C-O 118.774 -0.631 . . . . 65.14 111.483 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.573 0.225 . . . . 75.4 111.276 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.68 146.07 41.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.899 0.38 . . . . 72.12 110.48 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.28 135.82 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.268 0.556 . . . . 71.32 111.98 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 30.8 mt-10 -118.68 148.33 44.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.794 -0.639 . . . . 75.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.68 121.56 8.47 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.23 1.953 . . . . 65.44 112.71 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.56 11.64 59.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.252 -0.499 . . . . 72.13 114.148 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 34.6 mmtp -105.97 163.23 12.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.665 0.732 . . . . 74.12 112.587 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -94.76 120.51 35.09 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.921 -0.581 . . . . 65.25 112.431 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -142.95 132.83 24.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.462 0.305 . . . . 74.2 111.68 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -89.53 144.98 25.6 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.89 -0.507 . . . . 54.4 110.574 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.4 178.42 27.86 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.009 -0.615 . . . . 33.44 113.096 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -119.07 138.37 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.902 0.382 . . . . 72.53 111.444 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -74.24 129.22 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.375 -0.375 . . . . 74.41 111.932 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -93.34 -55.6 3.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.971 0.415 . . . . 70.23 111.447 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -145.59 155.58 43.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.856 0.36 . . . . 65.14 110.99 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.34 121.89 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.876 0.369 . . . . 74.33 111.443 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -103.93 158.93 16.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.979 0.419 . . . . 71.43 111.019 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -81.43 9.63 7.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.133 0.492 . . . . 74.4 111.668 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -134.7 13.73 3.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.007 -0.542 . . . . 75.41 110.887 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.65 -163.14 28.54 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.048 -0.523 . . . . 33.4 112.526 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.76 133.56 27.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.216 -0.579 . . . . 42.2 111.212 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -77.0 132.19 38.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.089 0.471 . . . . 73.1 111.145 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -128.99 130.12 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.145 -0.48 . . . . 71.34 111.597 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.23 116.36 28.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.579 -0.282 . . . . 72.32 110.985 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.91 -23.63 26.93 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.338 0.59 . . . . 71.14 110.296 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -161.66 168.51 23.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.586 -0.733 . . . . 63.14 109.597 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -49.9 -40.94 44.72 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.772 0.656 . . . . 62.42 112.772 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -113.05 13.62 19.44 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.396 0.517 . . . . 74.24 112.396 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.65 106.33 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.039 0.447 . . . . 64.24 111.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -130.43 132.55 45.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.878 -0.601 . . . . 54.32 111.328 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.65 -167.12 11.21 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.213 -0.518 . . . . 74.33 113.478 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.3 tp -130.68 123.55 29.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.177 0.513 . . . . 63.2 111.808 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 38' ' ' MET . 45.8 tp -94.1 131.5 39.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.85 0.46 . . . . 61.54 110.964 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -100.72 138.58 20.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 112.348 0.499 . . . . 74.43 112.348 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 23.4 Cg_endo -61.62 -44.66 20.78 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.138 2.559 . . . . 73.23 114.48 -173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -70.32 -15.07 62.84 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.075 0.398 . . . . 63.5 112.075 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 11.2 m-20 -93.81 5.83 50.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.19 0.519 . . . . 74.13 110.986 176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.786 ' SD ' ' HB2' ' A' ' 70' ' ' TYR . 98.1 mmm -97.44 113.34 25.0 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.094 -0.503 . . . . 70.01 111.335 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.3 mm -71.04 -58.48 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.211 0.448 . . . . 75.23 112.211 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.1 p -98.5 -59.9 1.65 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.891 0.377 . . . . 70.15 111.907 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' O ' ' HB3' ' A' ' 38' ' ' MET . 96.5 mt -79.29 117.29 20.15 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.291 0.478 . . . . 74.41 112.291 -176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.7 mmt180 -98.67 156.5 16.8 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.276 -0.265 . . . . 64.32 111.131 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 80.6 mt -52.44 -35.4 52.17 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.312 0.577 . . . . 64.52 111.343 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.32 -21.77 62.4 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.602 -0.726 . . . . 70.42 111.853 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -113.09 -4.42 13.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.274 0.472 . . . . 73.51 112.274 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 41' ' ' LEU . 24.7 mt -80.31 143.38 33.66 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.151 0.5 . . . . 73.15 111.591 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -127.44 161.94 27.53 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.978 -0.556 . . . . 62.35 110.859 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.17 113.34 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.859 0.361 . . . . 73.13 110.642 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.21 3.09 26.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.871 -0.68 . . . . 71.42 114.073 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.57 136.59 37.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 117.784 0.792 . . . . 74.51 111.238 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.17 103.03 14.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.057 -0.519 . . . . 75.32 111.105 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.18 132.7 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.022 0.439 . . . . 72.24 112.163 -174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.45 109.7 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.315 -0.402 . . . . 53.51 110.287 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.29 144.57 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.728 0.775 . . . . 72.42 112.833 -175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -100.7 119.5 38.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.76 -0.655 . . . . 64.31 109.715 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.02 56.46 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.672 0.272 . . . . 60.11 111.381 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 34.2 mt -90.11 -73.93 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.693 0.282 . . . . 73.02 110.554 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' HH12 ' A' ' 60' ' ' ARG . 20.1 m-20 -127.96 150.54 49.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 75.42 111.156 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 66' ' ' ILE . 78.9 t -122.95 108.66 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.294 -0.412 . . . . 73.33 110.144 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.501 HH12 ' HB2' ' A' ' 58' ' ' ASP . 65.6 mtm-85 -110.17 98.39 35.0 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.664 -0.244 . . . . 74.13 111.615 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 -51.0 11.44 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.851 2.368 . . . . 71.22 113.289 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.93 -22.81 67.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.36 0.504 . . . . 73.22 112.36 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -95.56 -17.27 21.54 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.307 -0.245 . . . . 73.24 111.051 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 61.05 29.28 18.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.215 0.531 . . . . 72.45 111.241 -173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -110.89 131.28 55.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.141 -0.481 . . . . 73.03 111.923 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 59' ' ' VAL . 69.1 mt -124.25 109.56 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.069 -0.514 . . . . 60.3 109.683 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 18.3 m-20 -85.67 141.94 29.41 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.779 0.323 . . . . 73.14 111.39 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 33' ' ' LEU . 26.1 m-85 -117.56 152.5 34.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.07 0.462 . . . . 73.44 111.811 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 35.2 ttpt -135.65 142.27 45.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.705 -0.68 . . . . 75.52 110.632 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.786 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 44.5 t80 -88.71 135.31 33.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.18 0.514 . . . . 70.43 111.324 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.7 pt -132.51 133.45 23.61 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.322 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.51 75.14 2.03 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.013 1.809 . . . . 61.15 111.719 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.4 tp -71.51 130.0 40.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.862 -0.608 . . . . 73.41 111.848 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.76 -0.638 . . . . 75.11 111.597 177.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.378 0.132 . . . . 71.44 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -119.46 143.32 47.58 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.899 0.381 . . . . 73.15 111.162 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HG11 ' A' ' 29' ' ' VAL . 83.9 t -109.99 121.52 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.023 0.439 . . . . 53.14 111.903 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.22 150.05 38.4 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.955 -0.566 . . . . 73.53 111.217 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.51 105.21 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.374 2.049 . . . . 71.03 112.55 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.47 5.57 10.18 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.412 -0.423 . . . . 73.42 113.344 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -95.59 156.15 16.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 72.23 111.971 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.9 122.48 38.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.841 -0.618 . . . . 74.34 111.61 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -138.09 161.65 36.22 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.301 0.572 . . . . 72.13 112.176 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -110.82 133.94 52.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.998 -0.547 . . . . 61.04 109.972 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.73 25.98 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.631 -0.795 . . . . 65.5 113.333 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.99 135.79 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.045 0.45 . . . . 71.33 111.985 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.03 126.9 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.154 -0.475 . . . . 65.33 111.373 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.447 HG21 ' ND2' ' A' ' 24' ' ' ASN . 64.8 p -104.52 -38.48 6.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.383 0.512 . . . . 64.33 112.383 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -148.08 144.24 27.73 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.056 0.455 . . . . 74.14 111.843 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.74 120.01 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.127 -0.488 . . . . 74.13 111.473 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -99.71 176.16 5.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 73.12 110.986 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.95 -10.96 58.54 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.288 0.566 . . . . 74.45 111.417 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -119.98 8.81 11.09 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.817 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.01 -168.14 31.24 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.201 -0.523 . . . . 44.41 112.726 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 132.41 38.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.463 -0.433 . . . . 61.14 111.408 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.65 128.97 34.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.047 0.451 . . . . 74.43 111.372 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -124.34 132.44 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 115.988 -0.551 . . . . 65.52 111.634 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.5 m-20 -97.9 120.46 38.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.559 -0.291 . . . . 73.21 110.863 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.71 -29.11 40.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.784 0.802 . . . . 71.24 109.577 171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -160.46 164.03 32.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.665 -1.152 . . . . 63.35 109.046 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -49.95 -31.73 13.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.334 0.494 . . . . 75.24 112.334 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -101.01 -4.08 28.14 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.561 0.578 . . . . 63.23 112.561 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 3' ' ' VAL . 60.8 t -125.18 117.85 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.121 0.415 . . . . 63.44 112.121 -175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -134.6 152.66 51.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.911 0.386 . . . . 74.43 111.662 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.93 -167.65 15.84 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.116 -0.564 . . . . 15.5 113.231 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.6 tp -128.93 123.41 32.46 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.998 0.428 . . . . 73.23 111.603 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 38' ' ' MET . 51.9 tp -94.03 124.16 37.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.618 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -100.6 136.52 19.89 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.681 0.277 . . . . 74.31 111.664 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.87 -39.64 85.09 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.98 2.454 . . . . 63.1 114.421 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -73.89 -10.69 59.91 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.946 -0.471 . . . . 63.03 112.167 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -95.89 6.58 48.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.364 0.602 . . . . 71.22 110.61 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.688 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 93.5 mmm -92.64 148.57 21.96 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.863 -0.608 . . . . 70.34 110.952 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.37 -59.76 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.03 0.443 . . . . 62.41 111.171 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -107.34 -47.06 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.805 0.668 . . . . 71.21 112.805 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 46' ' ' LEU . 76.2 mt -80.15 125.08 29.38 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.117 0.784 . . . . 71.12 113.117 -173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -87.82 147.12 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.462 -0.79 . . . . 74.34 110.891 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.63 -35.23 60.73 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.379 0.609 . . . . 62.33 110.78 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 21.1 mt-10 -53.29 -32.15 47.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.36 -0.836 . . . . 70.14 111.863 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -99.54 -3.16 34.01 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.093 -0.503 . . . . 74.21 112.05 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 41' ' ' LEU . 33.7 mt -90.18 130.67 36.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.856 0.36 . . . . 64.15 111.132 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -127.76 170.87 12.26 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.196 0.522 . . . . 62.13 111.273 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.81 116.82 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.062 0.458 . . . . 45.25 110.994 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.02 -13.32 16.94 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 71.23 113.508 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.04 110.36 2.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 117.185 0.493 . . . . 72.3 111.577 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.82 102.58 15.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.119 -0.491 . . . . 72.02 110.575 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.61 140.18 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.167 -0.469 . . . . 71.24 111.912 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.46 110.1 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.846 0.355 . . . . 71.32 110.227 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.9 m -124.11 149.07 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.337 0.589 . . . . 65.11 112.136 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.06 129.62 45.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.135 -0.484 . . . . 64.1 110.345 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.3 105.4 4.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.553 0.216 . . . . 71.22 111.327 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.7 mt -62.14 -61.38 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.991 0.424 . . . . 72.32 111.28 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -136.31 146.65 46.84 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.51 111.709 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.3 t -114.79 109.23 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.936 -0.574 . . . . 73.03 110.018 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 50.9 mtt180 -97.94 98.13 5.1 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.456 -0.338 . . . . 63.12 110.734 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.68 -58.0 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.689 2.259 . . . . 75.54 113.373 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.51 -40.29 96.66 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.214 0.53 . . . . 63.4 111.911 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -79.45 -16.6 55.85 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.353 -0.385 . . . . 71.35 111.659 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 62.11 26.73 16.1 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.193 0.52 . . . . 62.04 111.626 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.62 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 41.1 mt-10 -113.15 126.11 55.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.031 -0.531 . . . . 61.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -115.7 117.32 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 110.318 -0.252 . . . . 55.54 110.318 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -84.68 136.89 33.55 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.745 0.307 . . . . 74.11 111.268 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -115.26 151.11 35.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.289 0.566 . . . . 74.51 112.334 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -127.48 145.08 50.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.395 -0.821 . . . . 73.13 110.188 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 66.2 t80 -87.78 117.56 26.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.134 0.492 . . . . 73.32 111.119 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 15.4 pt -110.49 132.17 21.69 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.17 -0.468 . . . . 75.31 111.366 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 12.2 Cg_exo -71.11 67.91 2.52 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.816 2.344 . . . . 72.11 112.373 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 tt -101.45 113.59 26.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.835 0.35 . . . . 75.21 110.194 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.676 -0.678 . . . . 72.14 111.806 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 26.2 ttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.881 0.372 . . . . 75.35 111.548 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 157.47 44.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.369 -0.378 . . . . 74.31 110.303 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.24 136.16 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.675 0.62 . . . . 43.42 112.675 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 7' ' ' LYS . 31.4 mt-10 -100.51 149.69 36.33 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 71.33 109.976 173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.45 93.89 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.261 1.974 . . . . 65.15 112.673 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.47 9.18 3.71 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.246 -0.434 . . . . 30.23 113.452 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.7 mmpt? -86.74 141.9 28.54 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.47 0.544 . . . . 75.13 112.47 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 73' ' ' LEU . 1.8 m-85 -86.85 124.42 33.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.514 -0.767 . . . . 75.22 111.008 176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.85 164.22 31.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.545 0.688 . . . . 72.24 112.267 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -116.15 126.94 54.36 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.405 -0.816 . . . . 75.41 109.812 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -132.71 171.44 21.65 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.695 -0.764 . . . . 74.22 113.2 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.64 138.19 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.029 0.442 . . . . 74.13 111.652 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.57 122.03 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.282 -0.417 . . . . 75.33 111.696 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.4 p -85.67 -50.93 6.81 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.593 -0.276 . . . . 54.44 111.614 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -152.41 156.54 39.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.843 0.354 . . . . 70.54 111.22 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -98.15 116.82 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.031 0.443 . . . . 60.34 111.824 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.23 160.57 14.49 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.45 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -83.39 5.51 23.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.105 0.479 . . . . 73.23 111.464 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.73 11.22 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.057 -0.519 . . . . 64.45 110.938 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.01 -167.12 30.0 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.194 -0.457 . . . . 42.01 112.797 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.69 132.15 34.53 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.109 -0.642 . . . . 71.21 111.474 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -79.89 115.09 19.28 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 74.44 111.213 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.64 137.28 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.182 -0.463 . . . . 73.24 111.553 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -99.22 118.9 36.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.307 . . . . 70.41 111.357 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA3' ' A' ' 11' ' ' GLY . 69.4 mt -83.85 -18.36 37.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.792 0.806 . . . . 63.2 109.465 170.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.47 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 48.9 t30 -162.34 161.77 27.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.721 -1.127 . . . . 72.34 108.74 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -44.37 -40.96 5.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.226 0.454 . . . . 72.55 112.226 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -89.65 -33.31 16.7 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.417 0.525 . . . . 74.05 112.417 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.55 104.25 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 112.376 0.51 . . . . 55.02 112.376 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -125.72 128.38 47.69 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.428 -0.351 . . . . 65.44 111.28 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.43 -179.0 15.94 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.13 -0.557 . . . . 64.3 113.105 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.6 tp -115.34 119.03 34.94 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.025 0.44 . . . . 71.15 111.726 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.59 HD11 ' SD ' ' A' ' 38' ' ' MET . 60.3 tp -94.71 113.91 25.76 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.357 174.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 34' ' ' ARG . 30.3 mtm-85 -97.56 145.01 28.96 Favored Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 112.178 0.436 . . . . 73.2 112.178 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 25.7 Cg_endo -59.38 -23.29 69.63 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.944 2.43 . . . . 73.12 113.316 -176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 36' ' ' ARG . 38.0 mtp-105 -78.97 -28.93 43.6 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.937 0.399 . . . . 70.34 111.409 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.56 14.14 12.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.256 0.551 . . . . 74.1 111.309 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' HD11 ' A' ' 33' ' ' LEU . 96.3 mmm -96.5 148.31 22.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.333 -0.394 . . . . 74.15 111.914 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -95.54 -47.74 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 111.919 0.341 . . . . 55.22 111.919 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -126.63 -43.26 1.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.596 0.591 . . . . 54.41 112.596 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.614 ' HB3' HD21 ' A' ' 46' ' ' LEU . 77.1 mt -79.24 128.09 32.87 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.493 0.553 . . . . 75.54 112.493 -174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.26 154.14 18.01 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.208 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 86.7 mt -55.39 -33.99 63.96 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.674 0.75 . . . . 74.31 110.879 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -57.86 -19.79 31.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.962 -1.017 . . . . 65.43 112.445 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -115.9 9.57 15.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.917 0.34 . . . . 75.41 111.917 -175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 41' ' ' LEU . 25.6 mt -100.64 136.38 40.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.557 0.218 . . . . 74.13 110.962 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -121.72 158.55 28.51 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.044 0.45 . . . . 52.25 111.182 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.22 124.65 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.848 0.356 . . . . 73.41 110.9 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.82 -4.19 45.95 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.914 -0.66 . . . . 32.04 114.083 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -80.14 136.5 36.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.628 0.714 . . . . 70.44 111.752 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.67 111.31 21.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.235 -0.439 . . . . 60.1 110.765 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.2 mt -111.34 136.6 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.008 0.432 . . . . 74.44 111.533 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 73' ' ' LEU . 55.9 mt -85.81 112.71 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.842 0.353 . . . . 74.33 110.839 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.39 145.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.46 0.648 . . . . 71.43 112.452 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HB2' HD13 ' A' ' 71' ' ' ILE . 59.4 tt0 -100.39 129.2 46.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.831 -0.622 . . . . 73.34 110.192 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.47 103.55 6.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.527 0.203 . . . . 73.43 111.383 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.8 mt -59.04 -58.25 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.066 0.46 . . . . 40.12 111.242 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.88 154.21 46.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.182 0.515 . . . . 74.43 111.347 177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.9 t -114.65 117.53 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.015 -0.539 . . . . 73.31 110.147 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -109.89 96.48 24.85 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.524 -0.11 . . . . 72.54 111.023 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 23.6 Cg_exo -65.3 -46.75 5.26 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.727 2.285 . . . . 61.13 112.569 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.1 pt-20 -53.61 -37.68 63.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.821 -0.627 . . . . 74.32 112.151 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.65 -11.5 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.485 -0.325 . . . . 64.12 111.441 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 63.41 17.37 10.26 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.021 0.528 . . . . 73.14 111.54 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.18 132.6 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.976 0.417 . . . . 71.44 111.889 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.75 132.83 60.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.34 -0.391 . . . . 71.04 110.142 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 34.6 m-20 -84.51 124.83 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.532 0.206 . . . . 74.5 110.939 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -108.93 140.82 41.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.517 0.675 . . . . 75.34 112.178 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.2 ttpt -126.12 146.55 49.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.181 -0.918 . . . . 74.24 109.706 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 67.7 t80 -87.42 133.35 33.75 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.984 -0.447 . . . . 65.41 110.671 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.9 pt -125.52 139.97 35.26 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.283 -0.417 . . . . 60.32 111.637 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 71' ' ' ILE . 8.9 Cg_exo -73.9 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.389 2.726 . . . . 73.11 113.645 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.5 HD12 ' HD2' ' A' ' 8' ' ' PHE . 6.7 tt -74.69 127.51 33.32 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.116 -0.328 . . . . 75.53 110.116 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 112.226 0.454 . . . . 52.12 112.226 -177.298 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.607 0.241 . . . . 73.34 111.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -114.55 127.38 55.77 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.785 0.326 . . . . 64.23 110.498 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.1 t -89.05 127.91 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.817 0.342 . . . . 53.21 111.599 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.6 mt-10 -115.63 139.35 24.66 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.374 -0.376 . . . . 62.23 111.428 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 29.9 Cg_exo -61.96 94.31 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.733 2.289 . . . . 71.15 113.111 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.31 -12.83 3.27 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.369 -0.443 . . . . 64.24 113.086 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -79.32 150.23 31.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.489 0.551 . . . . 72.12 112.489 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -92.53 131.02 38.01 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.919 -0.582 . . . . 74.21 111.46 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -139.15 165.38 27.31 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.145 0.497 . . . . 64.24 111.655 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -108.13 122.61 47.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.349 -0.387 . . . . 70.2 110.044 167.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 166.09 19.03 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.902 -0.665 . . . . 55.45 113.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HB ' ' HG2' ' A' ' 51' ' ' GLU . 8.6 p -112.45 134.74 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 122.525 -0.397 . . . . 75.0 111.668 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.6 121.22 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.351 -0.386 . . . . 64.13 111.397 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -98.84 -46.01 5.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.332 0.493 . . . . 75.23 112.332 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 15' ' ' ARG . 16.9 ptt180 -146.98 144.52 29.25 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.982 -0.449 . . . . 73.2 111.917 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.3 mm -96.36 114.19 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.834 -0.621 . . . . 74.42 111.133 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 68.4 mm-40 -107.92 154.02 22.21 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.098 0.475 . . . . 70.15 110.937 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -66.67 -4.75 9.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.153 0.427 . . . . 75.41 112.153 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -122.61 14.92 10.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.66 0.384 . . . . 71.42 111.47 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 137.87 166.96 10.89 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.358 -0.448 . . . . 73.22 113.366 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.3 126.38 52.37 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.363 -0.492 . . . . 74.44 111.439 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 59.5 m-85 -77.51 133.18 38.61 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.756 0.313 . . . . 71.52 111.404 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.04 139.06 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.572 0.582 . . . . 63.44 112.572 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -97.82 122.8 41.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.293 -0.412 . . . . 63.23 111.49 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.21 -34.68 20.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.786 0.803 . . . . 73.11 109.185 167.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.49 164.3 37.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.393 -1.276 . . . . 71.3 108.697 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' HE21 ' A' ' 28' ' ' GLN . 38.2 tt0 -45.58 -50.5 13.1 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.347 0.499 . . . . 64.03 112.347 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.3 mm-40 -83.85 -2.8 57.16 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.607 0.595 . . . . 70.25 112.607 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.09 105.4 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 112.208 0.448 . . . . 75.14 112.208 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -132.18 128.8 38.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.496 -0.32 . . . . 70.24 110.756 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.75 -162.35 10.01 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.92 -0.657 . . . . 73.12 113.436 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -128.67 132.89 48.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.13 0.49 . . . . 71.42 112.295 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 38' ' ' MET . 55.5 tp -110.09 113.59 26.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.973 -0.558 . . . . 63.33 110.317 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 38' ' ' MET . 20.0 mtm180 -95.97 153.61 39.16 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 112.606 0.595 . . . . 72.41 112.606 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.543 ' HD3' HD11 ' A' ' 43' ' ' LEU . 19.6 Cg_endo -59.13 -34.11 98.54 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.783 2.322 . . . . 70.13 113.395 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -68.96 -24.42 64.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.86 0.362 . . . . 61.11 111.607 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.68 5.26 50.42 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.02 0.438 . . . . 75.3 111.394 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 97.7 mmm -93.83 142.46 27.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.795 0.331 . . . . 73.23 111.446 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 70' ' ' TYR . 45.1 mm -104.82 -80.26 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 120.688 0.28 . . . . 73.14 111.686 178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -78.26 -55.71 5.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.054 0.454 . . . . 61.14 111.377 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 38' ' ' MET . 85.4 mt -80.52 142.05 34.55 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.798 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -115.19 162.97 16.32 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.324 -0.398 . . . . 74.24 110.247 172.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD11 ' HD3' ' A' ' 35' ' ' PRO . 76.9 mt -50.0 -30.04 9.8 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.12 0.486 . . . . 63.33 111.542 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -55.55 -33.35 63.75 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.459 -0.791 . . . . 73.32 112.655 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -112.3 12.01 20.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.792 0.664 . . . . 61.5 112.792 -171.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.25 137.35 32.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.948 0.404 . . . . 72.3 111.495 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -124.52 148.99 47.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.234 0.54 . . . . 72.31 111.793 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -66.51 112.76 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.824 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.32 -8.76 17.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.306 -0.473 . . . . 73.44 113.535 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -75.42 114.09 13.56 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.453 0.627 . . . . 74.11 111.304 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 12' ' ' VAL . 46.3 mt-10 -83.81 116.67 22.83 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.907 0.384 . . . . 73.44 111.093 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.8 mt -124.04 149.29 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.915 0.388 . . . . 53.31 111.404 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 69.0 mt -83.11 111.95 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.105 0.478 . . . . 61.3 110.71 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.81 147.06 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.202 0.525 . . . . 75.44 111.947 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -97.82 128.09 44.21 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.148 -0.478 . . . . 74.35 111.019 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.3 111.29 5.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.633 0.254 . . . . 71.33 111.06 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 69' ' ' LYS . 34.1 mt -76.13 -66.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.945 0.402 . . . . 43.2 111.517 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 24.1 m-20 -129.89 145.95 51.6 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.753 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.409 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 57.4 t -121.59 104.46 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.368 -0.378 . . . . 61.43 110.129 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 65' ' ' GLU . 65.9 mtt180 -106.69 99.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.379 -0.373 . . . . 75.55 111.602 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 22.9 Cg_exo -64.39 -53.99 0.93 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.638 2.225 . . . . 72.01 112.742 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.8 pt-20 -58.94 -33.54 70.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.037 0.446 . . . . 74.24 112.024 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 35.0 mmtp -91.83 -14.77 29.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.412 -0.358 . . . . 74.52 111.94 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 64' ' ' ARG . 40.0 mtm105 62.57 32.94 16.21 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.099 0.476 . . . . 73.13 111.208 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 48.9 mt-10 -116.35 137.35 52.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.102 -0.499 . . . . 73.02 111.471 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -132.94 109.64 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 73.4 110.207 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 48.3 m-20 -86.08 143.05 28.28 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.115 0.483 . . . . 74.13 112.251 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -122.45 151.67 41.05 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.021 -0.536 . . . . 75.11 111.052 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.8 ttpt -123.84 141.82 51.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 74.23 110.763 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.635 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 56.2 t80 -87.17 129.34 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.692 -0.485 . . . . 75.13 109.692 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.3 pt -132.84 145.6 57.79 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.378 0.51 . . . . 73.31 112.378 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.93 103.27 1.18 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.556 2.171 . . . . 65.42 111.211 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.11 122.53 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.995 0.426 . . . . 71.4 112.031 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.397 -0.811 . . . . 65.55 111.436 175.781 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.694 0.257 . . . . 74.21 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -102.36 135.03 44.7 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.543 -0.54 . . . . 55.24 109.543 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 29' ' ' VAL . 74.4 t -94.57 125.44 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.69 0.626 . . . . 75.01 112.69 -171.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.24 155.68 37.82 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.935 -0.575 . . . . 72.15 110.942 174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.23 150.34 87.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.383 2.055 . . . . 72.24 113.009 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.68 18.98 72.68 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 114.374 0.51 . . . . 53.12 114.374 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -106.45 149.96 26.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.4 0.619 . . . . 63.45 112.527 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -91.23 130.53 37.1 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.649 -0.705 . . . . 74.32 111.208 -177.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -147.72 145.54 28.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.092 0.775 . . . . 65.11 113.092 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -82.59 132.56 35.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.377 -0.829 . . . . 71.11 110.614 169.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.72 175.78 20.33 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.006 -0.616 . . . . 73.53 113.139 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.65 138.75 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.87 0.367 . . . . 63.21 111.443 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 16' ' ' ILE . 58.0 t -75.39 131.54 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.423 0.527 . . . . 72.43 112.423 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -105.2 -41.1 5.64 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.09 0.404 . . . . 71.45 112.09 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -153.92 143.2 21.44 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 72.55 111.577 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG11 ' A' ' 13' ' ' VAL . 43.4 mm -98.39 112.86 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.521 . . . . 53.33 111.537 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 6.4 mm-40 -98.86 154.25 18.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 71.53 110.582 174.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -68.49 -6.39 24.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.092 0.404 . . . . 73.42 112.092 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -120.63 7.31 10.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.445 -0.343 . . . . 72.14 111.674 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 155.38 160.9 10.22 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.895 -0.669 . . . . 74.45 113.545 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.23 126.16 52.06 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.383 -0.481 . . . . 75.01 111.309 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.617 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 70.5 m-85 -77.36 119.95 21.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.993 0.425 . . . . 71.0 110.933 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.78 131.73 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.784 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.9 124.68 36.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.842 0.353 . . . . 63.52 111.313 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.85 -29.99 18.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.355 0.598 . . . . 75.42 110.379 172.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -151.31 165.95 32.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.341 -0.845 . . . . 75.22 110.464 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' HE21 ' A' ' 28' ' ' GLN . 36.6 tt0 -43.55 -42.31 4.96 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.736 0.643 . . . . 74.25 112.736 176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.1 mm-40 -109.82 5.11 22.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.224 0.824 . . . . 71.11 113.224 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 3' ' ' VAL . 97.1 t -114.2 102.01 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.319 0.489 . . . . 64.44 112.319 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -109.86 143.72 39.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.986 -0.552 . . . . 73.11 110.65 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.11 -173.38 14.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.093 -0.575 . . . . 50.34 113.138 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.7 tp -130.12 121.27 26.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.975 0.417 . . . . 63.53 111.921 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' SD ' ' A' ' 38' ' ' MET . 50.9 tp -95.86 116.89 29.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.504 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -96.6 147.31 32.75 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 112.669 0.618 . . . . 73.35 112.669 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG3' ' CD1' ' A' ' 43' ' ' LEU . 51.5 Cg_exo -52.86 -48.71 20.63 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.499 2.799 . . . . 53.35 114.731 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -61.38 -28.59 69.35 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.791 0.663 . . . . 61.23 112.791 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 21.2 m-20 -92.44 13.06 20.7 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.984 0.421 . . . . 63.04 112.134 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' LEU . 99.0 mmm -90.19 144.43 25.87 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.535 -0.302 . . . . 71.13 111.035 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.94 -78.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.959 0.409 . . . . 74.41 111.928 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 m -80.4 -47.75 13.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.904 0.383 . . . . 41.02 111.858 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.2 mt -90.34 141.79 28.37 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.005 0.372 . . . . 73.52 112.005 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 38.5 mmt180 -115.92 157.94 23.77 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 110.126 -0.324 . . . . 64.23 110.126 170.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 35' ' ' PRO . 63.6 mt -55.53 -28.02 52.28 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.118 0.485 . . . . 65.54 111.507 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.52 -33.46 71.39 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.869 -0.605 . . . . 73.44 111.652 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -98.37 -3.77 36.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.301 0.482 . . . . 62.24 112.301 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 41' ' ' LEU . 37.4 mt -89.48 140.35 29.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.883 0.373 . . . . 74.33 111.418 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -127.62 163.6 23.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.085 0.469 . . . . 64.14 111.268 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.61 113.22 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 74.44 111.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.62 -3.68 21.48 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.045 -0.598 . . . . 55.21 113.926 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.92 136.35 36.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.152 0.476 . . . . 60.45 111.826 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.9 137.26 35.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 70.13 110.796 174.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 46' ' ' LEU . 55.8 mt -139.56 135.27 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.865 0.364 . . . . 70.22 111.228 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.3 111.15 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.894 0.378 . . . . 54.33 110.45 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.71 148.86 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.436 0.636 . . . . 71.42 112.322 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.5 tt0 -101.32 127.15 48.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.094 -0.503 . . . . 75.01 110.124 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 100.78 1.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.595 0.236 . . . . 73.25 111.152 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 69' ' ' LYS . 55.4 mt -59.29 -68.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.195 0.521 . . . . 73.3 110.949 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -127.65 128.49 45.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 51.33 111.231 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.4 t -101.47 104.35 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.409 -0.589 . . . . 73.22 109.409 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 66.7 mtp180 -114.21 97.03 44.48 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 111.932 0.345 . . . . 73.13 111.932 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.92 -21.14 50.54 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.44 2.093 . . . . 74.03 112.029 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 14.7 pt-20 -55.07 -37.11 66.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.251 0.548 . . . . 75.44 111.177 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 34.7 mmtp -119.2 -1.56 10.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.879 -0.6 . . . . 45.13 111.04 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 62.7 24.38 14.51 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.21 0.529 . . . . 72.44 110.951 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -109.2 130.52 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.873 -0.603 . . . . 73.54 111.777 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.6 mt -118.9 118.16 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.778 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -84.93 136.67 33.52 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.772 0.32 . . . . 74.11 111.023 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -113.09 150.99 31.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.218 0.533 . . . . 73.22 112.109 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 57' ' ' ILE . 38.1 ttpt -125.64 142.74 51.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.505 -0.771 . . . . 71.12 110.117 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 57.9 t80 -87.87 128.3 35.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.098 0.475 . . . . 74.41 110.863 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 55' ' ' GLN . 13.6 pt -132.77 151.07 77.41 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.082 -0.508 . . . . 75.42 111.392 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.51 154.56 18.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.429 2.086 . . . . 74.42 112.678 176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.39 108.45 11.75 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.079 0.466 . . . . 72.33 110.291 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.792 -0.623 . . . . 73.41 111.346 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.713 0.292 . . . . 74.13 111.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.33 149.71 42.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.888 0.375 . . . . 71.34 110.258 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 25' ' ' LEU . 87.2 t -107.47 134.02 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 -170.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 45.6 mt-10 -105.12 162.11 20.73 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.369 -0.832 . . . . 74.42 110.695 174.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 31.3 Cg_endo -63.95 136.02 50.69 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.164 1.909 . . . . 65.04 112.458 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.86 75.63 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.612 -0.328 . . . . 65.42 113.855 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 9' ' ' TYR . 44.3 mmtm -78.18 151.2 33.34 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.062 0.764 . . . . 65.3 113.062 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.13 120.95 43.14 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.44 -0.8 . . . . 70.12 111.148 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 7' ' ' LYS . 73.2 m-85 -147.61 147.98 30.62 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.546 0.573 . . . . 63.14 112.546 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.2 ttmt -94.49 125.45 39.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 50.22 110.465 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.547 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -122.14 175.93 16.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.254 -0.498 . . . . 75.32 112.857 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.1 135.6 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.044 0.449 . . . . 53.23 111.656 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 82.5 t -74.59 119.37 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.234 -0.439 . . . . 74.43 111.247 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.483 HG21 ' ND2' ' A' ' 24' ' ' ASN . 47.5 p -93.6 -39.36 10.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.966 0.358 . . . . 64.34 111.966 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -156.32 145.96 20.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.166 0.507 . . . . 72.21 112.35 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mm -97.54 120.32 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.799 -0.637 . . . . 55.12 111.395 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -100.39 164.02 12.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.442 0.639 . . . . 75.33 111.507 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -68.46 -18.76 64.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.479 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -114.9 12.83 16.95 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 74.43 112.031 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 147.52 -151.67 23.89 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.25 -0.5 . . . . 63.44 112.622 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.59 138.72 26.19 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.368 -0.489 . . . . 62.44 111.3 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.36 124.93 31.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.113 0.482 . . . . 74.33 111.421 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.11 132.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.955 -0.566 . . . . 74.12 111.175 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' ND2' HG21 ' A' ' 14' ' ' THR . 84.3 m-20 -102.91 121.92 43.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.884 0.373 . . . . 63.15 110.912 176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 3' ' ' VAL . 74.1 mt -84.28 -26.05 28.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.12 0.486 . . . . 63.14 110.651 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.48 163.08 35.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.611 -0.722 . . . . 71.31 110.242 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -50.14 -27.52 5.9 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.586 0.588 . . . . 74.35 112.586 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -113.46 9.14 18.04 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.412 0.523 . . . . 64.5 112.412 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 3' ' ' VAL . 89.7 t -126.26 113.8 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.055 0.391 . . . . 61.34 112.055 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -129.94 139.9 51.02 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.938 -0.573 . . . . 72.21 111.061 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 66' ' ' ILE . . . -151.57 -177.09 25.01 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.689 -0.767 . . . . 23.44 113.781 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -124.12 127.85 48.41 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.163 0.506 . . . . 54.21 111.542 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 38' ' ' MET . 49.9 tp -102.87 122.69 45.05 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.11 -0.495 . . . . 74.21 110.322 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -101.92 141.51 22.71 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 112.11 0.411 . . . . 73.22 112.11 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 25.6 Cg_endo -60.59 -17.77 50.75 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.933 2.422 . . . . 73.21 113.503 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -76.17 -28.72 57.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.116 0.484 . . . . 70.53 111.301 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 4.4 m-20 -94.36 10.62 33.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.375 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 33' ' ' LEU . 97.1 mmm -92.31 129.0 38.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.862 0.363 . . . . 71.41 111.567 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.94 -44.68 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 63.52 112.54 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 t -137.81 8.44 2.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.096 0.776 . . . . 73.4 113.096 -173.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HB3' HD21 ' A' ' 46' ' ' LEU . 36.6 mt -129.96 120.39 24.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.404 0.621 . . . . 72.51 112.457 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -90.0 149.18 22.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.64 -0.709 . . . . 75.13 110.964 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.4 mt -53.35 -32.32 48.66 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.032 0.444 . . . . 74.22 111.679 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -56.42 -33.45 65.83 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.911 -0.586 . . . . 74.25 111.832 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -94.4 -1.28 53.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.938 -0.574 . . . . 71.22 112.335 -175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 52' ' ' ILE . 21.2 mt -93.99 122.2 36.24 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.802 0.334 . . . . 73.22 110.703 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -114.0 156.35 24.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.879 0.371 . . . . 75.43 111.077 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.38 113.12 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.999 0.428 . . . . 72.24 111.177 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.5 -14.1 18.05 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.291 -0.48 . . . . 74.0 113.445 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.25 132.03 45.1 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.408 0.604 . . . . 72.35 111.667 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.24 115.1 27.3 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.816 -0.629 . . . . 50.15 111.194 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 46' ' ' LEU . 58.0 mt -116.43 144.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.076 0.465 . . . . 51.32 112.181 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.8 mt -89.42 118.4 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.259 -0.428 . . . . 60.42 110.991 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.18 154.04 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 72.2 112.274 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 71' ' ' ILE . 63.7 tt0 -101.23 129.26 47.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.95 -0.568 . . . . 73.45 110.4 173.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.56 98.36 7.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.457 -0.338 . . . . 52.2 111.326 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 69' ' ' LYS . 48.9 mt -60.77 -60.72 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.712 0.292 . . . . 75.43 111.692 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -133.46 153.52 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.019 0.437 . . . . 64.41 111.792 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 66' ' ' ILE . 57.9 t -132.39 119.08 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.296 -0.411 . . . . 72.55 111.014 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 81.1 mtp180 -124.21 97.77 39.74 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-O 120.795 0.331 . . . . 74.0 111.665 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 19.4 Cg_endo -58.34 -27.9 82.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.094 2.529 . . . . 73.42 113.677 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 13.1 pt-20 -60.29 -38.66 84.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.326 0.584 . . . . 61.22 111.42 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.0 mmmm -94.0 -17.27 23.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.986 -0.552 . . . . 73.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 59.48 25.81 14.66 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.527 0.679 . . . . 63.31 110.6 -173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.58 121.75 43.56 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.159 -0.928 . . . . 70.25 111.032 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 59' ' ' VAL . 56.6 mt -106.66 133.34 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.038 0.446 . . . . 72.22 110.778 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -84.42 120.98 26.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.22 110.666 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -107.84 158.92 16.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.725 0.774 . . . . 72.43 112.926 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' HB2' HD11 ' A' ' 57' ' ' ILE . 36.2 ttpt -141.43 145.75 35.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.712 -1.131 . . . . 73.11 109.619 175.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 68.8 t80 -87.98 130.3 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.885 0.374 . . . . 74.0 110.868 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 55' ' ' GLN . 19.0 pt -130.89 144.92 55.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.354 -0.384 . . . . 73.01 111.638 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.16 167.49 24.79 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.085 2.523 . . . . 51.53 113.122 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.3 tp -149.74 124.56 9.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.141 -0.481 . . . . 73.02 110.928 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.254 -0.879 . . . . 60.1 112.455 -178.179 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 ttp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.523 0.201 . . . . 74.23 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -110.05 165.89 11.37 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.195 -0.669 . . . . 71.5 109.195 170.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 25' ' ' LEU . 60.8 t -107.79 137.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.732 0.642 . . . . 73.0 112.732 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 43.0 mt-10 -110.27 145.69 32.69 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.847 -0.615 . . . . 63.12 110.92 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 36.1 Cg_exo -58.22 127.37 24.62 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.701 2.267 . . . . 75.03 113.429 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.98 61.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.204 -0.453 . . . . 60.11 114.003 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -87.32 149.16 24.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.282 0.845 . . . . 72.25 113.282 -175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -89.24 124.38 34.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.362 -0.836 . . . . 72.04 111.21 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -142.72 163.6 32.36 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.683 0.754 . . . . 73.14 112.4 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -117.08 142.79 46.54 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.52 -0.764 . . . . 63.41 109.957 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.96 -179.37 28.44 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.683 -0.77 . . . . 60.32 113.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.36 140.95 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.893 0.377 . . . . 44.02 111.7 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.07 125.83 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.023 0.439 . . . . 70.0 112.063 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 48' ' ' VAL . 80.4 p -88.98 -47.98 7.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.15 -0.477 . . . . 72.12 111.675 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' HG22 ' A' ' 48' ' ' VAL . 5.1 ptp85 -156.34 150.83 25.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.019 0.438 . . . . 70.24 111.509 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -95.67 111.33 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.02 -0.536 . . . . 64.21 110.875 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 28.8 mm-40 -95.8 156.71 16.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.042 0.449 . . . . 74.33 110.936 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.24 10.62 1.89 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.111 0.481 . . . . 55.44 111.929 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -136.3 9.31 3.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.418 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 150.15 178.35 24.98 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.492 -0.385 . . . . 63.43 112.811 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.86 125.83 48.51 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.96 -0.729 . . . . 61.12 111.608 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.495 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 62.7 m-85 -78.68 119.02 21.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.918 0.389 . . . . 74.31 111.451 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.84 132.22 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.837 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.09 119.18 32.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.917 0.389 . . . . 74.1 111.412 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 3' ' ' VAL . 78.7 mt -89.1 -17.32 29.49 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.106 0.479 . . . . 71.33 110.959 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 39.7 t30 -157.52 162.27 38.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.596 -0.729 . . . . 60.31 109.738 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' HE21 ' A' ' 28' ' ' GLN . 38.6 tt0 -53.89 -35.42 61.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.855 0.317 . . . . 64.03 111.855 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' A' ' 27' ' ' GLU . 23.5 mm-40 -110.13 19.05 19.36 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.158 0.429 . . . . 73.41 112.158 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 26' ' ' ASN . 99.4 t -132.54 125.71 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.081 0.467 . . . . 74.32 112.05 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 134.14 38.46 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.657 -0.701 . . . . 74.23 110.861 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' PHE . . . -133.11 -169.32 12.15 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.862 -0.685 . . . . 73.41 113.487 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.6 122.1 21.85 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.02 0.438 . . . . 63.51 111.475 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.681 HD21 ' SD ' ' A' ' 38' ' ' MET . 53.0 tp -93.99 123.51 37.4 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.796 0.439 . . . . 74.0 110.964 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 38' ' ' MET . 99.5 mtt180 -84.29 146.81 48.71 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.712 0.634 . . . . 71.42 112.712 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HG3' HD11 ' A' ' 43' ' ' LEU . 16.6 Cg_exo -63.8 -42.42 20.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.737 2.291 . . . . 74.32 113.032 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 58.3 mtt-85 -69.45 -20.83 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.141 -0.481 . . . . 71.25 112.268 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.711 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.6 m-20 -97.35 10.82 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.143 0.497 . . . . 64.31 111.696 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.681 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -88.72 104.75 17.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.403 . . . . 64.41 111.074 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 mm -68.69 -67.69 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.199 0.444 . . . . 60.32 112.199 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.8 p -94.3 -46.09 7.2 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.19 0.441 . . . . 51.14 112.19 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 38' ' ' MET . 84.4 mt -82.3 154.15 25.47 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.384 0.612 . . . . 60.23 112.554 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 20.2 mmt85 -114.22 147.36 39.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.646 -0.706 . . . . 71.32 109.829 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 35' ' ' PRO . 53.6 mt -54.95 -31.41 60.49 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.544 0.688 . . . . 64.25 109.805 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.7 -21.38 60.53 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.025 -0.989 . . . . 74.42 112.083 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -112.22 2.93 16.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.93 0.344 . . . . 53.34 111.93 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 30.9 mt -92.2 135.76 33.74 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.959 0.409 . . . . 41.33 111.287 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.69 148.87 42.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.032 0.444 . . . . 75.43 111.211 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 15' ' ' ARG . 98.3 t -58.32 112.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.413 -0.358 . . . . 71.31 111.005 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.92 -10.43 18.26 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.127 -0.559 . . . . 54.13 113.689 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.57 129.42 38.24 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 117.564 0.682 . . . . 75.34 111.942 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.21 123.59 30.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.421 -0.354 . . . . 74.53 110.8 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 46' ' ' LEU . 57.6 mt -127.98 141.41 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.945 0.402 . . . . 63.12 111.895 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.67 121.3 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.248 -0.433 . . . . 71.34 110.454 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.73 146.58 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.375 0.607 . . . . 72.02 112.398 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.4 tt0 -96.65 126.79 42.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.11 -0.495 . . . . 74.04 110.087 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HD1' ' A' ' 68' ' ' PHE . . . -69.54 120.09 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.632 0.253 . . . . 54.44 111.527 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.3 mt -78.11 -63.44 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.182 0.515 . . . . 73.42 110.629 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 m-20 -131.22 128.84 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 71.44 111.563 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 66' ' ' ILE . 48.0 t -115.73 103.82 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.208 -0.664 . . . . 74.43 109.208 170.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 64.2 mtt180 -125.19 97.61 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.177 0.436 . . . . 75.1 112.177 -171.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 22.7 Cg_endo -61.26 -23.88 77.84 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.789 2.326 . . . . 73.33 112.761 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 12.9 pt-20 -54.12 -33.96 59.08 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.44 0.638 . . . . 72.21 111.107 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 13.2 mmmm -116.84 -6.23 11.51 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 63.24 111.33 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 58.41 25.9 13.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.183 0.516 . . . . 63.42 111.444 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.68 141.34 36.62 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.988 -0.551 . . . . 73.41 111.01 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 59' ' ' VAL . 65.4 mt -134.37 116.71 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.264 -0.425 . . . . 60.14 110.521 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.78 138.99 31.88 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.602 0.239 . . . . 43.21 111.464 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 56' ' ' ALA . 18.9 m-85 -118.47 159.84 22.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.176 0.512 . . . . 74.34 112.218 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 37' ' ' ASP . 39.1 ttpt -136.3 146.65 46.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.742 -0.663 . . . . 62.25 110.88 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -88.92 137.01 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.74 0.305 . . . . 71.32 110.242 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 55' ' ' GLN . 17.0 pt -132.41 144.3 52.44 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.421 0.526 . . . . 64.23 112.421 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.3 144.58 41.67 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.616 2.21 . . . . 62.32 112.739 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -88.47 130.27 35.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.335 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.082 -0.508 . . . . 63.24 111.904 178.277 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.601 0.239 . . . . 73.21 111.432 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -90.52 155.55 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.893 0.378 . . . . 73.45 111.111 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 29' ' ' VAL . 84.3 t -127.16 132.13 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.091 0.472 . . . . 64.32 111.72 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.03 149.8 51.96 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.128 -0.487 . . . . 54.24 110.961 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.33 103.21 0.15 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.611 2.207 . . . . 75.22 112.926 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.26 6.2 9.99 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.449 -0.405 . . . . 65.35 113.643 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.82 153.46 19.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.263 0.532 . . . . 74.04 111.961 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' CD1' HD13 ' A' ' 71' ' ' ILE . 91.9 m-85 -98.38 132.23 44.02 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.612 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -145.21 146.8 31.88 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.356 0.598 . . . . 72.14 112.199 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -95.68 114.45 26.2 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.019 -0.537 . . . . 73.43 110.196 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 170.08 16.57 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.846 -0.693 . . . . 65.11 113.465 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.09 140.96 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.969 0.414 . . . . 64.03 111.864 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.97 129.02 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.295 -0.411 . . . . 74.33 111.599 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -92.86 -54.41 3.76 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.147 0.425 . . . . 73.11 112.147 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -152.93 156.65 39.31 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.819 0.342 . . . . 64.52 111.203 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.49 121.2 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.903 0.382 . . . . 71.3 111.708 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -104.0 172.5 6.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 75.24 111.613 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -77.17 -20.44 55.44 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.155 0.502 . . . . 64.34 111.36 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -111.68 10.65 21.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.236 -0.438 . . . . 75.15 112.071 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.55 -154.33 25.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.169 -0.538 . . . . 75.34 112.879 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.74 137.37 31.59 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.407 -0.466 . . . . 73.14 111.182 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.71 127.71 33.21 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 64.31 111.323 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.33 133.61 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.381 -0.372 . . . . 73.44 111.582 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -95.71 117.19 30.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.511 -0.313 . . . . 64.21 110.698 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.93 -29.27 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.712 0.767 . . . . 60.41 110.025 173.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -155.08 163.36 40.37 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.225 -0.898 . . . . 73.53 109.551 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -46.13 -46.98 17.5 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.949 0.404 . . . . 63.44 112.058 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.32 2.25 55.85 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.655 0.613 . . . . 72.33 112.655 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 3' ' ' VAL . 61.3 t -123.14 112.44 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.366 0.506 . . . . 15.42 112.366 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -129.11 149.0 51.1 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.162 -0.472 . . . . 65.0 111.308 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -150.69 -169.97 17.23 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.237 -0.506 . . . . 72.25 113.288 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -127.17 133.58 50.29 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.002 0.429 . . . . 71.12 111.967 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' A' ' 38' ' ' MET . 52.6 tp -113.66 126.52 55.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.266 -0.425 . . . . 71.0 110.711 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 38' ' ' MET . 63.3 mtt-85 -105.72 149.14 37.58 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 112.18 0.437 . . . . 74.21 112.18 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.76 -30.02 89.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.801 2.334 . . . . 53.22 113.552 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -68.78 -19.75 64.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.992 0.425 . . . . 73.41 111.647 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.09 7.39 44.67 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.211 0.529 . . . . 72.23 111.273 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.676 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.1 mmm -99.64 120.55 39.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.194 -0.457 . . . . 75.12 111.488 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.584 HG13 ' HD3' ' A' ' 72' ' ' PRO . 43.3 mm -77.56 -59.02 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.056 0.391 . . . . 71.24 112.056 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 t -107.0 -43.22 4.7 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.607 0.595 . . . . 62.12 112.607 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 46' ' ' LEU . 75.1 mt -85.43 118.11 24.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.709 0.633 . . . . 72.21 112.709 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -89.57 158.47 17.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.483 -0.326 . . . . 65.45 111.019 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.4 mt -55.81 -34.09 65.02 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.311 0.577 . . . . 63.34 110.926 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -62.76 -19.55 64.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.414 -0.812 . . . . 70.43 111.849 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -104.51 -6.08 20.96 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.438 -0.346 . . . . 65.32 111.66 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 41' ' ' LEU . 35.9 mt -86.75 139.92 30.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.99 0.424 . . . . 53.32 111.582 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -120.9 147.76 44.98 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.186 -0.461 . . . . 70.54 110.919 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 112.75 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.158 0.504 . . . . 70.34 110.281 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.77 -6.21 20.31 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.935 -0.65 . . . . 54.32 113.654 -176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -72.15 137.88 47.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.355 0.578 . . . . 61.21 111.359 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -103.4 105.44 15.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.81 -0.632 . . . . 74.23 110.768 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -113.21 142.53 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.196 0.522 . . . . 72.14 112.238 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.0 111.92 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.131 -0.486 . . . . 73.02 110.678 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.48 157.3 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.298 0.571 . . . . 62.34 112.001 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -106.56 133.49 51.17 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.211 -0.449 . . . . 71.53 110.544 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.11 120.33 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.61 -0.268 . . . . 55.02 111.388 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.1 mt -81.66 -68.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.838 0.352 . . . . 53.04 110.992 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' A' ' 57' ' ' ILE . 2.3 m-20 -126.39 141.14 52.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.297 0.57 . . . . 62.25 111.879 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 63.3 t -121.27 105.37 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.591 -0.731 . . . . 71.34 110.299 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -104.09 98.51 13.95 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 112.083 0.401 . . . . 60.35 112.083 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 33.6 Cg_exo -58.77 -36.82 96.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.64 2.226 . . . . 61.41 112.312 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 9.2 pt-20 -50.58 -38.94 48.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.038 -0.528 . . . . 75.44 112.027 175.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.7 mmtm -108.13 -10.56 15.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.389 -0.369 . . . . 74.04 111.652 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 59.52 20.82 9.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.066 0.547 . . . . 74.51 111.089 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -103.77 123.73 47.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.112 -0.495 . . . . 65.0 111.518 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 59' ' ' VAL . 61.2 mt -116.89 127.82 74.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.014 -0.539 . . . . 73.03 111.029 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -94.65 139.14 31.62 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.672 0.272 . . . . 74.45 111.508 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -115.08 167.86 10.44 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.439 0.638 . . . . 73.42 112.068 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.4 ttpt -140.74 142.32 34.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.397 -0.82 . . . . 74.24 110.599 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 53.1 t80 -88.6 128.89 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 110.019 -0.364 . . . . 72.53 110.019 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CD1' ' A' ' 8' ' ' PHE . 42.4 pt -109.89 133.65 20.9 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.316 0.487 . . . . 53.12 112.316 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.584 ' HD3' HG13 ' A' ' 39' ' ' ILE . 73.7 Cg_endo -79.77 87.14 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.142 1.895 . . . . 70.3 111.64 172.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.5 pt? -76.57 152.09 36.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.087 -0.506 . . . . 74.53 112.108 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 115.895 -0.593 . . . . 74.55 111.623 178.052 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.663 0.268 . . . . 75.15 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.22 129.73 32.04 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.946 0.403 . . . . 75.02 110.963 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.07 122.83 52.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.957 0.408 . . . . 71.21 111.41 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -108.49 147.22 35.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.281 -0.418 . . . . 75.03 111.227 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.32 102.62 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.489 2.126 . . . . 75.54 112.492 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.72 -15.08 6.0 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.287 -0.415 . . . . 61.44 113.198 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 11.6 mmpt? -77.07 148.09 36.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.608 0.596 . . . . 72.51 112.608 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.447 ' HD1' ' N ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -94.3 124.63 38.44 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.782 -0.645 . . . . 63.12 110.994 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -138.55 161.04 38.08 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.08 0.467 . . . . 53.1 111.926 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.36 124.41 47.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.299 -0.409 . . . . 51.02 110.416 171.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -125.55 164.87 18.96 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.146 -0.549 . . . . 55.04 112.98 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.73 135.68 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.189 0.519 . . . . 72.03 111.648 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.67 115.92 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.212 -0.449 . . . . 74.4 111.362 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.512 HG21 ' ND2' ' A' ' 24' ' ' ASN . 63.9 p -87.38 -44.86 11.04 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.344 -0.389 . . . . 73.52 111.932 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -154.27 147.64 24.97 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.133 0.492 . . . . 72.34 111.938 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.68 133.21 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.814 -0.63 . . . . 71.21 110.994 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 41.4 mm-40 -123.62 169.08 11.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.957 0.408 . . . . 52.33 111.176 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 6.46 13.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.034 0.445 . . . . 55.01 112.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -134.1 8.4 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.989 0.423 . . . . 61.23 111.397 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.66 -171.86 28.14 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.237 -0.438 . . . . 75.4 112.477 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.15 127.65 44.91 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.595 -0.356 . . . . 73.01 111.266 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 64.9 m-85 -77.0 122.58 25.12 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.073 0.464 . . . . 74.35 110.917 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.88 131.04 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.067 -0.515 . . . . 73.34 111.293 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' ND2' HG21 ' A' ' 14' ' ' THR . 88.9 m-20 -106.11 129.39 54.2 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.962 0.411 . . . . 44.43 110.632 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 11' ' ' GLY . 62.3 mt -81.1 -19.18 44.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.984 0.421 . . . . 74.42 111.166 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -169.78 162.4 9.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.085 -0.507 . . . . 75.11 110.827 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HG2' HE21 ' A' ' 28' ' ' GLN . 39.2 tt0 -47.92 -28.91 2.94 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.989 0.737 . . . . 71.13 112.989 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' A' ' 27' ' ' GLU . 29.8 mm-40 -114.71 14.46 17.53 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.855 0.687 . . . . 73.22 112.855 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.75 122.25 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 112.422 0.527 . . . . 74.43 112.422 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -113.78 134.22 54.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.84 0.456 . . . . 74.11 111.613 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -149.14 179.11 26.22 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.671 -0.776 . . . . 54.13 114.241 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 tp -143.57 132.33 22.59 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.962 0.41 . . . . 54.42 111.479 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -111.6 127.31 55.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.849 0.459 . . . . 72.31 110.329 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 40.7 mtp85 -117.37 148.92 43.7 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.473 0.546 . . . . 72.02 112.473 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD3' HD11 ' A' ' 43' ' ' LEU . 4.0 Cg_endo -49.06 -37.19 37.38 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 123.723 2.949 . . . . 74.12 114.985 -174.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -61.22 -25.99 67.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.945 -0.472 . . . . 63.51 111.647 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 14.8 m-20 -96.84 5.8 49.88 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.743 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 33' ' ' LEU . 99.6 mmm -95.92 118.46 32.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.98 0.419 . . . . 72.4 111.797 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.86 -73.61 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 112.306 0.484 . . . . 75.31 112.306 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -95.68 -3.35 46.22 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.023 0.749 . . . . 53.31 113.023 -173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.0 mt -117.44 140.3 49.77 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.453 0.645 . . . . 71.15 112.689 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -101.83 147.22 26.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.332 -0.849 . . . . 72.21 110.489 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 35' ' ' PRO . 79.9 mt -55.94 -28.29 56.25 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.306 0.574 . . . . 54.24 110.825 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.61 -24.5 67.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.533 -0.758 . . . . 65.04 112.068 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -105.24 -6.95 19.3 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.516 0.561 . . . . 73.14 112.516 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.3 mt -77.41 138.28 39.19 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.099 0.476 . . . . 51.25 111.822 -175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -118.66 142.44 47.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.159 -0.473 . . . . 54.24 111.617 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.54 113.46 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.332 -0.395 . . . . 72.32 110.209 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.47 -3.77 24.9 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.007 -0.615 . . . . 52.45 113.484 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.54 121.85 16.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.215 -0.58 . . . . 71.12 111.44 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.51 99.46 10.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.347 0.594 . . . . 63.34 110.491 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.35 143.17 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.822 -0.626 . . . . 75.21 111.995 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.9 mt -84.46 114.01 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.901 0.381 . . . . 74.2 110.785 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -126.6 165.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.269 0.556 . . . . 72.24 112.053 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.2 tt0 -108.07 134.29 51.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.29 -0.414 . . . . 70.13 110.997 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.0 105.47 7.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.663 0.268 . . . . 62.12 111.435 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 69' ' ' LYS . 43.3 mt -61.73 -71.42 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.894 0.378 . . . . 74.03 111.149 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -129.13 138.04 51.56 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.191 0.519 . . . . 72.44 110.797 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -101.3 105.13 17.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 75.13 109.973 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.4 mtm180 -107.32 96.49 16.0 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 112.19 0.441 . . . . 70.53 112.19 -175.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 36.0 Cg_endo -65.51 -24.37 56.52 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.741 2.294 . . . . 71.14 112.191 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 17.0 pt-20 -57.97 -37.18 73.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.936 -0.575 . . . . 75.34 111.69 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 42.1 mmtm -105.3 -12.45 16.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 74.14 110.919 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 62.94 25.28 14.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.405 0.622 . . . . 72.44 111.221 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.51 133.81 53.21 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.475 -0.784 . . . . 75.43 110.013 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -106.41 132.83 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.76 0.314 . . . . 75.42 110.963 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 19.4 m-20 -84.7 129.72 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.685 0.279 . . . . 73.33 110.745 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 23.9 m-85 -112.61 153.14 28.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.2 0.524 . . . . 74.45 111.873 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 57' ' ' ILE . 37.9 ttpt -131.9 144.91 51.2 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.74 -0.663 . . . . 62.34 110.892 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -87.89 111.81 21.83 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.556 -0.535 . . . . 71.43 109.556 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.735 HD13 ' HB2' ' A' ' 55' ' ' GLN . 23.2 pt -108.61 149.46 39.45 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.253 0.464 . . . . 70.41 112.253 -174.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 109.89 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.229 1.953 . . . . 70.05 111.596 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.42 96.51 1.49 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.079 0.466 . . . . 64.11 110.702 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.834 -0.603 . . . . 72.22 111.512 179.471 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.1 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.524 0.202 . . . . 74.45 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -140.2 141.16 35.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.839 0.352 . . . . 71.2 110.717 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 25' ' ' LEU . 62.6 t -121.91 132.21 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.117 0.485 . . . . 64.33 111.982 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.75 155.58 54.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.825 -0.625 . . . . 74.43 110.658 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 33.2 Cg_endo -63.63 100.56 0.29 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.289 1.993 . . . . 64.31 112.491 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.79 -13.89 6.07 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.531 -0.366 . . . . 41.25 113.36 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -71.97 152.94 42.12 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.165 0.507 . . . . 42.13 112.302 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -103.69 123.58 47.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.961 -0.563 . . . . 75.13 111.224 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -145.27 158.4 43.84 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.046 0.45 . . . . 72.21 111.722 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 53' ' ' ILE . 38.3 ttmt -97.16 121.47 39.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.812 0.339 . . . . 65.22 110.424 172.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.06 159.36 15.64 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.934 -0.65 . . . . 54.45 112.999 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -109.39 134.36 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.032 0.444 . . . . 72.32 111.909 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.27 116.22 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.108 -0.496 . . . . 73.53 111.402 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 p -86.95 -50.16 6.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.392 -0.367 . . . . 53.52 111.67 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -152.85 153.95 34.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.133 0.492 . . . . 75.21 111.681 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.61 123.6 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.186 -0.461 . . . . 71.22 111.821 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.11 179.18 4.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.974 -0.557 . . . . 71.44 110.602 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -83.72 -24.08 31.37 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.001 0.429 . . . . 61.01 111.137 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -105.95 -7.27 18.24 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.168 -0.469 . . . . 75.34 112.205 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.25 38.82 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.936 -0.65 . . . . 62.23 113.155 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.51 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.483 -0.422 . . . . 74.42 110.295 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.65 129.72 36.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.321 0.582 . . . . 74.42 111.403 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.8 mt -131.7 128.82 60.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.478 -0.783 . . . . 71.41 111.131 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.86 132.59 52.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.31 111.188 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 3' ' ' VAL . 66.0 mt -91.46 -32.04 15.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.185 0.516 . . . . 72.0 110.796 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 56.0 t30 -158.14 170.41 22.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.791 -0.64 . . . . 73.12 110.613 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -38.0 -60.31 0.76 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.549 0.74 . . . . 74.41 112.944 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -98.19 9.06 43.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.809 0.67 . . . . 75.41 112.809 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.96 102.04 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.9 -0.5 . . . . 72.12 111.937 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.11 147.22 32.78 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.712 -0.676 . . . . 72.43 111.124 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -151.81 179.51 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.045 -0.598 . . . . 72.42 113.765 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.8 tp -138.8 127.92 24.01 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.062 0.458 . . . . 73.21 111.486 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.767 HD21 ' SD ' ' A' ' 38' ' ' MET . 57.4 tp -97.64 135.38 39.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.74 0.416 . . . . 71.24 110.991 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -109.22 146.35 33.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-O 120.774 0.321 . . . . 61.52 111.807 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HD3' HD11 ' A' ' 43' ' ' LEU . 35.5 Cg_endo -64.71 -44.53 10.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.26 2.64 . . . . 61.05 115.383 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -71.62 -17.8 62.25 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.783 -0.573 . . . . 72.52 111.971 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -89.17 7.65 34.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.301 0.572 . . . . 72.22 111.03 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.767 ' SD ' HD21 ' A' ' 33' ' ' LEU . 88.9 mmm -91.31 165.8 13.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.691 -0.686 . . . . 74.11 110.946 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 47.9 mm -110.57 -80.46 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 120.747 0.308 . . . . 73.41 111.345 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -90.37 -45.37 9.06 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.115 0.483 . . . . 73.53 111.862 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.02 132.89 36.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.094 0.473 . . . . 65.05 112.072 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 29.9 mmt180 -100.4 163.7 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.113 -0.494 . . . . 72.43 109.89 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD11 ' HD3' ' A' ' 35' ' ' PRO . 62.5 mt -52.85 -39.09 62.26 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.587 0.708 . . . . 61.1 110.499 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -60.6 -27.75 67.97 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.842 -1.072 . . . . 74.53 111.999 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -94.25 -10.57 32.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.833 0.349 . . . . 72.03 111.577 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 42' ' ' ARG . 52.4 mt -79.36 128.29 33.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.254 0.55 . . . . 70.22 111.074 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.02 152.52 22.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.143 -0.48 . . . . 73.43 111.18 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.95 115.55 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.915 0.388 . . . . 74.03 110.773 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.53 -12.49 18.58 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.919 -0.658 . . . . 45.23 113.686 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.29 113.44 4.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.433 0.617 . . . . 73.51 111.874 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -91.23 102.56 15.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.09 0.471 . . . . 74.22 110.502 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.2 mt -110.44 144.48 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.041 -0.527 . . . . 62.1 111.609 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 64.3 mt -83.2 111.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.987 0.422 . . . . 74.31 110.511 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.13 154.76 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.213 0.53 . . . . 72.24 111.911 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . 61.8 tt0 -103.35 131.8 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.091 -0.504 . . . . 74.43 110.362 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 117.47 13.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.748 0.309 . . . . 74.54 111.679 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.18 -68.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.114 0.483 . . . . 73.42 110.633 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 47.2 m-20 -130.57 135.29 47.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.161 -0.472 . . . . 74.0 111.939 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 96.6 t -108.47 103.34 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.371 -0.974 . . . . 73.35 108.371 166.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -103.05 98.5 11.79 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.114 -0.494 . . . . 73.55 111.537 -169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.35 -36.7 43.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.07 2.514 . . . . 63.53 113.401 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 10.3 pt-20 -55.04 -34.11 63.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.221 0.534 . . . . 72.42 111.294 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 14.1 mmmm -107.27 -11.6 15.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.071 -0.513 . . . . 73.33 111.973 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 54.29 31.62 14.65 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 74.53 111.79 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -106.93 141.37 38.25 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 61.53 110.801 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.16 121.2 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.803 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -105.42 141.81 36.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.905 0.383 . . . . 72.13 111.55 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' HA3' ' A' ' 31' ' ' GLY . 30.9 m-85 -113.13 166.0 11.85 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.57 0.7 . . . . 72.31 112.533 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -134.35 146.84 50.31 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.246 -0.888 . . . . 73.31 110.388 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.639 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 59.9 t80 -88.09 115.05 25.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.031 0.443 . . . . 73.54 110.913 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 55' ' ' GLN . 21.7 pt -110.56 150.06 41.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.145 -0.48 . . . . 73.04 111.729 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.71 92.48 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 50.03 113.424 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.4 pt? -71.5 151.43 43.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.99 0.424 . . . . 64.31 111.175 175.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.368 -0.825 . . . . 73.22 112.464 -177.068 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 111.889 0.329 . . . . 73.05 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -107.89 158.55 17.24 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.837 -0.431 . . . . 71.21 109.837 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HD12 ' A' ' 25' ' ' LEU . 90.3 t -106.58 144.29 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 113.216 0.821 . . . . 71.41 113.216 -170.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.74 144.98 31.74 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.725 -0.67 . . . . 62.12 111.282 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.81 139.21 56.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.504 2.136 . . . . 53.32 112.789 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.41 7.31 87.97 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 114.327 0.491 . . . . 64.52 114.327 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -107.08 164.26 12.3 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.865 0.832 . . . . 73.23 113.066 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -91.45 127.91 37.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.262 -0.881 . . . . 72.51 111.501 -174.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 3' ' ' VAL . 97.6 m-85 -142.16 163.46 32.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.393 0.616 . . . . 73.2 112.452 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.94 127.28 51.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.049 -0.523 . . . . 65.51 110.854 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -136.61 173.63 21.96 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.827 -0.701 . . . . 54.24 113.535 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.22 138.47 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.881 0.372 . . . . 74.14 111.625 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.46 128.58 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.028 0.381 . . . . 73.44 112.028 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.1 p -101.88 -57.1 2.13 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.059 0.392 . . . . 75.05 112.059 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -141.25 144.68 34.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.127 0.489 . . . . 65.33 111.671 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.7 mm -97.21 108.09 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.047 -0.524 . . . . 71.35 111.613 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 20.3 mm-40 -94.85 151.19 19.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.356 -0.609 . . . . 72.33 109.356 172.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -65.19 -11.68 43.18 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.957 -0.464 . . . . 72.55 112.071 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -110.26 1.66 18.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 111.936 0.347 . . . . 73.42 111.936 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . . . 153.87 159.3 9.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.975 -0.631 . . . . 50.22 113.436 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.67 128.46 52.74 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.076 -0.661 . . . . 71.51 111.325 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HE1' ' HG3' ' A' ' 17' ' ' GLU . 51.1 m-85 -76.5 126.25 30.65 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.047 0.451 . . . . 75.1 111.093 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.8 136.15 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.26 -0.427 . . . . 70.04 111.79 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.8 125.77 48.54 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.487 -0.324 . . . . 65.24 110.812 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 3' ' ' VAL . 79.5 mt -89.56 -17.73 27.97 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.091 0.472 . . . . 75.32 110.83 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -164.48 161.94 21.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.488 -0.778 . . . . 75.23 109.377 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG2' HE21 ' A' ' 28' ' ' GLN . 42.6 tt0 -52.96 -36.69 60.34 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 73.31 112.036 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.422 HE21 ' HG2' ' A' ' 27' ' ' GLU . 28.4 mm-40 -99.0 11.27 39.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.105 0.409 . . . . 54.23 112.105 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 3' ' ' VAL . 78.4 t -131.0 120.61 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.616 0.598 . . . . 70.12 112.616 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 4.3 ttp180 -125.53 148.8 48.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.834 -0.621 . . . . 54.35 110.79 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 30' ' ' ARG . . . -153.55 -169.49 18.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.9 -0.667 . . . . 63.34 113.264 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.6 tp -135.18 135.42 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.91 0.386 . . . . 72.12 111.299 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.687 HD21 ' SD ' ' A' ' 38' ' ' MET . 66.6 tp -117.13 113.08 21.76 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.597 0.359 . . . . 73.21 110.552 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -93.78 145.38 29.79 Favored Pre-proline 0 CA--C 1.537 0.466 0 O-C-N 122.076 -0.39 . . . . 65.32 111.879 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HD3' HD11 ' A' ' 43' ' ' LEU . 36.9 Cg_endo -62.92 -24.58 74.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.533 2.155 . . . . 64.24 112.764 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.99 -9.54 59.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.951 -0.568 . . . . 63.12 111.165 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -105.92 8.05 32.39 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.213 0.53 . . . . 71.21 110.675 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.687 ' SD ' HD21 ' A' ' 33' ' ' LEU . 98.3 mmm -103.43 127.64 50.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.278 -0.419 . . . . 71.34 111.705 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.4 mm -63.66 -71.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.438 -0.346 . . . . 72.31 111.897 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.5 t -118.66 -26.57 6.1 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.569 0.581 . . . . 73.54 112.569 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 46' ' ' LEU . 83.7 mt -78.33 119.36 21.56 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.974 -0.454 . . . . 72.12 111.479 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -99.55 154.31 18.35 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.069 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 35' ' ' PRO . 84.8 mt -55.36 -28.44 53.92 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.828 0.347 . . . . 53.43 111.775 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.22 -25.75 67.27 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.051 0.453 . . . . 71.13 111.837 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -98.98 -25.76 14.47 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.386 -0.37 . . . . 64.21 111.771 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 38.9 mt -75.24 124.35 26.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.924 0.392 . . . . 71.21 111.656 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 47' ' ' ASN . 0.8 OUTLIER -105.81 163.39 12.76 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.291 0.567 . . . . 51.01 111.177 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.6 t -67.12 114.91 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.46 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.44 -5.22 19.4 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.082 -0.58 . . . . 72.11 114.229 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.09 123.82 24.33 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 117.613 0.707 . . . . 75.45 111.473 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -90.12 102.49 15.2 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.001 0.429 . . . . 71.42 110.822 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 46' ' ' LEU . 53.6 mt -108.06 142.5 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.165 0.507 . . . . 61.42 111.976 -175.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.4 mt -87.77 110.08 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.208 -0.451 . . . . 60.11 110.724 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.06 152.39 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.342 0.591 . . . . 75.2 112.17 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -96.64 125.37 41.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 72.11 110.303 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.1 96.89 2.79 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.532 -0.303 . . . . 72.1 111.143 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 69' ' ' LYS . 53.5 mt -54.67 -69.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.86 0.362 . . . . 72.42 111.609 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -128.05 128.35 44.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.974 0.416 . . . . 65.32 111.333 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 58.2 t -102.69 105.44 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.64 -0.504 . . . . 72.21 109.64 173.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -100.99 97.98 7.84 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.288 -0.414 . . . . 70.12 111.222 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 30.2 Cg_exo -62.55 -47.37 9.52 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.765 2.31 . . . . 71.41 112.684 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 12.9 pt-20 -56.74 -30.37 63.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.65 -0.705 . . . . 74.24 112.654 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 30.7 mmtp -108.63 -10.9 15.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.841 0.312 . . . . 74.54 111.841 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 56.73 38.88 29.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.378 0.608 . . . . 74.2 112.005 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -117.93 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.725 -0.671 . . . . 51.34 110.72 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.7 mt -122.99 119.07 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.525 0.202 . . . . 75.34 110.8 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.26 134.11 34.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.617 0.246 . . . . 71.44 111.015 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 25.1 m-85 -113.5 152.72 29.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.338 0.589 . . . . 64.31 112.178 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB2' HD11 ' A' ' 57' ' ' ILE . 35.8 ttpt -133.81 148.44 51.33 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.644 -0.707 . . . . 71.44 110.093 174.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' HB2' ' SD ' ' A' ' 38' ' ' MET . 40.3 t80 -87.85 123.89 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.563 . . . . 62.54 110.252 176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.9 125.63 32.17 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 71.33 111.389 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.22 83.71 0.59 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.196 1.931 . . . . 54.42 112.478 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.2 pt? -59.34 112.34 1.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.383 0.611 . . . . 72.43 111.197 176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.762 -0.637 . . . . 71.34 112.199 -177.616 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 26' ' ' ASN . 27.4 ttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.712 0.291 . . . . 65.41 111.586 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.19 136.76 21.56 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.14 110.598 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 59' ' ' VAL . 92.4 t -89.25 134.19 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.293 0.568 . . . . 63.33 112.201 -175.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 38.1 mt-10 -125.12 146.79 54.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.694 -0.685 . . . . 74.31 111.188 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 126.1 16.5 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.388 2.059 . . . . 73.42 112.841 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.28 61.75 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 116.366 -0.379 . . . . 72.0 113.559 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 4' ' ' GLU . 75.5 mmtt -88.14 155.91 19.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.236 0.518 . . . . 61.44 112.221 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -96.81 132.58 42.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.029 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -139.7 162.5 34.96 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.269 0.557 . . . . 73.23 112.138 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.64 129.59 54.66 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.115 -0.493 . . . . 50.34 110.025 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . -141.27 175.42 22.32 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.864 -0.684 . . . . 31.33 113.374 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.37 136.42 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.971 0.415 . . . . 74.01 112.048 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 81.8 t -73.59 120.85 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.223 -0.444 . . . . 75.45 111.199 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.5 p -92.74 -55.32 3.42 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.166 0.432 . . . . 72.41 112.166 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -140.95 148.01 39.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.899 0.38 . . . . 71.42 111.674 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.61 107.79 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.265 -0.425 . . . . 72.43 111.51 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 17.7 mm-40 -96.97 155.93 16.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.929 0.395 . . . . 73.33 110.494 173.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.89 -7.39 34.28 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.231 0.456 . . . . 52.14 112.231 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -113.83 5.72 16.4 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.75 0.31 . . . . 61.42 111.756 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . 146.83 168.69 13.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.071 -0.585 . . . . 71.53 113.514 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.35 126.64 52.72 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.619 -0.342 . . . . 73.41 111.253 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HE2' ' HG3' ' A' ' 17' ' ' GLU . 80.1 m-85 -79.26 120.09 23.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.186 0.517 . . . . 71.3 111.376 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.98 133.1 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.868 -0.606 . . . . 74.04 111.99 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.07 122.27 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.338 -0.392 . . . . 62.52 110.975 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD23 ' HA3' ' A' ' 11' ' ' GLY . 81.4 mt -90.49 -20.76 22.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.314 0.578 . . . . 73.44 110.252 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 42.7 t30 -164.12 161.26 22.26 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.407 -0.815 . . . . 72.42 109.588 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' HE21 ' A' ' 28' ' ' GLN . 43.9 tt0 -47.55 -40.73 19.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.114 0.483 . . . . 62.42 112.16 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.428 HE21 ' HG2' ' A' ' 27' ' ' GLU . 27.6 mm-40 -100.67 10.58 40.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.406 0.521 . . . . 73.45 112.406 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.43 119.55 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -135.16 139.17 44.38 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.98 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.5 -174.26 13.35 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.372 -0.442 . . . . 62.23 113.074 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.2 tp -123.22 124.43 43.01 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.065 0.459 . . . . 74.25 112.033 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 54' ' ' VAL . 40.9 tp -104.49 113.47 27.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.4 -0.364 . . . . 73.21 110.592 175.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -88.78 142.68 30.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 71.23 111.816 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 36.1 Cg_endo -62.36 -32.04 81.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.983 2.455 . . . . 74.22 113.374 -174.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -65.35 -27.84 68.87 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.952 0.405 . . . . 75.43 111.404 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.64 12.14 19.9 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.353 0.597 . . . . 52.44 111.392 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.436 ' HA ' ' HB3' ' A' ' 70' ' ' TYR . 8.3 mmt -85.19 162.3 19.25 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.932 -0.577 . . . . 75.02 111.682 174.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.35 -56.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.281 -0.418 . . . . 71.34 111.104 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -111.65 -42.4 3.85 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.192 0.442 . . . . 71.33 112.192 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' HD21 ' A' ' 46' ' ' LEU . 84.3 mt -80.3 138.01 36.68 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.708 0.633 . . . . 62.0 112.708 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -115.9 151.52 35.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.502 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 35' ' ' PRO . 86.3 mt -52.33 -35.01 49.76 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.003 0.43 . . . . 70.22 111.653 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -57.2 -20.09 24.74 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.757 -0.656 . . . . 63.34 112.639 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -113.23 -5.33 13.64 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.599 0.592 . . . . 74.24 112.599 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 41' ' ' LEU . 48.4 mt -82.8 146.02 29.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.085 0.469 . . . . 64.35 111.903 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -123.25 153.79 39.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.182 0.515 . . . . 45.03 111.151 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.34 113.3 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.279 -0.419 . . . . 71.24 110.401 174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.15 -12.53 16.87 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.889 -0.672 . . . . 60.31 113.543 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -63.23 124.25 20.74 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.252 0.526 . . . . 75.14 111.599 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -89.31 108.41 19.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.665 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.7 mt -114.14 139.24 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.203 0.525 . . . . 73.01 112.267 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -84.75 121.1 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.581 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 33' ' ' LEU . 28.8 m -134.38 153.45 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.384 0.611 . . . . 65.05 112.322 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HB2' HD13 ' A' ' 71' ' ' ILE . 64.1 tt0 -104.52 133.89 48.63 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.941 -0.572 . . . . 65.34 110.43 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.6 106.64 5.46 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.74 0.305 . . . . 71.54 111.537 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 67' ' ' ASP . 48.6 mt -64.48 -70.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.982 0.42 . . . . 63.23 111.492 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -127.86 139.44 52.62 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.43 -0.35 . . . . 54.14 110.651 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 66' ' ' ILE . 59.8 t -127.77 104.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.387 -0.369 . . . . 74.43 110.7 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 64.5 mtp180 -119.41 100.72 49.58 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 120.543 0.211 . . . . 71.11 111.155 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 12.4 Cg_endo -54.6 -31.76 71.72 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.846 2.364 . . . . 73.11 112.638 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 15.1 pt-20 -59.12 -35.24 73.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.118 -0.492 . . . . 63.23 111.681 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 9.9 mmpt? -93.67 -17.55 23.12 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.557 -0.292 . . . . 64.1 111.133 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 64.14 19.28 11.7 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.927 0.491 . . . . 72.33 111.267 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.32 137.21 52.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.077 0.465 . . . . 72.24 111.544 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 59' ' ' VAL . 64.7 mt -128.71 117.64 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.737 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 36.5 m-20 -86.08 138.8 31.67 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.922 0.392 . . . . 73.13 111.306 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.71 156.01 23.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.222 0.534 . . . . 75.3 111.513 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -134.72 145.45 48.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.766 -0.652 . . . . 63.41 110.612 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' A' ' 38' ' ' MET . 36.9 t80 -88.16 122.15 31.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.749 -0.463 . . . . 75.55 109.749 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 55' ' ' GLN . 20.1 pt -119.19 148.52 45.27 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.652 0.612 . . . . 55.21 112.652 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.53 127.8 16.17 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.756 2.304 . . . . 61.04 111.569 172.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.14 97.42 4.1 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.858 0.361 . . . . 72.05 110.821 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.688 -0.672 . . . . 62.51 111.208 175.178 . . . . . . . . 0 0 . 1 stop_ save_